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Chapter I 
 
FREE RADICALS, LIPID PEROXIDATION, AND THE LINK TO HUMAN PATHOLOGIES 
 
1.1. Introduction 
Lipids are loosely defined as a group of naturally occurring organic compounds which are 
hydrophobic or amphipathic in nature, but which are also readily soluble in organic solvents.1 
These solubility features are present in an extremely heterogeneous collection of molecules such 
as fatty acids, phospholipids, eicosanoids, and sterols.2 Some selected structures are shown in 
Figure 1. 
 
 
The functions of various lipids are as diverse as their structure (Figure 1). For instance, 
arachidonic acid is a polyunsaturated fatty acid (PUFA) that can be found in a variety of 
phospholipids and that plays an important role in cellular signaling.3 It is also a substrate for 
cyclooxygenase-2 (COX2) which synthesizes prostaglandin H2 (PGH2) in response to 
Figure 1. Selected lipids. 
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environmental stress.4,5,6 1-Palmitoyl-2-oleoyl-sn-glycero-phosphocholine (POPC) is a member of 
the phosphatidylcholine class, which is a major component of biological membranes. Cholesterol 
is an essential component of animal cell membranes, providing structural integrity and fluidity; it 
also serves as a precursor to the biosynthesis of bile acids and steroid hormones.7  
Many lipids are susceptible to free radical oxidation and degradation in the presence of 
reactive oxygen species (ROS)8 and reactive nitrogen species (RNS).9 The oxidation of lipids has 
physiological consequences ranging from the breakdown of lipid bilayers to inflammation and the 
progression of human disease states such as Parkinson’s disease (PD)10, 11 and atherosclerosis.12,13  
The aim of this introductory chapter is to provide an overview of free radicals, the free 
radical oxidation of lipids, and a description of how the rate constants for these processes are 
measured. The links between the oxidation of lipids and the progression of various human 
pathologies will also be discussed. 
1.2. Historical Background 
 Around the year 1800, Swiss chemist Theodore de Saussure conducted the first recorded 
experiments concerning lipid oxidation.  Armed with a primitive mercury manometer, de Saussure 
was able to observe a layer of walnut oil absorb nearly 150 times its own volume of oxygen over 
a one year period.14 This was the first instance in which oxygen was implicated in a reaction with 
some constituent of the oil.  However, its involvement in free radical mediated processes was at 
least a century away from being fully understood. 
 Evidence for the existence of the free radical species was first reported in the literature in 
1900 by Gomberg in his article in the Journal of the American Chemical Society outlining the 
existence of the triphenylmethyl radical.15  The discovery came about during attempts to synthesize 
hexaphenylethane with the intent to study stereochemical aspects attached to the compound. 
3 
 
Gomberg made a number of experimental observations that ultimately pointed to the existence of 
the triphenylmethyl radical: 
1. Zinc abstracts the halogen atom from the precursor triphenylchloromethane to give the 
carbon centered radical; 
2. The formed radical is stable in both solution and dry crystalline state for weeks under 
an inert atmosphere; 
3. Oxygen adds to triphenylmethane to give a peroxide; 
4. Triphenyliodomethane is formed from triphenylchloromethane in the presence of 
iodine; 
 Gomberg unequivocally reserved the field for himself at the end of the article, and he would 
eventually come to be known as the father of organic free radical chemistry. 
 Nearly twenty years after Gomberg’s landmark paper, many aspects of peroxidation began 
to emerge.  It was found that linoleic acid (LA) oxidized at a higher rate than oleic acid,16 and two 
years later that linolenic acid oxidized faster than LA.17  The mechanism of oxidation continued 
to be explored in the years after Stephens’ successful isolation of a cyclohexene derived peroxide.18  
1.3. Free Radicals  
As it is understood today, a free radical is an atom, molecule, or ion that has an unpaired 
valence electron residing in one of its electronic orbitals.  According to the Pauli principle, this 
lone electron has a magnetic moment that can be expressed by a quantum number of + ½ or – ½, 
making the radical paramagnetic in nature.  The stability of carbon free radicals mirrors that of 
carbocations, with a stability hierarchy of 3˚ > 2˚ > 1˚, with conjugation resulting in further 
stabilization.  Relative stability for various organic compounds may also be discerned by studying 
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bond dissociation enthalpy (BDE) (Figure 2).  In general, as the BDE of the bond being broken 
increases, the stability of the resulting radical decreases.19  
 
 
 
  
Free radicals can be formed through a homolysis (bond breaking event) in which the pair 
of electrons comprising the bond are split evenly and each fragment retains one electron (Figure 
2). An electron transfer can also occur to give a radical species and a charged species.   This can 
be spontaneous in nature as some compounds are inherently unstable, but more often an external 
perturbation is required for the generation.  These events can include irradiation, heat, natural 
biological processes (i.e. electron transport chain),20 or a biological response to various 
environmental stimuli.21,22,23,24 
1.3.1. Free Radical Oxidation 
 As the 20th century progressed, production-line assembly of vehicles and two world wars 
spurred the West’s appetite for rubber. The British Rubber Producers Research Association 
(BRPRA) was born out of these unique pressures. Bolland and Gee carried out a number of studies 
on the oxidation of polyunsaturated fatty acids and other related isoprenoids at the BRPRA during 
the ‘40s and early ‘50s.25 Their work on ethyl linoleate outlined a mechanism for the autoxidation 
of this compound in which a hydrogen atom is abstracted from the center carbon flanked on either 
side by an olefin, a process resulting in a conjugated pentadienyl radical with three resonance 
structures.  Molecular oxygen from the atmosphere adds to this radical to give conjugated peroxyl 
Figure 2. Bond Dissocation Enthalpy 
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radicals which then propagate the chain reaction through another hydrogen atom transfer as shown 
in Figure 3.26   
  
Interest in the free radical oxidation of lipids increased in the last five decades as scientists 
began to discover the role of free radicals in various areas of biological interest27 including radical 
production by enzymes,28 photosynthesis,29,30 and the superoxide anion radical.31,32 Lipid 
peroxidation has been intrinsically linked to human pathologies such as heart disease,33,34 
environmental exposures,35 neurodegenerative disorders,36,37 cancer,38,39 and diabetes.40  
 The autoxidation of lipids and other organic compounds results in the buildup of peroxides 
which can initiate chain reactions under certain conditions, a process that leads to the consumption 
of oxygen as further peroxide products are formed. The process follows three separate steps: 
initiation, propagation, and termination (Figure 4).  
Figure 3. Autoxidation of methyl linoleate. 
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1.3.2. Initiation of Autoxidation  
The first step of free radical chain oxidation is initiation, in which a carbon centered radical 
is formed. In biological systems, the initiation event can occur through a variety of environmental 
events. These include UV-light, ionizing radiation, or chemical species found in air pollution. The 
initiating event may also be sparked via enzymatic means such as cytochrome P450s, xanthine 
oxidase, or a variety of other enzymes. 
 In order to study these mechanistically complex reactions, solution oxidations have been  
carried out to remove or control variables associated with initiation events. Under these controlled 
laboratory conditions, it is desirable to generate a consistent stream of free radicals at a well 
defined rate for the reaction being studied. Azo initiators have filled this role for the following 
reasons: 
1. Azo initiators decompose by first-order kinetics under most conditions 
2. Water and lipid soluble initiators are widely available 
3. Initiators can be tailored to fit particular temperature regimes 
4. Peroxyl or alkoxyl radical species are produced 
Figure 4. General scheme for the autoxidation of lipids 
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Azo initiators decompose thermally to give molecular nitrogen and a pair of radicals 
(Figure 5A). The radical formed after decomposition may be carbon centered, as is the case with 
AAPH, AMVN, AIBN, and MeOAMVN (Figure 5B). Once decomposition occurs, the resulting 
carbon-centered alkyl radicals readily add molecular oxygen to give two peroxyl radicals. These 
peroxyl radicals then initiate the free radical chain reaction by abstracting hydrogen from 
neighboring organic compounds to give new carbon centered radicals. 
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Figure 5. Azo initiators are used to generate a consistent stream of free radicals at a 
well-defined rate and are commonly used in solution oxidations of organic 
compounds. A. Scheme for decomposition of azo initiators; B. Selected azo initiators. 
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1.3.3. Propagation of Autoxidation 
 Once a carbon-centered radical is formed, propagation usually occurs through the two steps 
shown in Figure 6. In the first step molecular oxygen adds to the newly formed carbon-centered 
radical to give a peroxyl radical. This addition occurs at the diffusion controlled rate constant when 
oxygen pressures are above 100 mmHg.41 Subsequent steps occur at rates slower than oxygen 
addition, thus the peroxyl radical is the predominant radical species present during autoxidation.42  
 The second step in propagation occurs when the newly formed peroxyl radical abstracts 
hydrogen from a reactive molecule. This step is bound by parameters that result in a much slower 
reaction rate when compared to the addition of oxygen to the carbon centered radical. Thus, H-
atom abstraction is considered to be the rate-determining step for the peroxidation process. 
Measurement of the propagation rate constant (kp) provides insight to the oxidizability of the 
compound being interrogated. 
 
  
 
 
 
 
Peroxyl radicals can also undergo addition to carbon-carbon double bonds as shown in 
Figure 7. Once the peroxyl radical adds, a new carbon centered radical is formed to which oxygen 
can rapidly add to generate a new peroxyl radical. This type of reaction is commonplace in 
copolymerizations of compounds such as styrene and oxygen.40,43  
 
Figure 6. Peroxyl radical formation and hydrogen atom abstraction 
(kp) occurring during propagation. 
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1.3.4. Termination of Autoxidation 
 Generally, termination involves the coupling or disproportionation of two radicals in 
solution to generate non-radical products. This can occur through a stepwise Vaughan 
termination42 or a cyclic, concerted reaction of an intermediate tetroxide known as a Russell 
termination,43 both shown in Figure 8. 
 
 
 
 
 
 
 
 
 
 
Figure 7. A. Addition of a peroxyl radical to a double bond; B. Copolymerization of 
Styrene with Oxygen.39,40,41,43 
Figure 8. Schemes for Vaughan and Russell Termination.42,43 
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1.4. Lipid Peroxidation 
 Lipid peroxidation is defined as the autoxidation of any lipid species. Compounds 
containing weak C-H bonds undergo rapid autoxidation.44 Thus, PUFAs are very susceptible to 
radical attack due to the presence of homo-conjugated double bonds (or bis-allylic methylene 
groups).45 Radical attack preferentially occurs at these sites due to the low bond dissociation 
enthalpy (BDE) of the bis-allylic methylene C-H bond (75 kcal/mol) compared to an allyl (≈ 88 
kcal/mol) C-H bond.46 This lower BDE is a consequence of the formation of a stabilized 
pentadienyl radical in which the radical is delocalized across five carbon atoms. Certain sterols are 
also prone to peroxidation. The primary examples are 7-dehydrocholesterol47 (7-DHC) and 8-
dehydrocholesterol39 (8-DHC), both of which give highly stabilized pentadienyl radicals after 
hydrogen atom abstraction (Figure 9). 
 
 
 
  
  
 
 
 
 
 
 
 
Figure 9. Pentadienyl radical formation for PUFAs and sterols 
7-DHC and 8-DHC. 
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1.4.1. Rate Constant Measurements 
 Determination of rate constants has been critical in the understanding and advancement of 
free radical chemistry. Rate constants for the reaction of oxygen centered radicals - particularly 
peroxyl radicals - are of interest since they are the main species present during the autoxidation of 
organic compounds or the peroxidation of lipids. Thus, determining peroxyl radical reaction rates 
has been a focus of chemists for over fifty years. 
Direct Measurement 
 Direct determination of rate constants may be achieved through the use of techniques, 
including the rotating sector method and flash photolysis. The rotating sector method was first 
used in 1937 to measure the mean lifetime of radicals in the polymerization of gaseous methyl 
methacrylate.48 The technique was carried out by interrupting the exciting light produced by a 
water-cooled mercury arc lamp using a rotating slotted disk.48,49 Spinning the disk at a controlled 
speed yields equal periods of light and darkness.49 The overall rate of polymerization depends on 
the sector speed which allows for determination of the average lifetime of free radicals.49 The 
method can be used to measure rate constants in the gaseous or liquid phase50 of any chain reaction 
in which the kinetic chains are broken by a bimolecular reaction between the chain carrying 
species.49  
Indirect Measurement – Radical Clocks 
 The indirect measurement of rate constants can be achieved through the use of radical 
clocks.51,52,53 This type of experiment utilizes a unimolecular radical reaction having a known rate 
constant to determine a bimolecular radical reaction with an unknown rate constant. An example 
of a radical clock is the 5-hexeny radical cyclization shown in Figure 10. The 5-hexenyl radical 
cyclization clock utilizes a competition between a 5-exo-trig cyclization (kR) and hydrogen atom 
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abstraction from some substrate A-H (kH). Kinetic analysis of the mechanism leads to the 
conclusion that the ratio of the products [1]/[2] is proportional to kH/kR. Thus, if kR for the 
unimolecular 5-exo-trig cyclization and the concentration of A-H is known, the rate constant (kH) 
can be determined. In general, the radical clock is very useful for determining rate constants for 
reactions involving carbon centered radicals. A number of clocks have been reported for measuring 
rate constants in the range of 10-1 to 1012 M-1 s-1.51,52,53 
 
 
 
 
 
 
 
 
 
 
Peroxyl Radical Clocks 
 The work reported in this dissertation relies heavily on the peroxyl radical clock developed 
by Roschek et al.54 The clock was developed and calibrated based on the competition between 
intramolecular β-fragmentation (kβ) and intermolecular hydrogen atom abstraction from a donor 
molecule (kH). The clock was based on the autoxidation of methyl linoleate, the mechanism of  
which is shown in Figure 12. It was calibrated with both methyl linoleate and α-tocopherol (Figure 
11), both of which have well established rate constants for their reaction with peroxyl radicals (kH; 
Figure 10. 5-Hexenyl radical cyclization clock. 
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linoleate = 62 M-1 s-1, tocopherol = 3.5 x 106 M-1 s-1).55,56,57,58  These two calibration points have 
made the clock applicable to rate constants in the range of 100 to 107 M-1 s-1.54  
 
  
 
The autoxidation of methyl linoleate results in the buildup of four distinct 
hydroperoxyoctadecadienoic acids, or HpODEs (Figure 12, Compounds 6, 9, 11, 14). These 
hydroperoxides can be classified as the kinetically favored cis,trans-isomers and the 
thermodynamically more stable trans,trans-isomers. The distribution of the kinetic and 
thermodynamic products is dependent on the concentration and reactivity of hydrogen atom donors 
present in solution. 
   
Figure 11. Structures and rate constants for methyl linoleate55,56 and α-tocopherol57,58. 
15 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. The mechanism for autoxidation of methyl linoleate that forms the basis of the 
Linoleate Peroxyl Radical Clock.54 
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Methyl Linoleate Clock 
 The first-formed carbon radical in the autoxidation of linoleate is the delocalized 
pentadienyl radical (2, Figure 12). Oxygen partitions itself across this radical to give the kinetically 
favored nonconjugated (15) and cis,trans-conjugated peroxyl radicals (5 and 10). The 
nonconjugated peroxyl radical (15) undergoes rapid β-fragmentation (kβI). In the absence of an 
excellent hydrogen atom donor such as an antioxidant (i.e. TocH) this fragmentation occurs at a 
rate much faster than hydrogen atom donation (kH), rendering it kinetically invisible. 
 Once 5 or 10 are formed, multiple pathways are accessible depending on the hydrogen 
donating capability of the molecules present in solution. The peroxyl radical can abstract a 
hydrogen atom from another molecule (kH) to give the corresponding kinetically favored cis,trans-
conjugated hydroperoxide. Alternatively, peroxyl radical 5 or 10 can undergo bond rotation 
followed by β-fragmentation (kβIII in Figure 12) to form a new pentadienyl radical (7 or 12) that 
has a cis,trans-configuration. Oxygen can then partition across the transoid or cisoid ends of either 
7 or 12 to give the cis,trans- or trans,trans-peroxyl radicals (5 and 10 or 8 and 13) with partition 
coefficients of β and 1-β, respectively. Hydrogen atom abstraction by these peroxyl radical gives 
the corresponding hydroperoxide. Ultimately, the competition outlined above between 
bimolecular hydrogen atom abstraction/transfer (kH) and uniolecular β-fragmentation of the 
peroxyl radical forms the basis of the peroxyl radical clock. 
 Steady state analysis of the autoxidation of linoleate (Figure 12) leads to Equation 1, in 
which the product distribution (cis,trans- vs. trans,trans-HpODEs) is described as a function of 
oxygen partitioning (β), β-fragmentation (kβII and kβIII), and the concentration of H-atom donor 
([H-donor]).54  
[𝑡𝑟𝑎𝑛𝑠,𝑐𝑖𝑠]
[𝑡𝑟𝑎𝑛𝑠,𝑡𝑟𝑎𝑛𝑠]
=
[𝟔+𝟏𝟏]
[𝟗+𝟏𝟒]
=
𝑘𝐻[𝐻−𝐷𝑜𝑛𝑜𝑟]
𝑘𝛽𝐼𝐼(1−𝛽)
+
𝑘𝛽𝐼𝐼𝐼
𝑘𝛽𝐼𝐼
(
𝛽
1−𝛽
)   ( 1 ) 
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 The methyl linoleate clock was calibrated using methyl linoleate itself, whose β-
fragmentation rate constants and partition coefficients have been determined.54, 59 This allows for 
the use of a simplified kinetic expression given in Equation 2 which relates the 
trans,cis/trans,trans-product ratio and kinetic rate (or propagation rate) constants.47  
 
𝑡𝑟𝑎𝑛𝑠,𝑐𝑖𝑠
𝑡𝑟𝑎𝑛𝑠,𝑡𝑟𝑎𝑛𝑠
=
𝑘𝑝
1[𝑅1−𝐻]
214 𝑠−1
+
𝑘𝑝
2[𝑅2−𝐻]
214 𝑠−1
+
𝑘𝑝
3[𝑅3−𝐻]
214 𝑠−1
+ ⋯ + 0.16  ( 2 ) 
 
Where kp
n and [Rn-H] are the propagation rate constants and concentrations, respectively, for any 
H-atom donor in solution. Equation 2 can be further simplified to give the master Equation 3. 
 
𝑡𝑟𝑎𝑛𝑠,𝑐𝑖𝑠
𝑡𝑟𝑎𝑛𝑠,𝑡𝑟𝑎𝑛𝑠
= ∑
𝑘𝑝
𝑖 [𝑅𝑖−𝐻]
214 𝑠−1
+ 0.16𝑖=1−𝑛     ( 3 ) 
  
As kp[R-H] approaches zero, the boundary limit of Equation 2 represents oxidation 
conditions under thermodynamic control. The trans,cis/trans,trans-product ratio approaches 0.16 
in this instance.47  
 The formation of both trans,cis- and trans,trans-products results in the accumulation of 
these UV active compounds that can be separated using normal phased high performance liquid 
chromatography. If the ratio of trans,cis/trans,trans-products is plotted versus the concentration 
of H-atom donor present in solution, the slope of the resulting plot is proportional to kp[R-H], 
which can be used to solve for the propagation rate constant. 
Oxygen Consumption and Oxidizability 
Another method used for the indirect measurement of peroxidation rate constants involves 
the measurement of oxygen consumption. The method relies on the fact that as autoxidation of a 
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compound occurs, molecular oxygen will be ‘transferred’ from the surrounding medium to the 
forming peroxides. This consumption of oxygen is measured through the use of a Clark electrode 
that contains a catalytic platinum surface where the partial pressure of oxygen (pO2) is measured 
via Equation 4 below: 
 
𝑂2 + 4 𝑒
− + 2 𝐻2𝑂 → 4 𝑂𝐻
−    ( 4 ) 
 
The apparatus contains two bulbs in which Clark electrodes are inserted. One acts as the reaction 
vessel, the second as the reference cell. Both contain atmospheric pressures of O2. The bulbs are 
submerged in a water bath which is held at a constant temperature and shaken vigorously. The 
change in pO2 is reported using an integrator and is indicative of oxygen consumption. A schematic 
for the instrument can be seen in Figure 13. 
 
 
  
 
 
 
 
 
 
 
 
Figure 13. Oxygen consumption apparatus. 
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Under steady state analysis of the autoxidation of a PUFA of interest, the rate of oxygen 
consumption is given by Equation 5: 
 
−𝑑[𝑂2]
𝑑𝑡
= {
𝑘𝑝
√2𝑘𝑡
} [𝑅𝐻]√𝑅𝑖    ( 5 ) 
 
Where kp is the propagation rate constant, kt is the rate of termination, [RH] is the concentration of 
the PUFA or other compound of interest, and Ri is the rate of initiation.
56  
 In order to quantitatively study autoxidation kinetics, the rate of initiation must be known 
and controlled throughout the course of the experiment. Similar to the methyl linoleate clock 
described previously, thermally labile azo-intiators (Figure 5B) are used as they decompose at a 
known rate (kd) to give two separate radicals (Figure 5A). 
The rate of initiation is governed by both the rate of decomposition of the initiator (kD) and 
the efficiency in which the initial carbon centered radical I• is able to escape the solvent cage of 
its genesis. The Ri is generally measured by monitoring an ‘induction period’60 for the consumption 
of a phenolic antioxidant, the equation for which is shown below (Equation 6): 
 
𝑅𝑖 =
𝑛[𝐴𝑟𝑂𝐻]
𝜏
     ( 6 ) 
 
Where n is the number of radicals trapped by the phenolic antioxidant being used (for example, 
TocH and its analogs have n values of 2), and τ is the time over which oxygen uptake is inhibited. 
The value for τ can be calculated as long as n is known.56  
 Data from these experiments are typically visualized by plotting oxygen consumption 
versus time. The induction period method is used to measure Ri. To obtain these plots, known 
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amounts of antioxidant and the PUFA to be oxidized are added to the reaction vessel. After 
temperature equilibration, known amounts of initiator are added. The induction period (or period 
in which oxygen uptake is inhibited) is determined by tracing the slope for parts A (induction) and 
B (oxidation). The intercept between the two slopes marks the time at which induction ends and 
oxidation begins, and corresponds to the value of τ. From this determination, Ri is calculated and 
the oxidizability of the PUFA under study is readily calculated using Equation 5.56 A typical 
oxygen consumption plot demonstrating these characteristics is shown in Figure 14. 
 
 
 
  
τ 
(A) 
(B) 
Figure 15: Typical oxygen consumption plot of methyl 
linoleate. (A) indicates the induction period, and (B) 
shows the oxidation period. 
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1.4.2. Structure-Reactivity and Propagation Rate Constants 
 The propagation rate constant (kp) for most free radical oxidations involves hydrogen atom 
transfer from an organic substrate to a chain carrying peroxyl radical. This transfer is typically 
slower than all other steps that occur during autoxidation, making it the rate limiting (or rate 
determining) step for the process as a whole. Numerous kp values have been determined for organic 
substrates undergoing autoxidation using classical rotating sector techniques discussed above.55  
These experiments form the basic understanding of the mechanistic framework of free radical 
chain oxidations. Selected propagation rate constants from these experiments are given in Table 
1.44 61 62  
 
  
  
Table 1. Selected autoxidation propagation rate constants (kp) for organic 
compounds.44,61,62 
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The compounds shown in Table 1 have a substantial spread in structural features with an 
equally large distribution of measured propagation rate constants. The difference in rates can be 
understood by looking at the bond dissociation enthalpy (BDE), or the change in enthalpy 
associated with breaking a C-H bond during propagation. Substituent groups, levels of substitution, 
and delocalization present on the structure of the molecule with the reactive C-H bond will factor 
into the value of the BDE. 
 Radical stability follows the order shown below in Figure 15, with tertiary radicals being 
the most stable. The converse is applicable with respect to the reactivity towards hydrogen atom 
abstraction. The ultimate stability and reactivity of the particular radical species is dependent on 
the BDE of the bond which is being broken in the propagation step. Typically, as the substitution 
on the radical center increases the corresponding parent C-H bond BDE decreases.62  
 
  
 
 
Substituents surrounding the radical also play an important role in reactivity, specifically 
concerning its delocalization capabilities. Delocalization occurs when the free radical is no longer 
confined to the original carbon atom on which it was formed. In the frame of reference of a free 
radical, nearly every substituent can act as a source of stabilization. These include electron 
withdrawing groups (EWG) such as carbonyls and electron releasing groups (ERG) like methoxy 
substituents. The overall ability to provide stabilization for the radical can be illustrated in terms 
of resonance structures analogous to the allyl radical in Figure 16. Generally, increasing 
stabilization results in lower BDE for the C-H bond being broken.44  
Figure 16. Relative radical stability. 
23 
 
 
 
 
 
 
1.4.3. Autoxidation of Polyunsaturated Fatty Acids 
The benchmark rate constant used to establish the peroxyl radical clock is that of methyl 
linoleate (18:2). Its autoxidation has been studied in depth by several independent laboratories, 
and the consensus propagation rate constant is 62 M-1 s-1 at 30 °C.55,56  Linoleate is an ω-6 fatty 
acid that is 18 carbons long and contains two units of unsaturation, separated by a singular 
methylene group to give a homo-conjugated system. Under oxidative conditions, the methylene 
carbon (or bis-allylic carbon) is subject to hydrogen atom abstraction due to the lower BDE at this 
location (75 kcal/mol) in comparison to the mono-allylic carbons (88 kcal/mol) on either side of 
the double bonds (Figure 17).63  
 
 
 
  
 
  
 In general, propagation rate constants for PUFAs are related to the number of units of 
unsaturation present in the respective PUFAs structure as shown in Figure 18.47 Oleic acid (18:1) 
is a monounsaturated fatty acid and has a kp of less than 1 M
-1 s-1, a rate that is much smaller than 
Figure 18. C-H BDEs for sites of possible hydrogen atom abstraction during 
methyl linoleate autoxidation.46 
Figure 17. Resonance and delocalization 
of the allyl radical. 
24 
 
that of linoleate. Arachidonic acid (20:4) has two more units of unsaturation than linoleate and it 
has a kp of 201 ± 12 M
-1 s-1, 3.2 times that of linoleate. Both eicosapentaenoic acid (20:5; 249 ± 14 
M-1 s-1), and docosahexaenoic acid (22:6; 321 ± 32 M-1 s-1) show similar increases in kp (4.0 and 
5.4 times greater than linoleate, respectively). This assortment of PUFAs are all targets of peroxyl 
radicals, and their relative rates of hydrogen atom transfer or propagation are clearly dependent on 
the number of bis-allylic methylene groups present – 1, 3, 4, and 5 for 18:2, 20:4, 20:5, and 22:6 
respectively.47  
 
 
 
 
 
 
 
 
 
  
1.4.4. Sterol Autoxidation  
Sterols are also targets of peroxyl radicals, and propagation rate constants for these 
compounds also show the important link between structure and reactivity. Cholesterol, like oleate, 
has one double bond and four allylic hydrogen atoms. However, its kp of 11 M
-1 s-1 is over 10 fold 
that of oleate (0.9 M-1 s-1, Table 1). In general, cyclic alkenes are better hydrogen atom donors than 
comparable straight-chain molecules due to the allylic C-H bonds being oriented in such a way 
Figure 19. Propagation Rate Constants (kp) for Common PUFAs. 
Oleic (18:1)
Linoleic (18:2)
Arachidonic (20:4)
Eicosapentaenoic (20:5)
Docosahexaenoic (22:6)
Fatty Acids
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that allows the radical to be readily delocalized with minimal structural distortion. This can be 
attributed to maximum overlap between the alkene π bond and the developing radical from H-atom 
abstraction.47 Furthermore, the cholesteryl radical is highly substituted (disubstituted at C-5, 
monosubstituded at C-7) in comparison to oleate (Figure 19).  
 
  
 
 
 
 
 
 
 
Cholesterol is ubiquitous in cellular plasma membranes.64 It plays an important role in 
maintaining plasma membrane integrity,65,66 lipid-raft-mediated cell signaling,67 myelin 
formation,68 and brain development.69 Cholesterol can be taken up through the diet, or it can be 
biosynthesized via squalene-2,3-epoxide. Lanosterol is the first sterol formed from this epoxide 
and depending on whether its C24 double bond is reduced early or late by 3β-hydroxysterol-Δ24-
reductase (DHCR24), the pathways followed are either the Kandutsch-Russell pathway70 or Bloch 
pathway,71 respectively (Figure 20). 
 
 
 
Figure 19. Comparison of substitution for the 
Cholesterol allyl radical and Oleate allyl radical. 
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The free radical oxidation of cholesterol has been implicated in a variety of degenerative 
diseases including atherosclerosis,72 Alzheimer’s disease,73 and retinal degeneration.74 Oxysterols, 
the products formed during free radical oxidation of sterols, have been extensively studied.72 Some 
of these products are shown in Figure 21. In 1973, scientists reported that 7-ketocholesterol, 7α-
hydroxycholesterol, and 7β-hydroxycholesterol inhibited sterol biosynthesis.75 Since then, a large 
body of work has been completed concerning the important biological activity of oxysterols.76,77 
 
 
 
 
 
 
 
 
  
 
 
 
At low temperatures, peroxyl radicals primarily abstract hydrogen atoms from cholesterol 
at C778 resulting in an allylic radical with two resonance contributors at C5 and C7 as seen in 
Figure 22A. Radicals at both positions can be trapped by oxygen. However, the 5α- or 5β- 
hydroperoxides are typically not found in the product mixture. The 5α- and 5β- peroxyl radicals 
have been calculated to be 3 to 6 kcal/mol less stable, respectively, than their counterpart peroxyl 
Figure 21. Free radical oxidation of cholesterol leads to the formation of 
oxysterols. Commonly encountered oxysterols are shown above. All are 
known to originate from non-enzymatic free radical oxidations except for 
7α-hydroxycholesterol (which can come from enzymatic or non-enzymatic 
oxidation) and cholestenone (principally formed enzymatically).72 
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radicals formed at C7 and are expected to undergo rapid β-fragmentation (kβ). Recent work has 
shown that under kinetically controlled conditions in the presence of a good H-atom donor such 
as α-Tocopherol (TocH) the 5α-peroxyl radical may be trapped. The kβ for the 5α-peroxyl radical 
was calculated to be 5.6 x 105 s-1,79 explaining why the 5α-hydroperoxide is only observed under 
conditions in which TocH is present. 
 
 
Oxygen can add to the allylic radical at C7 shown in Figure 22A on both faces of the 
molecule (α and β) to give 7α- or 7β-hydroperoxycholesterol (7α-OOH-chol and 7β-OOH-chol). 
Both may be reduced by agents present in the biological environment, including peroxidase80 or 
Fe2+,81 to give the corresponding 7α- or 7β-hydroxycholesterol (7α-OH-chol and 7β-OH-chol, 
Figure 21). Both 7α-OH-chol and 7β-OH-chol as well as 7-ketocholesterol (7-keto-chol), can also 
Figure 22. A. Autoxidation of cholesterol after H7 abstraction, resulting in the formation of 
oxysterols 5α-OOH-Chol, 7α- and 7β-OOH-Chol (and corresponding hydroxides), and 7-Keto-
Chol;39 B. Mechanism of Russell fragmentation for sec-butyl peroxyl radicals.83 
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be formed from a disproportionation reaction of 7α-OOH-chol and 7β-OOH-chol.78 Furthermore, 
7-keto-chol can also be formed by dehydration of 7α- or 7β-OOH-chol82 or by decomposition of a 
tetroxide intermediate formed during termination reactions between 7α- or 7β-peroxyl radicals 
known as the Russell mechanism (Figure 22B).83 
Cholesterol may also undergo free radical oxidation through allylic H-atom abstraction at 
C4. This pathway results in the formation of 4α-OOH-Chol, 4β-OOH-Chol, 6α-OOH-Chol and 
6β-OOH-Chol (Figure 23A), and further downstream oxidation products. Peroxyl radical addition 
can also occur at the double bond to form the 5α,6α- and 5β,6β-epoxides are formed. An alkoxyl 
radical is formed as a byproduct during epoxide formation, and this radical can further propagate 
chain sequences (Figure 23B).39 
 
Figure 23. A. Free radical oxidation of cholesterol after H4-abstraction, producing 4α-OOH-Chol, 
4β-OOH-Chol, 6α-OOH-Chol, and 6β-OOH-Chol oxysterols; B. Peroxyl radical addition via SHi 
mechanism to generate the 5α,6α-epoxide and 5β,6β-epoxide.39 
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Other than their necessity in the biosynthesis of cholesterol, other intermediate sterols in 
the Bloch and Kandustch-Russell have interesting biological functions. For instance, 7-
Dehydrocholesterol (7-DHC) is the biosynthetic precursor to a number of sterols and other 
biologically important molecules other than cholesterol. The enzyme 3β-hydroxysterol-Δ7-
reductase (DHCR7) is responsible for reducing the C7-C8 double bond to give cholesterol. 7-DHC 
is also the precursor to 8-dehydrocholesterol (8-DHC) through the enzyme 3β-hydroxysteroid-
Δ8,Δ7-isomerase. Finally, 7-DHC is converted to previtamin D3 upon exposure to UV 
irradiation.84 All of these transformations are shown in Figure 24. 
 
 
Even though 7-DHC is vital for the biosynthesis of cholesterol and other biologically 
important molecules, it is the most oxidizable lipid known with a propagation rate constant of 2260 
M-1 s-1.47 This sterol has a conjugated diene in the B-ring, and four abstractable allylic hydrogen 
atoms distributed at C4, C9, and C14. Molecular mechanics calculations suggest that hydrogen 
Figure 24. Transformations of 7-DHC into 8-DHC, cholesterol, and previtamin D3. 
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atoms at C9 and C14 are both well positioned for abstraction by peroxyl radicals, with dihedral 
angles for both C7-C8-C9-H9 and C7-C8-C14-H14 close to 90˚ as seen in Figure 25.47  
 
 
 
 
 
 
 
 
 
The pentadienyl radical resulting from hydrogen atom abstraction at either C9 and C14 (Figure 
26) are also highly substituted, adding to their stability.47 With the availability of two highly 
reactive hydrogen atoms as well as two highly substituted pentadienyl radicals formed after 
hydrogen atom abstraction, the mechanisms for the autoxidation of 7-DHC is complex, as are the 
oxysterols which can be formed. 
 
 
Abstraction of H9 results in a pentadienyl radical spanning carbons C5-C6-C7-C8-C9. 
Oxygen can add to form either the C5 or C9-peroxyl radical (Figure 27). These peroxyl radicals 
Figure 25. A. 7-Dehycholesterol with H-9 and H-14 highlighted in red; B. 
7-Dehydrocholesterol low-energy conformation (MM2) showing reactive 
H-9 and H-14 and the B-ring conjugated diene frame.47 
Figure 26. Hydrogen atom abstraction of either H9 or H14 yields highly substituted 
pentadienyl radicals. 
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can form the 5- or 9-hydroperoxides, or undergo a 5-exo-cyclization to give the endoperoxide 
shown in the box in Figure 28. This intermediate oxysterol can undergo a number of further 
transformations, which are shown in detail in the same figure.39 
  
 
 
Abstraction of H14 leads to the pentadienyl radical spanning carbons C5-C6-C7-C8-C14 
(Figure 28). Oxygen addition to give the 5- or 14-peroxyl radical can be followed by H-atom 
transfer to give the corresponding hydroperoxides (5-OOH-DHC and 14-OOH-DHC, 
respectively). In contrast to the H-9 mechanism, the diene framework after H14 abstraction spans 
Figure 27. Mechanism for free radical oxidation of 7-DHC after H9 abstraction.39 
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both B and C rings and is unfavorable for 5-exo-cyclization. Still, further reactions are possible 
after 5- and 14-OOH-DHC formation due to the remaining reactivity in the molecule. These 
reactions could include a β-scission of the hydroperoxide (-OH·) followed by an SHi reaction to 
ultimately give an epoxy hydroperoxide. If 14-OOH-DHC is formed, H9 is vulnerable to further 
oxidation, leading to more complex products.39 
 
 
7-DHC can also undergo addition reactions with peroxyl radicals to form the 7-DHC-
5α,6α-epoxide (Figure 29).85 This reactive epoxide can undergo ring opening and further oxidation 
to give 3β,5α-dihydroxy-cholest-7-en-6-one (DHCEO), which is a major oxysterol observed in 
both cell and animal models for SLOS as a biomarker for the peroxidation of 7-DHC.86,87,85 
Figure 28. Mechanism for free radical oxidation of 7-DHC after H14 abstraction.39 
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Another highly oxidizable sterol is 8-DHC, having a propagation rate constant of 990 M-1 
s-1.88 8-DHC has a homo-conjugated diene in its B-ring and six reactive hydrogen atoms (4 allylic, 
2 bis-allylic). Abstraction of one of the bis-allylic hydrogen atoms at C7 yields a pentadienyl 
radical identical to that of 7-DHC after H9 abstraction. Thus, it is expected that free radical 
oxidation of 8-DHC will follow the H9 mechanism for 7-DHC shown in Figure 30.39 
 
 
 
 
 
 
As one can see, the autoxidation of sterols is very complex regardless of the propagation 
rate constant the particular molecule is able to sustain. The complexity of products, coupled with 
the propensity of sterols such as 7-DHC and 8-DHC to propagate free radical oxidations at 
extremely high rates, creates a situation in which the buildup of these sterols can quickly become 
detrimental in lipid-rich biological systems. Table 2 gives a brief recap of the three sterols 
discussed at length in this section, showing their structure and reactive hydrogen atoms, the 
Figure 29. SH
i reaction of a peroxyl radical and 7-DHC to give DHCEO, a major biomarker for 
peroxidation of 7-DHC. 
Figure 30. Free radical oxidation of 8-DHC follows the H9 
mechanism for 7-DHC.39 
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conjugated radicals formed after hydrogen atom abstraction, and the measured propagation rate 
constants for each. 
 
  
Table 2. Structure, delocalized radicals, and kp for Cholesterol, 8-
DHC, and 7-DHC. 
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1.4.5. Antioxidants 
 Peroxidation can be inhibited or halted when a peroxyl radical encounters an antioxidant 
capable of breaking the chain reaction. The chain breaking process generally occurs through the 
H-atom abstraction reaction shown in Figure 31 (1). 
 
 
 
 
 
Chain-breaking antioxidants are typically phenolic in nature,89 therefore the radical 
generated (X•) after H-atom abstraction by the peroxyl radical is highly stabilized through 
resonance delocalization. The radical (X·) is unsuited to continue the chain oxidation, hence the 
term ‘chain-breaking’. Eventually the phenolic radical will be destroyed through reaction with 
another radical, be it another peroxyl radical or disproportionation with another phenolic radical 
(Figure 31, 2 and 3).90  
 One of the most efficient and prevalent antioxidants in Nature is tocopherol, commonly 
referred to as Vitamin E. This antioxidant exists as four different structures which are shown in 
Figure 32.  Each member of the tocopherol series is an excellent chain breaking antioxidant, 
however α-tocopherol (TocH) has the largest inhibition rate constant (kinh=3.5 x 106 M-1 s-1) for H-
atom donation to a peroxyl radical than the rest of the series.91  
 
 
Figure 31. Mechanism of phenolic antioxidants. 
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Efforts to understand the effectiveness of TocH as a chain-breaking antioxidant and the 
search for equal or better antioxidants has been has been a major focus for some time. Howard and 
Ingold carried out a number of structure-activity relationship studies to understand the relationship 
between rates of inhibition (Equation 1, Figure 31) of simple phenols and the substituents located 
on the phenyl ring.92,93,94,95 They found that optimal inhibition rates were achieved when a phenol 
contains a methoxy substituent group at the para- (or 4-) position to the phenol, with the remaining 
positions methylated. Therefore, the logically superior antioxidant should be 4-methoxy-2,3,5,6-
tetramethylphenol (Figure 34A). But the inhibition rate constant for this phenol was determined to 
be 3.9 x 105 M-1 s-1,91 much less than TocH (3.5 x 106 M-1 s-1). 
Steric hindrance to the abstraction of the phenolic O-H hydrogen atom is likely to be similar 
for both TocH and 4-methoxy-2,3,5,6-tetramethylphenol. The remaining explanation for the 
difference in rates of inhibition for the two antioxidants lies in thermodynamic differences – i.e. 
the O-H bond in TocH must be weaker than that of 4-methoxy-2,3,5,6-tetramethylphenol. This 
means that the phenoxyl radical from TocH must be more stabilized than the same radical from 4-
methoxy-2,3,5,6-tetramethylphenol.89  
Figure 32. α, β, γ, and δ-Tocopherols. 
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This stabilization will be dependent on the orientation of the oxygen atom para- to the 
phenolic O-H group, as it is able to stabilize the phenoxyl radical by conjugative electron 
delocalization.89 The extent of overlap between the p-type orbital and the semioccupied molecular 
orbital (SOMO) of the radical will depend on the dihedral angle θ between the p-type orbital 
overlap on O1 and a perpendicular from the aromatic plane (Figure 33B). This particular dihedral 
should be equal to a secondary dihedral angle (θ’) between the O1-C2 bond and the aromatic plane.        
 
 
Therefore, as θ’ decreases to 0˚, overlap between the p-type orbital and SOMO should be 
maximized and inhibition rate constants should increase.89 This trend was confirmed through 
obtaining x-ray crystal structures for a number of phenols and TocH.91,57 The θ’ for TocH (17˚) is 
much lower than that of 4-methoxy-2,3,5,6-tetramethylphenol (89˚), suggesting that 
stereoelectronics are ultimately responsible for the excellent chain-breaking antioxidant activity of 
TocH.  
 Despite being an excellent chain-breaking antioxidant, Bowry and Stocker reported that 
the tocopheryl radical may also maintain a chain sequence by abstracting hydrogen from lipid 
Figure 33. A. 4-methoxy-2,3,5,6-tetramethylphenol, a simple phenolic compound 
containing features found to be optimal for chain-breaking antioxidant activity. B. 
Schematic showing dihedral angles θ (O1 p-orbital and perpendicular to aromatic 
plane) and θ’ (O1-C2 bond and the aromatic plane). As θ’ decreases, orbital 
overlap between the p-orbital on O1 and SOMO of the phenoxyl radical increases, 
resulting in higher rates of inhibition.73
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substrates if the rate of initiation is low and the concentration of tocopherol is high.96 This finding 
was the result of increased interest in the oxidative modification of human low-densitiy lipoprotein 
(LDL) and the involvement of this process in the development of atherosclerotic lesions. The major 
antioxidant present in LDL particles is TocH, and much research had been done with respect to 
the ability of TocH to disrupt the oxidative modification of LDL and as an epidemiological marker 
for ischaemic heart disease. 
 Initial experiments demonstrated that peroxidation of lipids within the LDL particle 
continue in the presence of over 90% of the original TocH in the particle.97 Further studies revealed 
that under mild free-radical initiated conditions using water soluble azo initiators, the presence of 
TocH actually accelerated lipid peroxidation. Increasing TocH under these conditions further 
increased the rate at which peroxidation occurred.98 This led to kinetic arguments which suggest 
that the apparent prooxidant activity of TocH under certain circumstances is due to the tocopheryl 
radical’s ability to attack and abstract active L-H bonds of PUFAs (Figure 34, kTMP).99  
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Figure 34. Tocopherol Mediated Peroxidation.83 
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1.4.6. Kinetic Isotope Effects 
A kinetic isotope effect (KIE) is observed if the replacement of an atom central to a 
mechanistic pathway by one of its isotopes (e.g. 1H to 2H or 3H, 12C to 13C, etc.) results in a change 
in the rate of a reaction. Isotopic substitution will usually have no effect on the qualitative chemical 
reactivity of a molecule but it can in some circumstances have a measurable effect on the rate of 
the reaction and lead to a kinetic isotope effect (KIE). When the bond broken during the reaction 
is isotopically substituted (i.e. C-H to C-D), any measurable change in rate is due to a primary 
KIE. The H/D KIE for a reaction can be calculated using Equation 7, where kH and kD are reaction 
rates for the H and D compounds, respectively. 
 
𝐾𝐼𝐸 =
𝑘𝐻
𝑘𝐷
     ( 7 ) 
 
 The largest differences in rate are typically observed when a hydrogen atom is replaced 
with one of its isotopes. The underlying reason for this is due to the fact that the zero-point energy 
(ZPE) of the bond being broken is an important determinant in the rate of the reaction. Each C-
H(D) bond has a characteristic vibration with some ZPE that is a consequence of quantized 
vibrational levels. The ZPE is directly linked to the mass of the atom by Equation 8, where En is 
the energy of ZPE, h is Plank’s constant, and ν is the fundamental vibrational frequency. 
 
𝐸𝑛 = (𝑛 +
1
2
) ℎ𝜐     ( 8 ) 
 
The vibrational freqnecy (v) is calculated using Equation 9, where κ is the force constant of the 
bond being broken. 
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𝜐 =
1
2𝜋
√
𝑘
𝜇
     ( 9 ) 
 
Finally, the denominator in Equation 9 is µ, the reduced mass of the atom being abstracted. The 
reduced mass is calculated using Equation 10. 
 
𝜇 =
𝑚1× 𝑚2
𝑚1+𝑚2
     ( 10 ) 
 
Note that as the mass of the atom abstracted increases, that atom vibrates at a lower 
frequency and contributes less to the ZPE of the bond being broken. Thus, the ZPE is lowered for 
the heavier isotopes (C-2H; 2100 cm-1, 3.0 kcal mol-1) in comparison to the ZPE for the lighter 
atom (C-1H; 2900 cm-1, 4.15 kcal mol-1). This difference results in a larger activation energy 
(ΔG=1.15 kcal mol-1) needed to reach the transition state (‡) for the heavier atoms, ultimately 
affecting the rate at which the reaction proceeds (Figure 35). At room temperature, the difference 
in activation energies corresponds to a measurable difference in the rate of reaction if and only if 
breaking the bond to hydrogen or deuterium is directly involved in the formation of the transition 
state .100  
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Figure 35. Reaction energy diagram outlining 
differing zero-point energies associated with isotopic 
substitution of hydrogen (1H) with deuterium (2H) and 
tritium (3H). 
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The rate of a particular reaction (k) or activation energy (Ea) associated with a 
transformation can be determined using the Arrhenius equation as shown in Equation 11. In this 
equation A is the Arrhenius constant, kB is the Boltzmann constant, and T is temperature. 
 
𝑘 = 𝐴𝑒
−
𝐸𝑎
𝑘𝐵𝑇     ( 11 ) 
 
Therefore, the KIE for the breaking of a hydrogen atom bond may also be described in terms of 
the Arrhenius equation as shown in Equation 12. For hydrogen atom abstraction occurring at 300 
K (27 ˚C), the maximum H/D KIE is 7 using this equation.100 
 
𝑘𝐻
𝑘𝐷
= 𝑒
−
𝐸𝑎
𝐻−𝐸𝑎
𝐷
2𝑘𝐵𝑇      ( 12 ) 
 
1.5. Enzymatic Oxidation 
 Lipids may be oxidized by enzymes that selectively abstract hydrogen atoms and direct 
oxygen addition to the intermediate carbon radicals to generate products having defined 
stereochemistry. The products of enzymatic oxidation are diverse, with many of those products 
acting as signaling molecules for various cellular functions. 
1.5.1. Cyclooxygenases 
 The cyclooxygenase (COX) family is comprised of cyclooxygenase 1 (COX1), the 
constitutively expressed species,4 and cyclooxygenase 2 (COX2), which is expressed in response 
to an inflammatory burst or attack.101 Both enzymes utilize a tyrosyl radical in the active site to 
abstract hydrogen from arachidonic acid (AA),102 and both oxygenate LA and AA103 as well as 
other ω-3 and ω-6 PUFAs.104  
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 Oxygenation of PUFAs by the COX family results in an array of signaling molecules that 
modulate cellular function such as vascular relaxation and constriction, platelet aggregation, and 
mucosal regeneration.105 Commensurate to the array of signaling molecules generated by the 
family, its expression has also been linked to a number of human pathologies including cancer,106 
cardiovascular disease,107 and neurodegenerative disorders.108  
 The COX family of enzymes are structural homodimers that act as functional heterodimers 
to bis-oxygenate and cyclize AA which has been released from the lipid bilayer by cytosolic 
phospholipase A2 (cPLA2).
109,110 Once AA is brought into the active site, the pro-S hydrogen atom 
situated on bis-allylic C-13 is abstracted by Tyr385-O•, after which oxygenation occurs at C-11 
and is followed by cyclization to give PGG2. This peroxide is reduced by the peroxidase active 
site to give PGH2, which is the precursor to other eicosanoid signaling molecules (via their 
respective synthases) of PGE2, PGD2, PGF2α, PGI2, and thromboxane A2 (TXA2) (Figure 36).
102 
Monooxygenated species are also generated by the COX family, including 11(R)-HETE and 15(S)-
HETE.111  
 
46 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36. COX metabolism of AA. AA is released from the lipid 
bilayer by cPLA2. Once in the active site, Tyr385-O• abstracts the 
pro-S hydrogen atom from C-13. Oxygenation and cyclization 
results in the formation of PGG2, and the formation of alcohol 
PGH2 is catalyzed by the peroxidase. PGG2 serves as a precursor 
for the other eicosanoids shown.86 
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1.5.2. Lipoxygenases 
 Lipoxygenases (LOXs) belong to a separate family of enzymes capable of controlled 
oxygenation of both LA and AA in either the free or esterified state.112,113 The LOX family 
enzymes are named depending on the lipid products formed in the oxidation. For instance, 9-LOX 
and 13-LOX catalyze the oxygenation of LA to form 9-HpODE and 13-HpODE, respectively.114 
Similarly, the LOX’s responsible for oxygenation of AA to give the hydroperoxyeicosatetraenoic 
acids (HpETEs) – 5-HpETE, 8-HpETE, 12-HpETE, or 15-HpETE (Figure 37) – are named based 
upon the preferred product (5-LOX, 8-LOX, etc.).115  
 
 
Figure 37. Oxygenation of AA to form HpETEs by members of the Lipoxygenase family.99
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1.6. Conclusions 
 The autoxidation of lipids has been extensively studied and linked to a number of cellular 
disruptions and human pathologies such as cardiovascular disease,116,117,118,119,120 Parkinson’s 
disease,121,122 and Alzheimer’s disease.34,123 It is clear that ROS can facilitate a broad spectrum of 
damage within different classes of lipids, and diminishing these reactions is key to controlling the 
downstream effects of oxidative damage. The aim of this dissertation is to expand on the ideas and 
findings discussed in this introductory chapter, focusing on kinetic studies of sterol autoxidation 
as well as physical studies surrounding a strategy to diminish lipid peroxidation in vivo through 
the use of isotopically reinforced PUFAs. Deuterium is substituted for hydrogen at the reactive 
bis-allylic centers in these synthetic lipids.124 The following work will be presented: 
1. Measurement of propagation rate constants for natural and isotopically reinforced PUFAs. 
2. Competition experiments to assess the effects of D-PUFAs on the rate of peroxide 
formation. 
3. Determination of rate constants for peroxidation of sterols important in the biosynthesis of 
cholesterol using the methyl linoleate clock. 
4. An examination of tocopherol-mediated oxidation of PUFAs and deuterated derivatives. 
5. A study of the effects of deuterated PUFAs in RAW 264.7 macrophages, a prototypical 
cell line used extensively in the study of lipid metabolism. 
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Chapter II 
 
DETERMINATION OF PROPAGATION RATE CONSTANTS OF STEROLS AND D-
PUFAS: THE APPLICATION OF RADICAL CLOCKS 
 
2.1. Introduction 
2.1.1. Polyunsaturated Fatty Acids 
 Polyunsaturated fatty acids (PUFAs) contain two or more carbon-carbon double bonds. 
PUFAs are essential nutrients, readily taken up by cells that are unable to synthesize them. In 
mammalian cells, PUFAs such as linoleic acid (LA) and linolenic acid (Lnn), are converted to 
longer chained PUFAs which are required for life such as arachidonic acid (AA) and 
docosahexaenoic acid (DHA) (Figure 13).1  
 
 
PUFAs are important membrane constituents, and they also play an important role in 
cellular metabolism. Various oxidative enzymes act on PUFAs to generate prostaglandins,2 
hydroxyl-fatty acids, and leukotrienes.3 Despite the essential need for PUFAs, these lipids are also 
extremely prone to peroxidation that is initiated by reactive oxygen species (ROS).4,5 Once 
Figure 1: Linoleic and linolenic acid are essential PUFAs. Mammalian cells are able to take these 
PUFAs up and metabolize them to longer chained PUFAs necessary for life function. 
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peroxidation is initiated, membrane permeability and fluidity are negatively affected due to 
accumulation of lipid peroxides6 and cis- to trans-isomerization of PUFA double bonds.7 
Moreover, the peroxidation of PUFAs has been implicated in a number of human diseases 
including atherosclerosis,8,9,10 cancer,11,12 and acute lung injury,13,14 as well as neurodegenerative 
disorders such as Alzheimer’s15,16 and Parkinson’s disease.17 
 Autoxidation of PUFAs can lead to a wide variety of products, especially for the oxidation 
of longer chained PUFAs. Autoxidation of AA, for example, leads to the formation of distinct 
class of compounds known as isoprostanes (as outlined in Chapter 1).18 In this section, the 
autoxidation of LA will be discussed, as will a recent strategy to diminish lipid peroxidation 
through isotopic reinforcement of PUFAs. 
2.1.2. Autoxidation of Linoleate 
The autoxidation of LA and its esters is initiated when an oxygen radical abstracts a bis-
allylic hydrogen atom from C11 of linoleate, forming a pentadienyl radical. During propagation, 
oxygen adds into this radical rapidly to give peroxyl radicals at C9 or C13 in either the trans,cis- 
or trans,trans-conjugated diene configuration. The peroxyl radicals then abstract an H-atom from 
a nearby lipid or other H-atom donor, giving a hydroperoxyoctadecadienoic acid (HpODE) and a 
new pentadienyl radical. This free radical chain reaction will result in the buildup of HpODEs as 
shown in Figure 14 and as discussed in Chapter I. 
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2.1.3. Isotopic Reinforcement of Polyunsaturated Fatty Acids 
 The reaction of oxygen radicals with PUFAs occurs preferentially at bis-allylic methylene 
groups. This reaction is favored by the low BDE of these C-H bonds, a consequence of the stable 
delocalized pentadienyl radical that is formed after H-atom abstraction.19,20,21 A recent strategy to 
diminish the rate at which lipid autoxidation occurs relies on isotopic reinforcement of these bis-
allylic sites, replacing hydrogen with deuterium to generate isotopically reinforced PUFAs such 
as 11,11-D2-linoleic acid (D2-LA, Figure 17). H- or D-abstraction at the bis-allylic site is the rate 
determining step in the autoxidation of linoleate, and substitution of a heavier D-atom results in 
an isotope effect for its removal. This is due to a lower zero-point energy (ZPE) for abstraction of 
the D-substituted linoleate which translates into a higher activation energy barrier to overcome in 
order for D-abstraction to occur. 
 
Figure 2: Autoxidation of methyl linoleate, generating HpODEs in 
the trans,cis- or trans,trans-diene configuration. 
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Hill and coworkers have shown that supplementation of D-PUFAs into biological systems 
results in resistance to oxidative stress and lipid peroxide buildup.22 In early studies, 
Saccharomyces cerevisia yeast (S. cerevisiae) were examined in proof of concept experiments. 
This strain of yeast biosynthesizes coenzyme Q (ubiquinone), the hydroquione form of which is 
used as a lipophilic antioxidant and electron shuttle within the respiratory chain in the 
mitochondria.23 The yeasts’ lipids consist primarily of saturated fatty acids but they also synthesize 
palmitoleic acid and oleic acid, both of which are resistant to autoxidation. These yeast also readily 
take up exogenous PUFAs. Wild type and mutant yeast lacking the genetic framework to produce 
ubiquinone and are thus more susceptible to oxidative stress, were used to study the effects natural 
PUFAs and D-PUFAs have during oxidative events. Workers in the Clarke group found that 
treatment of both wild type and mutant yeast with D-PUFAs (deuterated linoleic and linolenic acid 
derivatives) resulted in no overall toxicity, but natural PUFAs killed cells during incubation of up 
to 5 hours.24 Furthermore, robust protection against oxidative stress was observed in both wild 
type and mutant yeast after treatment with D-PUFA.24 Further studies have indicated that treatment 
of the same yeast with mixtures of PUFA and D-PUFA also show resistance to oxidative stress, 
and D-PUFA concentrations as low as 20% of the total mixture provide the same levels of 
protection as higher percentages of D-PUFA. This finding, named “the 20% effect”, suggested that 
the protection against oxidative stress afforded by D-PUFAs had some minimal threshold for 
activity.25 
Figure 3: Deuterated linoleic acid (D2-LA).  
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D-PUFAs have also shown beneficial effects in diseases where oxidative stress is a primary 
component of pathophysiology such as Friedreich’s ataxia26 and  Parkinson’s disease.27,28,29 These 
promising results stimulated further study of the physical aspects of autoxidation of D-PUFAs and 
the suppression of oxidation by these compounds. 
2.2. Results 
2.2.1. Measurement of the Propagation Rate Constant for Linoleate and 11,11-D2-Linoleate 
 The methyl linoleate clock,30 discussed in Chapter I, was used to determine propagation 
rate constants for D2-LA. PUFAs were purified and dried under vacuum prior to experiments. A 
stock solution of 0.1 M 2,2’-azobis(4-methoxy-2,4-dimethyl)-valeronitrile (MeOAMVN) in 
benzene was used to initiate all reactions. 
In a typical experiment to measure propagation rate constants for PUFAs and D-PUFAs, the 
concentration of LA or D2-LA ethyl esters used ranged from 0.14 to 2.1 M. Oxidations were carried 
out at 37 °C for 1 h and quenched with butylated hydroxytoluene (BHT) and triphenylphosphine 
(PPh3). Oxidation products (HODEs) were analyzed by HPLC-UV. The residual amount of D1-
LA and LA present in the D2-LA ethyl ester starting material was determined using 
1H NMR 
analysis. These values were found to be 2.9 and 0.8 mol%, respectively, and these values were 
used to correct the data from D2-LA assuming that 11-D1-LA is half as reactive as LA.
31 Results 
for LA and D2-LA ethyl esters are shown in Figures 4 and 5. 
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Figure 4. Determination of kp for LA ethyl ester. A and B show typical HPLC-UV 
chromatograms for LA ethyl ester oxidations at 0.7 M and 2.1 M LA. C. Plot of the 
trans,cis/trans,trans-HODEs versus the concentration of LA ethyl ester for each oxidation. 
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Figure 5. Determination of kp for D2-LA ethyl ester. A and B show typical HPLC-UV 
chromatograms for D2-LA ethyl ester oxidations at 0.7 M and 2.1 M D2-LA. C. Plot of the 
trans,cis/trans,trans-HODEs versus the concentration of D2-LA ethyl ester for each oxidation. 
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In order to determine the propagation rate constant for both LA and D2-LA ethyl ester 
clocking experiments, the ratios of trans,cis-HODEs to trans,trans-HODEs were plotted against 
the concentrations of LA or D2-LA ethyl esters. According to Equation 1: 
 
𝐭𝐫𝐚𝐧𝐬,𝐜𝐢𝐬
𝐭𝐫𝐚𝐧𝐬,𝐭𝐫𝐚𝐧𝐬
= ∑
𝐤𝐩
𝐢 [𝐑𝐢−𝐇]
𝟐𝟏𝟒 𝐬−𝟏
+ 𝟎. 𝟏𝟔𝐢=𝟏−𝐧    ( 1 ) 
 
The ratio of the trans,cis- to trans,trans-HODEs is proportional to the propagation rate constant, 
kp, for the compound of interest. Therefore, the slopes from the plots above are also proportional 
to the kp for both LA and D2-LA ethyl esters.
30 The H/D kinetic isotope effect can then be 
calculated by direct comparison of the slopes from the two plots using Equation 2: 
 
𝑲𝑰𝑬 =
𝒌𝑯
𝒌𝑫
=
𝑳𝑨 𝒔𝒍𝒐𝒑𝒆
𝑫𝟐−𝑳𝑨 𝑺𝒍𝒐𝒑𝒆
    ( 2 ) 
 
 Direct comparison of the LA and D2-LA ethyl ester oxidation slopes is presented in Figure 
6. The H/D kinetic isotope effect calculated by the application of this method was 9.3 ± 1.1. 31 
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Figure 6. Direct comparison of the trans,cis-/trans,trans-HODE 
ratios from LA and D2-LA ethyl ester oxidations. The slope for 
each data set is proportional to the kp for the respective substrate. 
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2.2.2. Cooxidation Experiments 
Experiments in yeast have shown that enrichment with natural PUFAs followed by the 
initiation of oxidative stress causes cell death. Enrichment of yeast with D-PUFAs under identical 
conditions as experiments with natural PUFAs resues the cells from damage and death due to 
oxidative stress. It was reported that levels of D-PUFA as low as 20% of the PUFAs added rescued 
the yeast from oxidative damage. Higher concentrations showed no effective difference in the 
reduction of peroxide buildup or cell survival.25 This data suggested that the protective effect was 
not linear. In other words, cell survival was identical when 20% D-PUFA or 90% D-PUFA was 
present after enrichment. 
In order to investigate these observations, cooxidation experiments were carried out in 
which LA and D2-LA mixtures were oxidized together in solution. The total amount of PUFA 
([LA] + [D2-LA]) was held constant at 0.64 M with mole fraction of D2-LA at 0.0, 0.05, 0.18, 0.30, 
0.47, 0.62, 0.82, and 0.90. Free radical oxidation was initiated by MeOAMVN at 37 ˚C. Solutions 
were quenched after 1 h with BHT and PPh3. The percent oxidation of pure LA after 1 h was 
calculated to be 2%. It can be assumed that the percent oxidation in other samples with higher 
mole fractions of D2-LA will be lower than that for Lin. 4-methoxybenzyl alcohol was added as 
an internal standard and samples were split into two separate parts. 
One part of the product mixture was analyzed by HPLC-UV to determine total HODE 
formation. The ratio of trans,cis-HODE to trans,trans-HODE was plotted against the percentage 
of D2-LA present in solution according to Equation 3: 
 
𝒑𝒆𝒓𝒄𝒆𝒏𝒕𝒂𝒈𝒆 𝑫𝟐 − 𝑳𝑨 =
[𝑫𝟐−𝑳𝑨]
[𝑳𝑨+𝑫𝟐−𝑳𝑨]
   ( 3 ) 
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The plot from these experiments, shown in Figure 7, reveals a linear decrease in total HODE 
formation as a function of the mole fraction of D2-LA present. 
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Figure 7. Results from cooxidation experiments of LA and D2-LA. A. Total HODE 
formation was analyzed by HPLC-UV, and levels of HODEs were quantified relative 
to the internal standard, 4-methoxybenzyl alcohol. B. Total HODE formation versus 
the percentage of D2-LA present in the oxidation mixtures. 
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To the remaining fraction of the product mixture, 13-(S)-D4-HODE was added as an 
internal standard. The samples containing ratios of LA:D2-LA greater than 1:5 were analyzed by 
LCMS in order to determine the H/D kinetic isotope effects which occur during cooxidation of the 
natural and deuterated substrates. Samples were introduced into the mass spectrometer by 
atmospheric-pressure chemical ionization (APCI) in negative mode. HODEs were analyzed by 
selective reaction monitoring (SRM) techniques described elsewhere.32,4 A typical chromatogram 
is shown in Figure 8. 
 
 
 
 
 
Figure 8. A typical chromatogram for analysis of cooxidations of LA and D2-LA with 
ratios of LA:D2-LA greater than 1:5. The top two panels show HODEs from LA. The 
bottom two panels show D1-HODEs from D2-LA. 
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During cooxidation at low conversion, the ratio of HODEs to D1-HODEs formed reflects 
the relative propagation rate constants for LA and D2-LA as shown by Equation 4: 
 
[𝐇𝐎𝐃𝐄𝐬]
[𝐃𝟏−𝐇𝐎𝐃𝐄𝐬]
=
𝒌𝐋𝐀[𝐋𝐀]
𝒌𝟏𝟏,𝟏𝟏−𝐃𝟐−𝐋𝐀[𝟏𝟏,𝟏𝟏−𝐃𝟐−𝐋𝐀]
  ( 4 ) 
 
The H/D kinetic isotope effect was calculated for three separate reactions in which the ratio of 
LA:D2-LA was greater than 1:5. The average KIE for these cooxidation experiments was 
calculated to be 12.8 ± 0.6. Results from each sample are shown in Table 1. 
 
 
 
 
 
 
2.2.3. Oxidizability Measurements of LA and D2-LA 
LA and D2-LA were subjected to oxidation in an automatic recording gas absorption 
apparatus similar to those described elsewhere.33,34 All oxidations were carried out at 37 ˚C under 
760 torr of O2. In a typical experiment, known concentrations LA (0.08 to 0.43 M) or D2-LA (0.08 
to 0.3 M) were placed into the reaction vessel along with a known concentration of 2,2’-azobis-
isobutyrylnitrile (AIBN). Once autoxidation starts, a known concentration of 2,2,5,7,8-
pentamethyl-6-chromanol (PMHC) was added to the reaction vessel in order to measure the 
induction period. A typical plot of oxygen consumption after the addition of PMHC is shown in 
Figure 9. 
Table 1. H/D KIE calculations from cooxidation experiments 
where [LA]:[D2-LA] ratios were greater than 1:5. 
Sample [LA]:[D2-LA] [D0-HODEs]/[D1-HODEs] H/D KIE
1 1 : 5.1 2.4 12.4
2 1 : 6.5 2 13.1
3 1 : 9.5 1.3 12.8
71 
 
 
 
 
 
 
 
 
 
 
The rate of chain initiation (Ri) was then determined using the induction period method 
which was discussed in length in Chapter I.35  Ri is calculated using Equation 5: 
 
𝐑𝐢 =
𝐧[𝐀𝐫𝐎𝐇]
𝛕
     ( 5 ) 
 
The rate of oxygen consumption during autoxidation of LA or D2-LA was then calculated 
for each concentration of substrate by using Equation 6: 
 
−𝐝[𝐎𝟐]
𝐝𝐭
= {
𝐤𝐩
√𝟐𝐤𝐭
} [𝐑𝐇]√𝐑𝐢    ( 6 ) 
 
 Finally, the calculated rate of oxygen consumption for each substrate was plotted against 
[PUFA]·Ri1/2. The slope of the resulting plots (typically designated Pryor plots) is equal to the  
oxidizability, or kp/(2kt)
-1/2, of the substrate.36 A combined Pryor type plot is shown in Figure 10 
for LA and D2-LA. . The oxidizability for LA was calculated to be 1.96 (± 0.16) x 10
-2 M-1/2 s-1/2 
Figure 9. Typical oxygen consumption plot for LA methyl ester autoxidation. 
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from the Pryor plot, in good agreement with previous values from the literature.36,37 The 
oxidizability of D2-LA was calculated to be 0.447 (± 0.04) using the same method. 
 
  
  
 
 
 
 
 
 
 
 
 
Two methods of cooxidation experiment were also carried out to once again investigate the 
“20% effect” described in studies of D-PUFA supplementation in yeast. In the first method The 
total concentration of PUFA ([LA + D2-LA]) was held constant at 0.16 M, and the ratio of LA:D2-
LA was varied from 1:0 to 0:1. The induction method was used to measure oxygen consumption 
of each mixture of LA and D2-LA. Oxygen consumption was plotted against the mole fraction of 
D2-LA for each reaction. The data, shown in Figure 11, suggests that oxygen consumption 
decreases in linear fashion as the mole fraction of D2-LA increases. 
 
Figure 10. Pryor plots for LA and D2-LA. 
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The second method of cooxidation involved the incremental addition of known 
concentrations of D2-LA to the reaction cell containing already autoxidizing LA. Oxygen 
consumption was calculated for each injection of D2-LA, and the induction period method was 
used to measure Ri every other injection of D2-LA through the addition of fresh PMHC at the same 
time. Oxygen consumption was again plotted versus the mole fraction of D2-LA present. The 
results, shown in Figure 12, again demonstrate a linear decrease in oxygen consumption with 
increasing mole fraction of D2-LA. 
 
  
 
 
 
Figure 11. Oxygen consumption versus mole fraction of D2-LA 
present in the reaction mixture. 
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Figure 12. Oxygen consumption versus mole fraction of D2-LA after 
addition of D2-LA to already autoxidizing LA. Ri was determined 
every second addition of D2-LA by the addition of fresh PMHC at a 
known concentration. 
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2.3. Discussion 
  Despite being essential nutrients, PUFAs are extremely prone to free radical oxidation 
with the bis-allylic hydrogen atoms being targeted for abstraction. These hydrogen atoms have a 
lower BDE relative to other hydrogen atoms in the molecule due to the stable, delocalized 
pentadienyl radical formed upon abstraction.19,20,21 The mechanism of LA and other PUFA 
autoxidation is shown in Figure 14.5  
 
 
 
 
 
 
 
A recent strategy to diminish autoxidation of PUFAs has focused on isotopic reinforcement 
of these bis-allylic sites, replacing hydrogen with deuterium. These D-PUFAs have been shown to 
lower autoxidation in yeast22 and have beneficial effects in diseases such as Fredreich’s ataxia26 
and Parkinson’s disease,77-79 both of which have oxidative stress assosciated with their pathology. 
In order to understand how deuterium reinforcement of the bis-allylic position results in protection 
from peroxidation, the free radical clock based on methyl linoleate30 was used to mesure the 
propagation rate constant of D2-LA. 
Determination of Propagation Rate Constants and KIE for D2-LA 
The propagation rate constant for D2-LA was calculated to be 6.8 ± 0.5 M
-1 s-1 using 
Equation 1. This rate is roughly ten times slower than that of the natural PUFA (62 M-1 s-1). The 
 
Figure 13. General scheme for the autoxidation of LA and other 
PUFAs. 
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H/D KIE was calculated to be 9.3 ± 1.1 using Equation 2.31 In a typical autoxidation of LA, the 
trans,cis-HODE to trans,trans-HODE ratio increases as the concentration of H-atom donor 
increases. The trans,cis-HODEs become much more prevalent in the product mixture as H-atom 
donation competes with β-fragmentation of the trans,cis-peroxyl radical. In oxidations of D2-LA 
however, the trans,cis-HODE to trans,trans-HODE ratio is relatively unchanged across the full 
concentration range of the experiments (Figure 14). This shows that D2-LA is much less oxidizable 
than LA and is unable to compete with β-fragmentation of the trans,cis-peroxyl radical. 
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Figure 14. Histograms demonstrating the changes in trans,cis-HODE to trans,trans-HODE ratios. 
A. The trans,cis-/trans,trans-HODE ratio increases in the presence of a good H-atom donor such 
as LA ethyl ester; B. The trans,cis-/trans,trans-HODE ratio remains unchanged with increasing 
concentration of D2-LA ethyl ester due to its poor H-atom donating capabilities. 
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Cooxidation of LA and D2-LA 
Cooxidation of LA and D2-LA was carried out in order to address the reports that levels of 
D-PUFA as low as 20% afforded maximum protection against peroxidation in yeast. In these 
experiments, the overall concentration of PUFA ([LA + D2-LA]) was held constant, and the ratio 
of LA:D2-LA was varied from 1:0 to 0:1. HPLC-UV analysis of the HODEs formed during these 
experiments revealed that HODE formation decreased in a linear fashion as the mole fraction of 
D2-LA increased in the oxidation mixtures (Figure 7B). This data shows that the 20% effect is not 
observed in solution cooxidations of D2-LA, suggesting that D2-LA does not act as an antioxidant 
but rather as a less reactive co-oxidant in solution31 
A KIE of 12.8 ± 0.6 was determined in cooxidation experiments, a value that is somewhat 
higher than the KIE determined using the methyl linoleate clock.31 This is likely due to error 
associated with the low slope for the plot of trans,cis-/trans,trans-HODEs coming from D2-LA 
autoxidation. Based on the errors inherent with the low slope of the D2-LA experiments, the KIE 
of 12.8 from cooxidation experiments would appear to be more reliable. Deuteration has been 
shown to substantially slow the rate of enzymatic oxidation of 11,11-D2-LA, with KIE values in 
the range of 80-100.38,39,40,41,42  However, the KIE for autoxidation of 11,11-D2-LA falls in the 
upper range of previously reported values for other primary deuterium KIEs in autoxidation, which 
normally are less than 7.43,44,45,46 
Oxygen Consumption 
The autoxidation of PUFAs results in depletion of oxygen in solution and previous work 
has used the changes in oxygen levels to report on relative maximum rates of oxidation for fatty 
acids ranging from oleate to arachidonate.47 If variables are carefully controlled (specifically Ri, 
Equation 5), it is possible to obtain quantitative measurements of a PUFAs’ susceptibility to 
78 
 
undergo autoxidation by measuring its oxidizability, or kp/(2kt)
1/2.36 With the use of thermally 
labile azo initiators such as AIBN, the induction period method35 can be used to measure Ri. This 
allows for the oxidizabilities of PUFAs to be determined according to Equation 6 (vida supra).36 
 Oxygen consumption studies were carried out in the laboratory of Ross Barclay (Mount 
Allison University, Sackville, New Brunswick, CA) by means of an automatic recording gas 
absorption apparatus. Using the induction period method, the value for oxidizability was calculated 
from a Pryor plot (Figure 10) to be 1.96 (± 0.16) x 10-2 M-1/2 s-1/2, in excellent agreement with 
previously reported values.36 Oxidizability for D2-LA (Figure 10) was calculated to be over four 
times less than LA at 0.447 (± 0.04) x 10-2 M-1/2 s-1/2. Assuming that the consumption of one 
molecule of  oxygen is directly proportional to the formation of one peroxyl radical (and 
subsequently, one HpODE after hydrogen atom donation during propagation), the propagation rate 
constant (kp) should also be directly proportional to the rate of oxygen consumption. If so, the KIE 
should be equal to the ratio of oxygen consumption as shown in Equation 7: 
 
𝑲𝑰𝑬 =
[
−𝒅[𝑶𝟐]𝑯
𝒅𝒕
]
[
−𝒅[𝑶𝟐]𝑫
𝒅𝒕
]
     ( 7 ) 
 
This assumption yields a KIE of 4.4, significantly lower than KIE values obtained by 
comparisons of propagation rate constants as determined through the use of the methyl linoleate 
clock. While the measurement of oxygen consumption is a useful tool for determining 
oxidizabilities of reactive substrates, the small changes in pO2 that would be associated with the 
autoxidation of unreactive compounds such as D2-LA introduce significant errors into the 
experiments. A recent study has also suggested that Clark-type electrodes introduce significant 
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error into measurement of oxygen tension within a bulk liquid. Hansen and coworkers found that 
electrodes inserted directly into solution act as baffles, altering the hydrodynamics of the liquid as 
it is shaken. This results in a rise in the maximum oxygen tranfer capacity between the liquid and 
the electrode surface. Furthermore, low volumes of liquid in the flask may result in measurement 
of oxygen present in the headspace of the apparatus.48 
Despite the shortcomings of the method, monitoring oxygen consumption during 
cooxidation of LA and D2-LA was useful for again testing reports that D-PUFA concentrations as 
low as 20% afforded maximum protection against peroxidation in yeast. Two variations of 
cooxidations were carried using this technique. In the first, LA and D2-LA were mixed in ratios 
from 1:0 to 0:1 (D0:D2). The measurement of oxidizability for the various mixtures of LA and D2-
LA revealed that oxidizability decreased in linear fashion as the mole fraction of D2-LA present in 
the reaction cell increased. A linear decrease in oxidizability was also observed in the second 
cooxidation experiments in which D2-LA was added incrementally added to already autoxidizing 
LA. These results are in agreement with cooxidations analyzed by HPLC-UV, supporting the 
earlier conclusions from competition experiments that D2-LA is merely a less oxidizable substrate 
in solution. 
2.4. Determination of Propagation Rate Constants for Sterol Intermediates from the Bloch 
and Kandutsch-Russell Biosynthetic Pathways to Cholesterol 
 Sterols are a subgroup of lipids defined as “any chiral tetracyclic isopentenoid which may 
be formed by cyclization of squalene oxide…and retains a polar group at C3 (hydroxyl or keto), 
an all-trans,anti-stereochemistry in the ring system and a side chain 20R-configuration.”49 
Cholesterol (Figure 15) is present in nearly all cellular plasma membranes50 and is biosynthesized 
by either the Kandutsch-Russell51 pathway or Bloch52 pathway, discussed in Chapter I. The free 
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radical oxidation of cholesterol has been implicated in a number of human disorders including 
atherosclerosis,53 Alzheimer’s disease,54 retinal degeneration,55 cataracts,56,57 and Niemann-Pick 
C1 disease.58  
 
 
  
 
 
 
 
Breakdown of the biosynthetic pathways to cholesterol is also detrimental to human 
development and health. One disorder of intense interest associated with this breakdown in 
cholesterol biosynthesis is Smith-Lemli-Opitz syndrome (SLOS). SLOS is an autosomal recessive 
disorder that affects 1 in 20-60,000 individuals. It is characterized by elevated levels of 7-
dehydrocholesterol (7-DHC) and by decreased levels of cholesterol. This is a direct result of 
mutations in the gene that encodes 7-dehydrocholesterol reductase (DHCR7), the enzyme that 
catalyzes the reduction of the 7,8-double bond of 7-DHC to form cholesterol (Figure 16). The 
consequences of mutations in DHCR7 are increased levels of 7-DHC and decreased levels of 
cholesterol.  
Figure 15. Cholesterol is biosynthesized in vivo by either the 
Kandutsch-Russell or Bloch pathways. The free radical oxidation 
of this important compound has been associated with a number of 
human diseases. 
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Recent work has determined propagation rate constants for both 7-DHC (2260 ± 40 M-1 s-
1) and cholesterol (11 ± 1 M-1 s-1).4 The unusually high propagation rate constant for 7-DHC, and 
the oxysterols formed during its autoxidation, have been implicated in the pathophysiology of 
SLOS.59 From these studies it has become apparent that any disruption in the biosynthesis of 
cholesterol can have drastic effects. Indeed, other disorders associated with deficiencies in 
cholesterol biosynthesis have been identified including CDPX260,61,62 and lathosterolosis,63,64 and 
oxidative stress is a component of each. 
Due to the importance of the biosynthesis of cholesterol and the damage that can occur 
when sterol homeostasis is perturbed, the propagation rate constants for a number of sterol 
intermediates on the cholesterol biosynthesis pathway have been determined and are reported 
here.30 
 
2.5. Results 
Propagation rate constants for various sterols and analogs were measured using the methyl 
linoleate clock.30 In a typical experiment, sterols or analogs and methyl linoleate were purified and 
Figure 16. Cholesterol is biosynthesized from 7-DHC by the enzyme 7-
dehydrocholesterol reductase (DHCR7). Patients with SLOS have deficiencies 
associated with DHCR7, resulting in inefficient conversion of 7-DHC to cholesterol, 
resulting in a buildup of 7-DHC and a number of oxysterols detrimental to cell 
health. 
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dried under vacuum prior to oxidation. In oxidations, methyl linoleate was held constant at 0.3 M, 
and concentrations of the lipid cooxidant were varied depending on their reactivity and solubility. 
All oxidations were initiated with the thermally labile azo initiator MeOAMVN. Reactions were 
initiated at 37 ˚C and quenched after 1 h with the addition of BHT and PPh3. The linoleate HODEs 
were analyzed by HPLC-UV, monitoring at 234 nm. Results from these experiments are presented 
below. 
Side Chain Analog of Bloch Pathway Sterols 
 One pathway for cholesterol biosynthesis is the Bloch pathway,52 in which the 20(R)-side 
chain bears a double bond between carbons C24-C25. This unit of unsaturation adds eight allylic 
hydrogen atoms that could potentially be abstracted by a peroxyl radical. Side chain unsaturation 
could increase propagation rate constants for the Bloch pathway sterol intermediates compared to 
their Kandutsch-Russell pathway analogs, which have a saturated C24-C25 bond. DHCR24 
reduces all Bloch intermediates to the Kandutsch-Russel analogs (Figure 17). 
 
 
 
 
 
 
 
 
 
 
Figure 17. The Bloch and Kandutsch-Russell biosynthetic pathways are separated 
by the reduction of the C24-C25 double bond by 24-dehydrocholesterol reductase. 
This ‘crossover’ can presumably occur at any time during biosynthesis. Desmosterol 
to cholesterol is shown here as an example. 
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 In order to understand the contribution of the side chain unsaturation to the overall 
propagation rate constant of Bloch pathway sterols, the propagation rate constant of a side chain 
model, 2-methyl-2-heptene, was determined (Figure 18). The propagation rate constant of this 
olefin was calculated to be 5.6 ± 0.2 M-1 s-1. 
 
 
 
 
 
 
 
 
Desmosterol 
 Desmosterol is a Bloch pathway sterol intermediate which is separated from cholesterol by 
the reduction of the C24-C25 double bond (Figure 17, vide supra). As with most of the sterols, the 
solubility of desmosterol is low in benzene. Therefore, the concentration range spanned from 0.05 
M to 0.625 M. The propagation rate constant for desmosterol was calculated to be 16 ± 5 M-1 s-1 
from the results shown below in Figure 19. Due to the small range of concentrations used and the 
relatively low reactivity, errors in this value are particularly high. 
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Figure 18.  The propagation rate constant for 2-methyl-2-heptene was calculated at 5.6 ± 0.2 
M-1 s-1 through the use of the methyl linoleate clock. The structure and plot of 
trans,cis/trans,trans-HODEs versus the concentration of 2-methyl-2-heptene are shown. 
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Lathosterol and Zymostenol 
 Propagation rate constants for lathosterol and zymostenol were also measured. Both sterols 
are a part of the Kandutsch-Russell pathway and have very low levels of solubility in benzene. 
Therefore, concentration ranges tested for both sterols ranged from 0.05 to roughly 0.17 M. The 
rate constants were calculated to be 57 ± 3 M-1 s-1 and 77 ± 5 M-1 s-1, respectively. Structures and 
plots of trans,cis-/trans,trans-HODEs versus the concentration of sterol are shown below in Figure 
20 for both compounds. 
 
 
 
 
 
 
Figure 19. The propagation rate constant for desmosterol was determined over a concentration 
range of 0.05 to 0.625 M. kp was calculated to be 16 ± 5 M
-1 s-1 by plotting the trans,cis-
/trans,trans-HODE ratio against the concentration of desmosterol in solution. 
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Figure 20. Results from measurement of propagation rate constants for A. Lathosterol and B. 
Zymostenol. Propagation rate constants were measured by plotting the ratio of                          
trans,cis-/trans,trans-HODEs versus the concentration of the respective sterol. Propagation rate 
constants were calculated to be 57 ± 3 M-1 s-1 for lathosterol and 77 ± 5 M-1 s-1 for zymostenol. 
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2.6. Discussion 
As discussed previously the free radical oxidation of cholesterol and 7-DHC has been 
implicated in a number of human diseases and disorders.  Furthermore, propagation rate constants 
vary widely for these sterols (11 M-1 s-1 and 2260 M-1 s-1 for cholesterol and 7-DHC, respectively).4 
Inborn errors in this pathway play and important role in the pathophysiology of certain human 
syndromes such as SLOS, CDPX2, and lathosterolosis. 
In general, sterols in the biosynthetic pathway are typically present at low levels relative to 
cholesterol. For instance, physiological concentrations of 7-DHC in healthy human plasma is very 
low (0.005 to 0.05 mg/dL)65 compared to cholesterol (~220 mg/dL).66 Patients with SLOS 
typically have  much higher plasma levels of 7-DHC (10 mg/dL or greater) and substantially 
reduced levels of cholesterol.65 There have also been reports of prescribed pharmaceuticals having 
marked effects on sterol profiles as well, even leading to elevated plasma levels of 7-DHC on par 
with those seen in SLOS for otherwise healthy individuals. Some drugs linked to these increases 
include aripiprazole, an atypical antipsychotic, and trazodone, an antidepressant(Figure 21).67,68  
 
 
Figure 21. A number of pharmaceuticals have been shown to alter the homeostasis of 
sterol intermediates in the biosynthesis of cholesterol. Aripiprazole and trazodone, both 
pictured here, are two commonly prescribed pharmaceuticals which have such effects. 
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 Based on the studies outlined previously, it is apparent that cholesterol biosynthesis and 
homeostasis can be affected by genetics, environmental exposures, and xenobiotics alike. 
Furthermore, certain intermediates of cholesterol biosynthesis such as 7-DHC and 8-DHC undergo 
autoxidation with high propagation rate constants.4,69 Therefore, the rate constants for other 
intermediates in the biosynthetic pathway were determined using the methyl linoleate clock30 in 
order to understand how their accumulation would affect oxidative stress. 
 The Bloch and Kandutsch-Russell biosynthetic pathways are separated by enzymatic 
reduction of the side chain C24-C25 double bond by 24-dehydrocholesterol reductase (Figure 
22A). This side chain double bond has the potential to contribute to the overall propagation rate 
constant as it adds eight abstractable allylic hydrogen atoms to the molecule. In order to understand 
the contribution of this unsaturation to the propagation rate constants of sterols, the propagation 
rate constant of a suitable side-chain analog, 2-methyl-2-heptene (Figure 22B), was measured. 
Using the methyl linoleate free radical clock, the propagation rate constant for this analog was 
calculated to be 5.6 ± 0.2 M-1 s-1. This low propagation rate constant suggests that the unsaturated 
side chain will contribute little to the overall propagation rate constant of Bloch pathway sterol 
intermediates. 
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Desmosterol is the biosynthetic precursor to cholesterol in the Bloch biosynthetic 
pathway.52 The C24-C25 double bond is reduced by 24-dehydrocholesterol reductase to give 
cholesterol. The propagation rate constant was calculated to be 16 ± 5 M-1 s-1 for desmosterol 
(Figure 23), similar to that of cholesterol (11 ± 1 M-1 s-1).4 This result suggests that even though 
desmosterol contains one more double bond (C24 to C25) than cholesterol, the unsaturation in the 
side chain contributes little to the overall propagation rate constant. This conclusion is supported 
by previous results from 2-methyl-2-heptene. Based on these findings, it seems reasonable to 
Figure 22. A. The biosynthesis of cholesterol occurs via the Bloch or Kandutsch-Russell 
pathways. Starting from lanosterol, the two pathways are separated by the reduction of the C24-
C25 double bond. B. 2-methyl-2-heptene was used as an analog for the side chain unsaturation of 
the Bloch pathway sterols. Its propagation rate constant was calculated to be 5.6 ± 0.2 M-1 s-1 using 
the methyl linoleate clock. 
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suggest that propagation rate constants for sterol intermediate analogs in the Bloch and Kandutsch-
Russell biosynthetic pathways will be similar. 
 
  
 
Lathosterol (Figure 24), the penultimate sterol to cholesterol in the Kandutsch-Russell 
pathway,51 is oxidized by lathosterol 5-desaturase to give 7-DHC. This sterol was calculated to 
have a propagation rate constant of 57 ± 3 M-1 s-1, five times faster than cholesterol (11 ± 1 M-1 s-
1)4 and similar to that of linoleate (62 M-1s-1).36,37 Zymostenol (Figure 24), the immediate precursor 
to lathosterol, was also found to have a propagation rate constant on the same order of magnitude 
at 77 ± 5 M-1 s-1. These propagation rate constants suggest that peroxidation and oxysterol buildup 
Figure 23. The C24-C25 double bond of desmosterol is reduced by 24-
dehydrocholesterol reductase to give cholesterol during the last step of 
cholesterol biosynthesis. The propagation rate constant of desmosterol was 
calculated to be 16 ± 5 M-1 s-1, similar to that of cholesterol (11 ± 1 M-1 s-1), 
suggesting that the unsaturated side chain contributes little to the overall 
propagation rate constants of Bloch pathway sterol intermediates. 
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could also be issues for individuals who experience elevated levels of these sterol intermediates 
whether due to a genetic disorder, environmental exposure, or prescription drug usage. 
 
 
The range of propagation rate constants for sterols is impressively large. Based on a 
comparison of rates for cholesterol (11 ± 1 M-1 s-1) and desmosterol (16 ± 5 M-1 s-1), it appears that 
the side chain unsaturation between C24-C25 contributes little to the overall propagation rate 
constant of Kandutsch-Russell pathway sterols. Experiments measuring the propagation rate 
constant for  2-methyl-2-heptene, an analog for the unsaturated side chain, confirm the small 
contribution to the overall rates. Therefore, the propagation rate for any sterol intermediate will be 
largely determined by the configuration of unsaturation located in the B-ring of the sterol. While 
the calculated propagation rate constants for  intermediate sterols zymostenol and lathosterol fall 
well short of those determined for 7-DHC4 and 8-DHC,69 they demonstrate that disruption of 
cholesterol biosynthetic pathways has the potential to promote undue levels of oxidative stress 
through the buildup of sterols with sizeable propagation rate constants. 
 
 
Figure 24. Propagation rate constants were calculated for zymostenol and lathosterol 
using the methyl linoleate clock. Values were 77 ± 3 M-1 and 57 ± 3 M-1 s-1, 
respectively. 
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2.7. Conclusions 
 As discussed, autoxidation of lipids has been implicated in a variety of human pathologies. 
Some of these, including SLOS, lathosterolosis, and CPDX2, involve errors in the cholesterol 
biosynthetic pathway resulting in an imbalance of sterols. In SLOS patients, 7-DHC levels have 
been shown to be elevated with respect to unaffected individuals. 7-DHC has also been shown to 
be the most reactive lipid towards autoxidation with a propagation rate constant of 2260 M-1 s-1.4 
Beyond diseases affecting cholesterol biosynthesis, small molecules have also been shown to alter 
the levels of various sterol intermediates along both the Bloch and Kandutsch-Russel cholesterol 
biosynthetic pathways.65 Thus, rate constants for other sterols upstream of both 7-DHC and 8-
DHC were determined using the methyl linoleate clock.30 Experiments revealed propagation rate 
constants on par with linoleate for some of the sterols. The side chain unsaturation integral to the 
Bloch pathway sterols was found to contribute little to the overall rate of autoxidation, through 
measurement of propagation rate constants for desmosterol and 2-methyl-2-heptene, an analog for 
the unsaturated side chain of Bloch pathway sterols. 
 Fatty acids, especially PUFAs, are also very susceptible to free radical attack. Peroxyl 
radicals primarily attack the bis-allylic methylene group, abstracting hydrogen atoms at this 
location due to their low BDE. A new method for curbing the damage done during during these 
attacks – the isotopic reinforcement of the bis-allylic methylene groups with deuterium – was 
studied. The data covered in this chapter suggests a significant deuterium isotope effect  for LA vs 
D2-LA during propagation, and that increasing levels of D2-LA present during autoxidation 
resulted in a linear decrease in HODE formation. Oxygen consumption experiments on 
cooxidizing mixtures of LA and D2-LA confirmed these observations. Oxidizability was also 
measured for both LA and D2-LA by using the induction method. Similar to measurement of 
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propagation rate constants by the methyl linoleate clock, oxidizability studies demonstrated that 
the D2-LA is indeed less reactive towards autoxidation LA. Therefore, isotopic reinforcement of 
PUFAs appears to be a plausible method for reduction of peroxide buildup during autoxidation. 
 In closing, Figure 25 presents the structures for every lipid whose propagation rate constant 
has been determined in these studies, as well as important lipids which have been studied 
previously. 
 
 
 
 
 
Figure 25. Catalog of propagation rate constants for select lipids. 
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2.9. Experimental 
Materials 
 The fatty acids used in these studies were LA, 11,11-D2-LA, and their ethyl esters. LA and 
its ethyl ester (>99 % purity) were obtained from Nu-Chek Prep (Elysian, MN). 11,11-D2-LA was 
obtained from Retrotope, Inc. Its synthesis has been described previously.22 2-methyl-2-heptene 
(98 %) and benzene (anhydrous, 99.8 %) were obtained from Sigma-Aldrich (St. Louis, MO). 
Benzene was passed through a plug of neutral alumina and stored over 4 Å molecular sieves prior 
to use. 
Measurement of Propagation Rate Constants for LA and D2-LA and Cooxidation Experiments 
 Propagation rate constants for LA and D2-LA were measured through the use of the methyl 
linoleate clock.30 Prior to all experiments, PUFAs were purified by flash column chromatography 
(10 % to 20 % ethyl acetate in hexanes) and dried overnight under vacuum. A stock solution of 
2,2’-azobis(4-methoxy-2,4-dimethyl)-valeronitrile (MeOAMVN) in benzene (0.1 M) was used to 
initiate all reactions. For clocking and cooxidation of PUFAs, reagents were added in the order of: 
(1) benzene, (2) PUFA, (3) MeOAMVN. For sterol intermediates, reagents were added in the order 
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of: (1) benzene, (2) sterol, (3) linoleate, (4) MeOAMVN. Reaction vials were vortexed for 5 s, 
followed by heating at 37 ˚C for 1 h. Each reaction was quenched by the addition of 25 μL of both 
0.5 M butylated hydroxytoluene (BHT) and 0.5 M triphenylphosphine (PPh3). All experiments 
were carried out in triplicate. 
 Ethyl esters of LA or D2-LA were used when measuring propagation rate constants. The 
oxidation products, HODEs, were analyzed by normal phase HPLC-UV (250 x 4.6 mm silica 
column; 5 μm; elution solvent, 0.5 % 2-propanol in hexanes; monitoring wavelength 234 nm). The 
residual amount of D1-LA and LA in the D2-LA starting material were determined by 
1H NMR 
analysis to be 2.9 and 0.8 mol %, respectively. These values were used to correct data from 
experiments using D2-LA, assuming that D1-LA is half as reactive as LA. 
 In cooxidation (or competition) experiments, the total amount of PUFA (LA + 11,11-D2-
LA) was held constant at 0.64 M while varying the ratio of LA:D2-LA. After quenching the 
reactions with BHT and PPh3, 4-methoxybenzyl alcohol was added as an internal standard for 
HPLC-UV analysis. The samples were then split. One part was analyzed by HPLC-UV for total 
HODE formation (250 x 4.6 mm silica column; 5 μm; elution solvent, 1.4 % 2-propanol and 0.1 
% acetic acid in hexanes; monitoring wavelength, 234 nm). To the other part, 500 ng of D4-13-
trans,cis-HODE was added as an internal standard for LCMS analysis (150 x 4.6 mm silica 
column; 3 μm; elution solvent, 1.4 % 2-propanol and 0.1% acetic acid in hexanes). Samples were 
introduced into the mass spectrometer using an atmospheric pressure chemical ionization (APCI) 
source in negative mode, and HODEs were monitored using selective reaction monitoring 
(SRM).4,32 
 LCMS analysis of cooxidation experiments with large ratios of LA:D2-LA (>1:5) were 
used to calculate KIE by comparing total D0-HODEs to D1-HODEs. Calculations of the total D1-
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HODE formed from D2-LA autoxidation took into account both D1-HODEs from 11-D1-LA 
oxidation as well as isotopic contribution from D0-HODEs. The percentage of D1-LA in the 11,11-
D2-LA starting material was 2.9 % (vide supra). This was used to correct the D1-HODEs fromed 
from D1-LA assuming that D1-LA is half as reactive as LA in solution. Isotopic contribution of 
D1-HODEs from LA oxidation (i.e. D0-HODEs) was determined by running the same LCMS 
analysis on the autoxidation of pure LA. 
Oxygen Consumption Studies 
 Oxygen consumption was measured using the induction period method.35 Experiments 
were carried out in an automatic recording gas absorption apparatus similar to those described 
elsewhere.33,34 All experiments were carried out at 37 ˚C under 760 torr of O2. In a typical 
experiment, both reaction and reference cells contained known volumes (1 mL) of benzene. 
Known volumes of LA or D2-LA stock solutions in benzene were injected into the reaction cell 
and shaken vigorously for 15-20 minutes to allow for thermal equillibrium to occur between the 
reaction and reference cells. A known volume of 2,2’-azobis-isobutyrylnitrile (AIBN) stock 
solution was then added to the reaction vessel after which autoxidation began immediately. Once 
a steady rate of autoxidaiton was achieved, known volumes of a stock solution of 2,2,5,7,8-
pentamethyl-6-chromanol (PMHC) in chlorobenzene was added to the reaction cell. 
 Using n=2 for PMHC and the length of time, τ, that the oxygen uptake is inhibited, Ri was 
determined by the slope of a plot of 2[PMHC] versus τ. Oxidizability of the substrate, kp/(2kt)1/2, 
is equal to the slope of the plot of oxygen consumption versus [PUFA]Ri
1/2. These plots are 
otherwise known as Pryor plots. 
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Measurement of Propagation Rate Constants for Sterols 
 Propagation rate constants for various sterols and the unsaturated side chain analog 2-
methyl-2-heptene were carried out using the methyl linoleate clock.30 Prior to all experiments, 
linoleate and sterols were purified by flash column chromatography (10% to 20% ethyl acetate in 
hexanes, depending on the compound) and dried overnight under vacuum. 2-methyl-2-heptene was 
purified by distillation at 122 ˚C. A 0.1 M stock solution of MeOAMVN in benzene was used to 
initiate all reactions. Reagents were added in the order of: (1) benzene, (2) sterol or 2-methyl-2-
heptene, (3) linoleate, (4) MeOAMVN. Reaction vials were vortexed for 5 s, followed by heating 
at 37 ˚C for 1 h. Each reaction was quenched by the addition of 25 μL of both 0.5 M BHT and 0.5 
M PPh3. HODEs were monitored using HPLC-UV under the conditions described above. 
 
Synthesis of Desmosterol 
 
 The sterol phosphonium salt 1 (889.3 mg, 1.05 mmol) was dissolved in THF (10 mL). A 
2.5 M solution of nBuLi in THF (0.42 mL, 1.05 mmol) was added dropwise. After turning orange, 
the reaction was stirred at rt for 30 min. The reaction was then cooled to -78 ˚C. Acetone (77 μL, 
1.05 mmol), which was freshly distilled from crushed Dri-Rite, was slowly added. The reaction 
was allowed to warm to rt and stirred for 4 h. Solvent was evaporated by rotary evaporation, and 
Figure 26. Synthesis of desmosterol. 
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the residue was purified by flash column chromatography (10 % ethyl acetate in hexanes). The 
resulting white solid was immediately dissolved in THF (10 mL). TBAF (1.0 M in THF) was 
added (0.8 mL) to the solution. The reaction was stirred overnight at rt, after which it was pouried 
into 10 mL of a DCM-water mixture (50:50). The aqueous layer was extracted with DCM (2 x 20 
mL). The organic fractions were collected and dried over magnisum sulfate. The solvent was then 
removed by rotary evaporation. The residue was purified by flash column chromatography (10 % 
ethyl acetate in hexanes) to give a white solid (127.5 mg, 80 %). Spectral data was in agreement 
with previously published results.70 1H NMR (CDCl3, δ): 5.32 (d, J = 6.8 Hz, 1H), 5.06 (m, 1H), 
3.49 (m, 1H), 2.24 (m, 2H), 1.99 (m, 3H), 1.81 (m, 4H), 1.65 (s, 3H), 1.57 (s, 3H), 1.43 (m, 8H), 
1.15 (m, 6H), 0.98 (s, 3H), 0.91 (d, J = 8.7 Hz, 3H), 0.65 (s, 3H). 13C NMR (CDCl3, δ): 140.7, 
130.9, 125.2, 121.7, 71.7, 56.7, 56.0, 50.1, 42.3, 42.2, 39.7, 37.2, 36.4, 36.0, 35.6, 31.8, 31.6, 28.2, 
25.7, 24.7, 24.3, 21.0, 19.4, 18.6, 17.6, 11.8. 
Synthesis of Lathosterol 70 
 
 
  
 
 
 
 
7-dehydrocholesterol (1.025 g, 2.67 mmol) was dissolved in a mixture of ethanol (50 mL) 
and dioxane (32 mL). Hydrogen was bubbled through the solution for 10 min. Raney-Nickel slurry 
(0.5 mL) was added to the flask. A hydrogen baloon was attached to the flask, and the reaction 
Figure 27. Synthesis of lathosterol from 7-DHC. 
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was allowed to run at room temperature for 5 h. The reaction was then filtered, and solvent was 
removed from the filtrate by rotary evaporation. Residue was purified by flash column (20 % ethyl 
acetate in hexanes) to yield a white flaky solid (0.85 g, 2.21 mmol, 83 %). Spectral data was in 
agreement with previously published results.70 1H NMR (CDCl3, δ): 5.16 (m, 1H), 3.60 (m, 1H), 
2.02 (m, 1H), 1.81 (m, 6H), 1.56 (m, 9H), 1.23 (m, 12H), 0.93 (d, J = 3.6 Hz, 3H), 0.86 (dd, J = 
6.6 Hz, 1.9 Hz, 6H), 0.80 (s, 3H), 0.53 (s, 3H). 13C NMR (CDCl3, δ): 139.6, 117.4, 71.07, 56.2, 
55.0, 49.4, 43.4, 40.3, 39.6, 39.5, 38.0, 37.1, 36.2, 36.1, 34.2, 31.5, 29.6, 28.0, 27.9, 23.9, 23.0, 
22.8, 22.6, 21.6, 18.8, 13.0, 11.8. 
Synthesis of Zymostenol 
 
  
Synthesis of 8,14-DHC (2). 7-dehydrocholesterol (1, 2.0 g, 5.2 mmol) was dissolved in a 
mixture of CHCl3 (20 mL) and acetic acid (5 mL). Concentrated HCl (0.5 mL, 6.0 mmol) was 
added and the reaction was heated to reflux. After 2 h, the reaction was cooled and diluted with 
ethyl acetate (20 mL). The organic layer was washed with  sat. sodium bicarbonate (30 mL) and 
brine (30 mL), then dried over magnesium sulfate. Solvent was removed by rotary evaporation, 
and residue was purified by flash column (20 % ethyl acetate in hexanes) to give a yellow powder 
Figure 28: Synthesis of zymostenol. a) AcOH/HCl; b) TBSCl; c) BH3•THF, NaOH/H2O2; d) 
Pyridine, phenyl chlorothionocarbonate; e) (Bu)3SnH, AIBN; f) TBAF. 
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(1.52 g, 76 %). 1H NMR (CDCl3, δ): 5.34 (br. s., 1H), 3.61 (m, 1H), 2.33 (m, 2H), 2.18 (m, 2H), 
2.03 (m, 3H), 1.83 (m, 3H), 1.51 (m, 11H), 1.12 (m, 6H), 0.97 (s, 3H), 0.91 (d, J = 6.2 Hz, 3H), 
0.84 (d, J = 6.6 Hz, 6H), 0.79 (s, 3H). 13C NMR (CDCl3, δ): 151.1, 140.8, 123.0, 117.4, 71.0, 57.2, 
45.0, 40.9, 39.5, 38.4, 36.9, 36.5, 36.1, 35.9, 35.3, 34.0 31.7, 28.0, 36.6, 25.3, 32.7, 22.8, 22.5, 
31.8, 18.8, 18.3, 15.4. HRMS (ESI) calcd [M+H]+ 385.3465, found 385.3438. 
 Synthesis of TBS protected 8,14-DHC (3). 8,14-DHC (2, 1.52 g, 3.95 mmol) was dissoved 
in THF/DMF (20 mL, 1:1). TBS chloride (0.9 g, 6.0 mmol) and imidazole (0.6 g, 8.8 mmol) were 
added to the solution. The reaction was allowed to proceed overnight at room temperature, after 
which it was diluted with ethyl acetate (20 mL). The organic layer was washed with water (30 mL) 
and brine (30 mL). The organic layer was then dried over magnesium sulfate. Solvent was removed 
by rotary evaporation, and residue was purified by flash column (10% ehtyl acetate in hexanes) to 
give a yellow powder (1.86 g, 94 %). 1H NMR (CDCl3, δ): 5.34 (br. s., 1H), 3.56 (m, 1H), 2.33 
(m, 2H), 2.18 (m, 2H), 2.04 (m, 3H), 1.76 (m, 2H), 1.44 (m, 11H), 1.12 (m, 6H), 0.96 (s, 3H), 0.92 
(d, J = 7.9 Hz, 3H), 0.87 (s, 9H), 0.86 (d, J = 4.4 Hz, 6H), 0.79 (s, 3H), 0.04 (s, 6H). 13C NMR 
(CDCl3, δ): 151.2, 141.1, 122.9, 117.2, 71.8, 57.2, 45.0, 41.0, 39.5, 38.8, 36.9, 36.6, 36.1, 35.9, 
35.5, 34.0, 32.1, 28.0, 26.6, 25.9, 25.3, 23.7, 22.8, 22.5, 21.8, 18.9, 18.4, 18.2, 15.6, -4.6. HRMS 
(ESI) calcd [M+H]+ 499.4330, found 499.4335. 
Synthesis of TBS protected Zymostenol-OH (4). 3-OTBS-8,14-DHC (3, 1.86 g, 3.73 mmol) 
was dissolved in THF (30 mL) and cooled to 0 ˚C. BH3·THF was added dropwise to the solution. 
After 4 h, the reaction was slowly quenched with aqueous 1 N NaOH (15 mL) and H2O2 (15 mL) 
and stirred for 1 h. The reaction was then diluted with ethyl acetate (30 mL) and washed with water 
(3 x 30 mL), saturated sodium bicarbonate (3 x 30 mL) and brine (3 x 30 mL). The organic layer 
was dried over magnesium sulfate, and solvent was removed by rotary evaporation. The residue 
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was purified by flash column (10 % ethyl acetate in hexanes) to give a white foam (1.0 g, 52 %). 
1H NMR (CDCl3, δ): 4.05 (dt, J = 9.5 Hz, 3.6 Hz, 1H), 3.55 (m, 1H), 2.11 (m, 4H), 1.90 (m, 2H), 
1.78 (dd, J = 8.8 Hz, 3.9 Hz, 1H), 1.68 (m, 2H), 1.41 (m, 20H), 1.11 (m, 8H), 0.93 (s, 3H), 0.86 
(m, 19H), 0.61 (s, 3H), 0.03 (s, 6H). 13C NMR (CDCl3, δ): 136.3, 126.5, 72.0, 71.9, 59.5, 52.9, 
43.2, 40.6, 40.5, 39.4, 38.7, 37.1, 36.0, 35.9, 35.8, 35.2, 32.0, 27.9, 27.3, 25.9, 25.5, 23.7, 22.8, 
22.7, 22.5, 18.5, 18.2, 17.7, 12.4, -4.6. HRMS (ESI) calcd [M+H]+ 517.4435, found 517.4422. 
 Synthesis of Thiocarbonate Ester (5). TBS Zymostenol-OH (4, 0.40 g, 0.77 mmol) was 
dissolved in CH2Cl2 (4 mL). Pyridine (0.12 mL, 1.48 mmol) was added, followed by thioformate 
(0.16 mL, 1.16 mmol). After 30 min, the reaction was diluted with ethyl acetate (10 mL) and 
washed with water (3 x 15 mL) and brine (3 x 15 mL) and dried over magnesium sulfate. Solvent 
was removed by rotary evaporation, and the resulting residue was purified by flash column (5 % 
ethyl acetate in hexanes) to give a white foam (0.38 g, 74 %). 1H NMR (CDCl3, δ): 7.27 (m, 5H), 
5.38 (dt, J = 9.9 Hz, 3.5 Hz, 1H), 3.56 (m, 1H), 2.56 (d, J = 10.3 Hz, 1H), 2.06 (m, 8H), 1.71 (m, 
3H), 1.42 (m, 12H), 1.10 (m, 6H), 0.95 (s, 3H), 0.92 (d, J = 6.1 Hz, 3H), 0.87 (m, 12H), 0.70 (s, 
3H), 0.04 (s, 6H). 13C NMR (CDCl3, δ): 194.9, 153.4, 137.0, 129.4, 126.4, 125.5, 122.0, 121.0, 
85.4, 71.9, 55.5, 53.2, 42.6, 42.5, 40.6, 39.4, 38.7, 37.0, 36.8, 35.9, 35.8, 35.2, 32.0, 28.0, 26.8, 
25.9, 25.4, 23.9, 22.8, 22.7, 22.5, 18.3, 18.2, 17.7, 12.3, -4.6. 
 Synthesis of TBS Protected Zymostenol (6). A solution of the thiocarbonate ester (5, 0.38 
g, 0.58 mmol), tributyltin hydride (0.23 mL) and azobisisobutyronitrile (10 mg) in toluene (3 mL) 
was sparged with argon for 20 min at rt. The reaction was then heated to 100 ˚C. After 30 min, the 
reaction was cooled and concentrated by rotary evaporation. The resulting residue was purified by 
flash column (10 % CH2Cl2 in hexanes) to give a white powder (0.16 g, 55 %). 
1H NMR (CDCl3, 
δ): 3.55 (m, 1H), 1.89 (m, 6H), 1.57 (m, 8H), 1.25 (m, 9H), 1.15 (m, 6H), 0.92 (s, 3H), 0.90 (d, J 
101 
 
= 6.6 Hz, 3H), 0.86 (m, 12H), 0.83 (d, J = 1.3 Hz, 3H), 0.58 (s, 3H), 0.03 (s, 6H). 13C NMR (CDCl3, 
δ): 135.2, 128.0, 72.0, 54.8, 51.9, 42.1, 40.9, 39.5, 38.8, 37.3, 37.0, 36.2, 36.1, 35.7, 35.3, 32.1, 
28.8, 28.0, 27.2, 25.9, 25.5, 23.9, 23.8, 22.8, 22.5, 18.7, 18.2, 17.9, 12.8, 11.1,   -4.6. 
 Synthesis of Zymostenol (7). Tetrabutylammonium fluoride (1.0 M in THF) (1 mL, 1.0 
mmol) was added to a solution of 3-OTBS-zymostenol (6, 0.32 g, 0.64 mmol) in THF (3 mL). 
Reaction proceeded overnight, after which it was diluted with ehtyl acetate (10 mL) and washed 
with brine (3 x 10 mL). The organic phase was dried over magnesium sulfate. Solvent was removed 
by rotary evaporation. Residue was then purified by column chromatography (20 % ethyl acetate 
in hexanes) to give a white powder (0.18 g, 74 %). The spectral data of 7 is in agreement with 
previously published results.71 1H NMR (CDCl3, δ): 3.58 (m, 1H), 1,98 (m, 6H), 1.74 (m, 5H), 
1.55 (m, 6H), 1.34 (m, 8H), 1.15 (m, 5H), 0.92 (s, 3H), 0.0.89 (d, J = 6.5 Hz, 3H), 0.84 (d, J = 1.3 
Hz, 3H), 0.82 (d, J = 1.3 Hz, 3H), 0.58 (s, 3H). 13C NMR (CDCl3, δ): 134.9, 128.2, 71.1, 60.4, 
54.8, 51.9, 49.3, 44.2, 42.0, 40.7, 39.5, 38.3, 37.2, 36.9, 36.7, 36.2, 36.1, 35.9, 35.7, 35.1, 31.6, 
29.6, 28.7, 28.0, 27.2, 25.8, 25.5, 23.9, 23.7, 22.8, 22.5, 19.9, 19.0, 18.7, 17.8, 14.1, 11.2. HRMS 
(ESI) calcd [M+H]+ 387.3621, found 387.3617. 
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Chapter III 
 
TOCOPHEROL-MEDIATED PEROXIDATION 
 
3.1. Introduction 
 The free radical oxidation of sterols and fatty acids has attracted attention in recent years 
due to the association of lipid peroxidation and oxidized lipid products with a number of human 
pathologies including atherosclerosis,1,2,3 cancer,4,5 acute lung injury6,7 and neurodegenerative 
disorders such as Alzheimer’s8,9 and Parkinson’s disease.10 Exposure to reactive oxygen species 
(ROS) from normal cellular metabolism or environmental toxicants is a common part of life. 
Aerobic organisms have a number of integrated enzymatic and nonenzymatic antioxidant systems 
to counteract ROS damage. In pathological conditions listed above, the antioxidant systems are 
often overwhelmed.11 
 Enzymatic antioxidant systems play an important role in counterbalancing the effect of 
ROS on biological systems. One of the major enzymatic systems is the superoxide dismutase 
(SOD)/catalase (CAT) couple. SOD, largely considered to be a bulk scavenger of superoxide 
radicals in biological systems, catalyzes the breakdown of superoxide through Equation 1, shown 
below. 
 
𝑂2
− + 2𝐻+ → 𝐻2𝑂2    ( 1 ) 
 
The hydrogen peroxide formed during SOD action is then reduced to water by catalase (CAT) as 
shown in Equation 2.  
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2𝐻2𝑂2 → 2𝐻2𝑂 + 𝑂2    ( 2 ) 
  
While enzymatic antioxidant systems such as the SOD/CAT couple play a large role in 
protecting organisms from rampant oxidative stress, small molecule antioxidants are also heavily 
utilized for the same purpose in biological systems. One of the most prevalent and highly studied 
of these antioxidants is α-tocopherol, commonly referred to as Vitamin E (Figure 1).  
 
 
Tocopherol is the most prevalent and efficient antioxidant in Nature.12 It exists in four 
different structures shown in Figure 1, with α-tocopherol (TocH) being the most potent free radical 
chain breaking antioxidant. The free radical chain oxidation of lipids propagates through a rate-
limiting hydrogen atom transfer (kp) to lipid peroxyl radicals (Equation 1, Figure 2).  TocH inhibits 
this propagation step through hydrogen atom donation to the chain carrying peroxyl radical 
species, generating a tocopheryl radical (Toc·) during the process (Equation 3, Figure 2). The 
phenolic Toc· is highly stabilized through resonance delocalization, making it relatively inert and 
unlikely to continue the chain reaction.12 This species will eventually trap a second peroxyl radical 
to terminate the chain sequence (Equation 4, Figure 2). 
 
Figure 1. The basic phenolic framework of all tocopherols is pictured on the left, with 
designations for R1, R2, and R3 for α, β, γ, and δ-tocopherols on the right. 
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While all of the tocopherols are good chain breaking antioxidants, α-tocopherol has the 
fastest inhibition rate constant (kinh = 3.5 x 10
6 M-1 s-1),13,14,15 even faster than numerous synthetic 
phenolic antioxidants. TocH also has a thermodynamic advantage for breaking free radical chain 
reactions. The BDE of the phenolic O-H is 77.1 kcal mol-1,16 at least 11 kcal mol-1 lower than that 
of a typical alkyl hydroperoxide O-H bond (82-89 kcal mol-1).17 This results in favorable 
thermodynamic conditions in which TocH readily transfers a hydrogen atom to a peroxyl radical 
as the new bond being formed is stronger than the bond being broken. 
TocH is the major lipid-soluble radical trapping antioxidant in Nature.12 It is present at 
concentrations higher than any other antioxidant in plasma lipoproteins, including human low-
density lipoprotein (LDL).12,18,19 The LDL particle, shown in Figure 3, is composed of three major 
components. The outer shell of this particle is comprised of Apoprotein B100 embedded in a coat 
of polar lipids, 85% of which are phosphatidylcholine (40% containing PUFA). The core of the 
Figure 2. Lipid peroxidation (kp) and inhibition (kinh) by α-tocopherol or 
other free radical chain-breaking antioxidants. 
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particle is comprised mainly of cholesterol esters, 40% of which are cholesteryl linoleate, as well 
as TocH (6 mol/mol of LDL), ubiquinol (CoQH2), and assorted carotenoids.
18,19,20 
 
 
 
LDL is one of the five major groups of lipoprotein. The main function of LDL and others 
is to shuttle lipids around the body for cells to take up as needed, with LDL being the major 
cholesterol-bearing lipoprotein in human blood plasma. Congruent with its physical composition, 
LDL is also susceptible to attack from reactive oxygen species (ROS). Indeed, oxidative 
modification of LDL has been implicated as an initiator of atherosclerosis,21,22 as oxidative 
modification can lead to increased and uncontrolled uptake of cholesterol by macrophages.23 This 
is largely thought to be an early step in a number of cellular responses leading to the formation of 
fatty streaks in arterial walls and the eventual formation of atherosclerotic lesions.21 A great deal 
of research has been devoted to the prevention of lipid peroxidation in LDL by natural antioxidants 
but cell, animal, and clinical studies have been largely disappointing.24 
Figure 3. Basic structure of the LDL particle. Apoprotein B100 is embedded in the polar 
coat lipids, which consists of roughly 85% phosphatidylcholine. The neutral core lipids 
are comprised primarily of cholesterol esters, 40% of which are cholesteryl linoleate. 
TocH, CoQH2, and other carotenoids also reside in this region.
12,18,19 
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 While studying the oxidation of LDL under a steady flux of peroxyl radicals, Bowry and 
coworkers found that rates of peroxidation decreased as TocH was consumed.25 The slowest rates 
of lipid peroxidation were recorded when one or fewer molecules of TocH remained in the LDL 
particle.25 Additional experiments showed that enrichment with exogenous TocH accelerated 
peroxidation rates.25 In other words, rates of lipid peroxidation within the LDL particle were higher 
when the concentration of TocH is high. Further studies on the oxidation of LDL by both lipid- 
and water-soluble peroxyl radicals showed that TocH can actually act as a prooxidant in LDL 
when rates of initiation are low and concentrations of TocH are high.26 
 The result of these studies was a new hypothesis on how TocH can act under the constraints 
discussed in the previous paragraph. When TocH acts as a chain-breaking antioxidant, it is able to 
scavenge peroxyl radicals at a rate (kinh) of 3.5 x 10
6 M-1 s
-1,13,14,15 leading to a decrease in 
concentration of the propagating peroxyl radical species (Equation 3, Figure 2). The tocopheryl 
radical (Toc·) generated after H-atom donation then rapidly reacts with other peroxyl radicals in 
solution (ca. 3 x 108 M-1 s-1) to give non-radical products (Equation 4, Figure 2).27 When TocH 
concentrations are high or rates of initiation are low, the steady state concentration of the 
tocopheryl radical becomes orders of magnitude greater than peroxyl radicals in solution. The 
tocopheryl radical becomes the main propagating species despite its low rate constant for 
abstracting a hydrogen atom (kTMP = 0.1 M
-1 s-1) (Equation 5, Figure 4).28 This results in 
suppression of Toc· termination reactions (Equation 4, Figure 2). The end result is an acceleration 
in rates of lipid peroxidation.29 This process has been named tocopherol-mediated peroxidation 
(TMP, Figure 4).29 
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As reported in Chapter II of this dissertation, the deuterated polyunsaturated fatty acid 
11,11-D2-linoleic acid (D2-LA) is 10-fold less reactive than the natural polyunsaturated fatty acid 
(PUFA) via comparison of their propagation rate constants.30 The H/D isotope effects measured 
were outside of the typical range of kH/kD (<10) that has been reported for other H/D-atom transfers 
from hydrocarbons to peroxyl radicals.31,32,33,34 These findings led to an expanded study of isotope 
effects in C-H/C-D free radical transfer reactions. Here, we report the results of studies of 
tocopherol-mediated oxidations of several D-PUFAs which are shown in Figure 5. 
  
 
Figure 4. Tocopherol-mediated peroxidation.  
Figure 5. Library of PUFAs and D-PUFAs used for studies of tocopherol-mediated oxidations in 
solution. 
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3.2. Results 
 Linoleic acid (LA), α-linolenic acid (Lnn), and deuterated derivatives of these fatty acids 
were subjected to azo-initiated free radical oxidations in benzene in the presence of TocH in 
concentrations of 0.05 to 0.5 M. The fatty acid concentration was 0.64 M, and a 0.1 M stock 
solution of 2,2’-azobis(4-methoxy-2,4-dimethyl)-valeronitrile (MeOAMVN) in benzene was used 
to initiate the oxidations (final concentration of 0.005 M) at 37 ˚C. As previously reported, these 
conditions resulted in a relatively simple mixture of trans,cis-conjugated diene products.35,36,37 
Peroxides formed during oxidations were reduced to the corresponding alcohols using PPh3 prior 
to analysis. HPLC-UV and HPLC-MS were used  to analyze products as previously 
described.38,39,30 High resolution mass spectrometry (HRMS) was also used to measure products 
formed during Lnn/11,11,14,14-D4-Lnn cooxidations. 
Tocopherol-Mediated Oxidations of LA and D2-LA Mixtures 
 Cooxidations of LA and D2-LA were carried out in the presence of 0.5 M TocH. The ratio 
of LA:D2-LA was greater than 1:5 in all experiments due to the low reactivity of D2-LA towards 
autoxidation.30 The extent of oxidation after 1 hr was measured to be approximately 2% for LA in 
the absence of TocH,40 therefore the concentration of LA (or D2-LA) will essentially remain 
constant over the course of an oxidation with TocH in solution. The presence of TocH results in 
the formation of a simple mixture of 9-trans,cis- and 13-trans,cis-HODEs which were analyzed 
by HPLC-MS. A typical chromatogram for these experiments is shown in Figure 6. The kH/kD was 
calculated to be 29.2 ± 2.9 in the presence of 0.5 M TocH and 24.4 ± 2.4 in the presence of 0.05 
M TocH. 
115 
 
  
The HODEs from the cooxidation experiments above were also collected by HPLC-UV. 
High resolution mass spectrometry (HRMS) was completed for each HODE on a Waters Synapt 
G2 time of flight (TOF) instrument using direct liquid introduction (DLI). Typical mass spectra 
from these experiments are shown below in Figure 7. The HODEs from LA autoxidation and D1-
HODEs from D2-LA autoxidation differed in m/z = 1 Da. Using data obtained from these 
experiments, KIE (kH/kD) was calculated to be 23.0 ± 2.3 after correction of the D1-HODEs for 
isotopic contribution from HODEs. 
 
 
 
 
Figure 6. Typical chromatogram for HPLC-MS analysis of the cooxidation of LA and D2-LA. 
From top to bottom panel are: 13-trans,cis-HODE, 13-trans,cis-D1-HODE, 9-trans,cis-HODE, 
and 9-trans,cis-D1-HODE. 
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Tocopherol-Mediated Oxidations of D1-LA 
D1-LA was also oxidized in the presence of 0.5 M TocH. In these experiments the attacking 
peroxyl or tocopheryl radical will have the option of abstracting either H or D from the reactive 
bis-allylic carbon atom. This results in a product mixture where H-atom abstraction results in 
products still containing deuterium at the bis-allylic center and vice versa for D-atom abstraction 
(Figure 8). HODEs were analyzed using LC-MS. The value of kH/kD for this experiment was 
calculated to be 8.9 ± 0.9. A typical chromatogram for LC-MS analysis of the product mixture is 
shown in Figure 9. 
 
 
 
 
 
 
Figure 7. Typical high resolution mass spectra for 13-trans,cis-HODE and 9-trans,cis-HODE 
after HPLC-UV separation and collection. Samples were introduced into the ion source (- APCI) 
by DLI. 
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Figure 8. The free radical oxidation of D1-LA in the presence of TocH results in a simple mixture 
of trans,cis-HODEs. H-atom abstraction gives HODEs that still contain deuterium at the bis-allylic 
carbon atom, with the opposite being true for D-atom abstraction. 
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Figure 9. Typical chromatogram from HPLC-MS analysis for oxidations of D1-LA in the presence 
of 0.5 M TocH. The top two panels show trans,cis-D1-HODEs from H-atom abstraction. The 
bottom two panels show trans,cis-D0-HODEs from D-atom abstraction. 
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Tocopherol-Mediated Oxidations of Lnn and its Deuterated Derivatives 
 When oxidized in the presence of TocH, Lnn gives four conjugated diene hydroperoxides 
with -OOH substitution at carbons 9, 12, 13, and 16. Hydrogen atom abstraction from C11 gives 
the 9- and 13-hydroperoxides. The 13- and 16-hydroperoxides come from hydrogen atom 
abstraction at C14. Reduction of the product mixture with PPh3 after oxidation gives the 
corresponding alcohols (Figure 10).   
 
 
 
Analysis of these products by HPLC-UV shows a slight preference for H-atom abstraction 
at C11 over C14 (1.05 to 1.00). This preference was factored in to calculations of kH/kD for all of 
Figure 10. Free radical oxidation of Lnn in the presence of TocH. The products arising 
from hydrogen atom abstraction at the two bis-allylic methylene groups (C11 and C14) 
are shown after PPh3 reduction. 
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the experiments in this section. A typical HPLC-UV chromatogram of the product mixture are 
shown in Figure 11. 
 
  
 
 
 
 
 
 
 
 
 
Cooxidations of Lnn and D4-Lnn were carried out in the presence of 0.5 M TocH, with 
ratios of PUFA to D-PUFA at 1 to 4 respectively. The extent of oxidation was kept below 5% by 
allowing oxidation to occur for only 1 hr. The four oxidation products were individually collected 
using the same HPLC-UV conditions described for LA and D2-LA cooxidations. Samples were 
then analyzed using a Waters Synapt G2 by DLI. Figure 12 shows typical mass spectra for each 
of the oxidation products (9-, 12-, 13-, and 16-OH). The D0- and D3-products differ by m/z = 3 Da, 
therefore minimal corrections were needed to account for isotopic overlap. The value of kH/kD for 
these experiments was calculated to be 32.3 ± 3.2. Oxidations were also carried out in the presence 
of 0.05 M TocH, resulting in a kH/kD value of 36.3 ± 3.6. 
 
 
Figure 11. A typical HPLC-UV chromatogram of the product mixture from 
Lnn oxidations in the presence of TocH after PPh3 reduction. 
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Figure 12. Typical mass spectra acquired by HRMS for the 9-, 12-, 13-, and 16-OH products from 
Lnn and D4-Lnn cooxidations. 
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The selectively deuterated Lnn series (11,11-D2-Lnn, 14,14-D2-Lnn, and 11-D1-Lnn) were 
oxidized individually in the presence of 0.5 M and 0.05 M TocH. Oxidations were analyzed by 
HPLC-UV. An overlay of typical chromatograms for each compound oxidized in the presence of 
0.5 M TocH is shown in Figure 13. The oxidation of 11,11-D2-Lnn resulted mainly in products 
derived from hydrogen atom abstraction at C14. Oxidation of 14,14-D2-Lnn resulted in products 
from hydrogen atom abstraction at C11. 11-D1-Lnn gave products from either hydrogen or 
deuterium atom abstraction at C11 and hydrogen atom abstraction at C14. Products arising from 
hydrogen or deuterium abstraction at C11 equaled 47% of the products formed by abstraction of 
hydrogen at C14. The kH/kD for 11,11-D2-Lnn was calculated to be 36.1 ± 3.6, and 35.9 ± 3.6 for 
14,14-D2-Lnn. The same compounds oxidized in the presence of 0.05 M TocH gave lower kH/kD 
values of 30.9 ± 3.1 for 11,11-D2-Lnn and 31 ± 3.1 for 14,14-D2-Lnn. 
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Figure 13. Typical HPLC-UV chromatograms for oxidations of 11,11-D2-Lnn, 
14,14-D2-Lnn, and 11-D1-Lnn (top to bottom) in the presence of 0.5 M TocH. 
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3.3. Discussion 
 TMP was first discovered while studying LDL oxidation under a steady flux of peroxyl 
radicals.25 Bowry and coworkers noted that rates of lipid peroxidation were higher within the LDL 
particle early on when concentrations of TocH were at their highest, suggesting that TocH was 
acting in a prooxidant capacity. These results were surprising since TocH is generally recognized 
as an excellent chain breaking antioxidant. 
 While the prooxidant activity of TocH was surprising, this behavior is not entirely 
unexpected for phenolic antioxidants and inhibitors. It has long been understood that unhindered 
phenols will increase oxidation rates of hydrocarbons. For example, addition of phenol to already 
oxidizing solutions of cumene results in the acceleration of oxidation rates while the addition of 
the more hintered 2,6-tert-butyl phenol has no influence (Figure 14A). These studies indicated that 
unhindered phenolic radicals are able to propagate radical reactions. This propagation reaction can 
interfere with typical termination reactions of phenolic radicals (Figure 14B).41,42 
Figure 14. Effects of phenolic antioxidants on rates of oxidation. A) Addition of phenol or 2,6-
tert-butyl phenol to already autoxidizing solutions of cumene shows that the unhindered phenol 
accelerates the rate of oxidation. B) Propagation by the phenolic radical inhibits typical termination 
reactions.40,41 
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As discussed in Chapter II, primary deuterium KIEs for H/D atom transfers are less than 
10 for hydrocarbons.31,32,33,34 Previous work has shown that in the absence of any antioxidants, the 
propagation rate constant for D2-LA is some 10-fold less than the propagation rate constant of the 
natural fatty acid, and that KIEs for the H or D atom transfer to a propagating peroxyl radical are 
as high as 12.8.30 These results stimulated an expanded study of the D-PUFAs under conditions in 
which tocopherol mediated peroxidation (TMP) will occur.  
Table 1 shows KIEs calculated from the tocopherol-mediated oxidations of a number of 
D-PUFAs (shown in Figure 5). The KIEs measured under conditions where tocopherol-mediated 
oxidation predominates43 were substantially higher than those previously reported in the absence 
of antioxidants30 for D-PUFAs containing two or more deuterium atoms. The finding of KIEs 
(kH/kD) greater than 20 for autoxidation in the presence of TocH does not have precedence in the 
literature. These large KIEs are only observed for geminal H2/D2 substitution (i.e. 11,11-D2-LA vs 
LA). The KIE observed for D1-LA (-CHD-) is unexeptional.  
 
 
 
0.5 M TocH 0.05 M TocH
PUFA k H /k D k H /k D Method of Analysis
11,11-D2-Lnn 36.1 ± 3.6 30.9 ± 3.1 HPLC-UV
14,14-D2-Lnn 35.9 ± 3.6 31.0 ± 3.1 HPLC-UV
Lnn/11,11,14,14-D4-Lnn Cooxidation 32.3 ± 3.2 36.3 ± 3.6 DLI-HRMS
LA/11,11-D2-LA Cooxidation 29.2 ± 2.9 24.4 ± 2.4 LCMS
LA/11,11-D2-LA Cooxidation 23.0 ± 2.3 NA DLI-HRMS
11-D1-LA 8.9 ± 0.9 NA LCMS
Table 1. List of KIEs ± 10% variance, along with the method of analysis. 
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 For both 11,11-D2-Lnn and 14,14-D2-Lnn, intermolecular competition between H and D-
atom abstraction was set up between CH2 and CD2 bis-allylic methylene groups. Both compounds 
were oxidized in the presence of TocH at low (0.05 M) or high (0.5 M) concentrations and kH/kD 
was determined at each TocH concentration by comparison of products arising from H- or D-atom 
abstraction (Figure 15). 
 
 
 
 
The kH/kD values calculated for both 11,11-D2-Lnn and 14,14-D2-Lnn were notably larger 
at the higher concentrations of TocH. Previous work by Bowry and Stocker noted that when TocH 
concentrations are high the tocopheryl radical is the main propagating species. This occurs despite 
the slow rate of H-atom abstraction by the tocopheryl radical (kTMP) because termination reactions 
of Toc· (kTerm) are suppressed by the Toc· forming reaction (kinh). As the concentration of TocH 
decreases the peroxyl radical begins to play a larger role in propagation and normal termination 
reactions of Toc· occur (Figure 16).29 Propagation by peroxyl radicals results in lower kH/kD values 
for D-PUFAs in the absence of antioxidants,40 suggesting that the decrease in KIE at lower TocH 
concentrations is due to participation by this species.  
 
Figure 15. Values calculated for kH/kD for both 11,11-D2-Lnn and 14,14-D2-Lnn at low and high 
concentrations of TocH. 
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Cooxidations of Lnn/D4-Lnn and LA/D2-LA gave similarly high kH/kD values (Figure 17). 
Products from the Lnn and D4-Lnn cooxidations were collected individually by HPLC-UV and 
analyzed using HRMS. The products from Lnn versus D4-Lnn oxidation differed by m/z = 3 Da, 
so values for kH/kD needed minimal corrections for isotopic overlap. Cooxidations of LA and D2-
LA analyzed by LCMS also showed decreased kH/kD values at lower TocH concentrations (Figure 
17).  
 
Figure 17. kH/kD values calculated for cooxidations of Lnn/D4-Lnn and LA/D2-LA 
cooxidations at high (red) and low (blue) concentrations of TocH. 
Figure 16. Free radical oxidation of PUFAs at low (blue) and high (red) concentrations of TocH, 
and the relationship to kH/kD values. 
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Mono-deuterated 11-D1-Lnn and D1-LA were also oxidized in the presence of 0.5 M TocH. 
HPLC-UV analysis of 11-D1-Lnn oxidations showed that products arising from H- or D-atom 
abstraction at C-11 were equal to 47% of the products formed from abstraction of either H-atom 
at C-14 (Figure 18). This suggests that no secondary isotope effects are present. Products from D1-
LA were analyzed by LCMS and kH/kD was calculated to be 8.9 (Figure 18). This significantly 
decreased KIE suggests that geminal substitution of D and H (-CHD-) does not offer the same 
resistance towards H- or D-atom abstraction as bis-allylic carbons substituted with two D-atoms 
(-CD2-). 
 
Figure 18. Large KIEs calculated for H or D atom transfer to other stabilized oxygen-centered 
radicals. A. H(D) atom transfer from hydrocarbons to phthalimide N-oxyl radicals44-46; B. KIE for 
H(D) atom transfer from hydroxyl amines to nitroxides47; C. H(D) atom transfer from tocopherol 
to oxygen centered radicals such as 2,6-di-tert-butyl-4-(4’-methoxyphenyl)phenoxyl.48 
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Although the high KIEs reported here are unprecedented for PUFA autoxidation, previous 
studies of KIEs have reported kH/kD values in excess of 10 in the presence a stabilized oxygen-
centered radical. For instance, KIEs of 27 have been reported for H or D atom transfers from 
carbon to phthalimide N-oxyl radicals, shown below in Figure 18A.44,45,46 Other large KIEs (kH/kD 
= 20-25) have been reported for the self-exchange of H or D from hydroxylamines to nitroxides 
(Figure 18B).47 Mukai and coworkers carried out exhaustive studies of reactions in which the 
tocopheryl radical is involved and found similarly high KIEs for hydrogen atom transfer from 
TocH (kinh) to oxygen centered radicals (kH/kD = 22.9) as shown in Figure 18C.
48 These studies 
suggest that hydrogen atom tunneling is important in the process of H or D atom transfer to 
oxygen-centered radicals. 
The results reported in this chapter are of interest not only because of the high KIEs 
measured, but also because tocopherol-mediated peroxidation (TMP) has been suggested to play 
an important role in the oxidative modification of human LDL.49,50,51 It is hypothesized that the 
LDL particle provides an excellent setting for this type of oxidation to occur due to its size and 
composition.29  The following arguments describe how TMP is able to oxidatively modify LDL:29 
1) Only one radical at a time may persist in an LDL particle for longer time intervals. 
2) Lipophilic radicals formed in LDL (i.e. tocopheryl radical) cannot diffuse freely between 
particles. 
3) LDL particles are struck by aqueous peroxyl radicals at a very low rate (10-3 s-1, or roughly 
1 strike every 17 minutes). 
4) Despite the slow rate for kTMP (0.1 M-1 s-1), the TMP reaction could occur around 100 times 
over the peroxyl radical strike intervals. 
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There is substantial evidence in the literature to suggest that these arguments are indeed a 
plausible description of how TMP occurs within the LDL particle. The tocopheryl radical has been 
observed by electron paramagnetic resonance (EPR) spectroscopy in peroxidizing LDL.52 Other 
experiments have revealed that the tocopheryl radical does not rapidly escape lipid particles such 
as liposomes,53 membrane fragments,53,54 and micelles55,56 in aqueous dispersions. These studies 
as a whole suggest that the tocopheryl radical persists (on EPR time scales) within the LDL 
particle, and is able to propagate free radical chain oxidation of PUFAs once antioxidant activity 
has been exhausted. 
The effect of isotopic substitution on the rate of tocopherol-mediated oxidations of 
linoleate and linolenate suggest that hydrogen atom tunneling plays a significant role in the 
particularly high KIEs reported here.43 Therefore, it may also play an important role in the 
oxidative modification of LDL when TMP is occuring. The kinetics of TMP have been the subject 
of numerous publications, and the involvment of TocH in the oxidative modification of LDL has 
been a hotly debated topic.50,51,57 The results presented in this chapter by no means settle the score 
on the ultimate function of TocH within the LDL particle. However, they do provide an important 
look into how TocH is able to act as a prooxidant under certain circumstances as opposed to a 
chain-breaking antioxidant. 
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3.5. Experimental 
General Methods and Materials: 
 Deuterium reinforced PUFAs were synthesized as described previously.  The synthesis of 
novel deuterated PUFAs are described below.  All other PUFAs were purchased from Nu-Chek, 
Prep.  MeOAMVN was purchased from Wako Chemicals.  α-Tocopherol (α-Toc) was purchased 
from Sigma-Aldrich Co. and purified by flash column chromatography (10% ethyl acetate in 
hexanes).  All HPLC solvents were purchased from Sigma-Aldrich Co. 
 HPLC analyses were carried out with a Waters 717plus Autosampler coupled to a Waters 
1525 Binary HPLC Pump, both of which were interfaced to a Waters 2996 Photodiode Array 
Detector.  Mass spectrometry was carried out on a Thermo Scientific TSQ Quantum Ultra Triple 
Stage Quadrupole mass spectrometer.  Atmospheric-pressure chemical ionization in negative 
mode was used for the ionization of PUFAs and their oxidation products.  Samples were introduced 
by direct liquid infusion (DLI) and monitored by full-scan in order to minimize any isotope effects
 which may occur during ionization and fragmentation of oxidation products.58  
 For oxidations where the products differ by 1 m/z (e.g. D1-LA oxidations and D0/D2-LA 
co-oxidations), analyses of products containing one deuterium had to be corrected for normal 
isotope contribution from D0-products.  This was done by subtracting 13.1% of the value of the 
integrated D0 product peak from the peak area of the D1 product peak.  This isotopic distribution 
was determined by injections of a standard mixture of D0-LA oxidation products. 
High resolution mass spectrometry isotope ratio analysis: 
For isotope ratio analysis it is crucial to have unbiased sensitivity for isotopic labeled 
molecules. Also, integration functions capable of calculating peak areas are needed in order to 
compare the abundance (concentrations) of these molecules. 
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A Synapt G2 equipped with MassLynx (Waters, Milford, MA) was used to analyze H4/D4-
αLn cooxidations. Three functions are available to obtain integration values for peaks of interest 
depending on the instrumentation used: Integrate (predominately for quadrupole mass analyzers), 
Center (for TDC data) and Automatic Peak Detection (for ADC data). Data was collected utilizing 
a combination of all three approaches thus a comparison of the three strategies is warranted. All 
three functions were used to calculate the KIE values for the H0/D4-αLn Cooxidation. They 
provided the results shown in Figure S1 and are summarized in Table 1, where the results do not 
vary significantly from function to function and all fall within a 10 % variance. Using a 1-sample 
t-test with a hypothesis mean of 32.9 no significant difference between these three KIE values is 
found (p-value of 0.968 with α = 0.05). 
The data in the Synapt G2 was acquired with DLI (15 µL/min) (11 Plus, Harvard 
Apparatus, Holliston, MA) in negative ion mode with an ESI source (T 80º C and capillary voltage 
of 2.7kV). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. kH/kD for Lnn oxidation products using three different 
integration functions for HRMS data. 
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 IR spectra were recorded with Vertex 70 spectrometer. 1H and 13C NMR spectra were 
obtained with a Bruker AC 400 instrument at 400 and 100 MHz respectively, in CDCl3 (TMS at 
δ = 0.00 or CHCl3 at δ = 7.26 for 1H and CHCl3 at δ = 77.0 for 13C as an internal standard). 
General Oxidation Procedure: 
 All PUFAs were purified by flash column chromatography (10 % EtOAc in hexanes to 20 
% EtOAc in hexanes) and dried for 2 to 3 hours under vacuum before use.  Stock solutions of 2,2’-
azobis(4-methoxy-2,4-dimethyl)-valeronitrile (MeOAMVN, 0.1 M) and α-Toc (1.0 M) were 
prepared in benzene.  For all experiments, reagents were added in the order of: (1) benzene, (2) 
PUFA, (3) α-Toc (if appropriate), (4) MeOAMVN.  Reaction vials were vortexed for 5 s and heated 
at 37 °C for 1 h.   Each reaction was quenched by the addition of 25 µL of both 0.5 M butylated 
hydroxytoluene (BHT) and 0.5 M PPh3.  All experiments were carried out in triplicate.  
Additionally, t=0 samples were prepared by dispensing purified PUFA into a vial and quenching 
via procedure outlined above without being oxidized, done concurrently with the corresponding 
experiment. 
HPLC Separations: 
 Oxidation products of PUFAs (as the free acid) were separated by HPLC-UV (250 x 4.6 
mm silica column; 5 µm; elution solvent, 1.4 % isopropanol, 0.1 % acetic acid in hexanes; 1.0 
ml/min; monitoring wavelength, 234 nm).  For samples where mass spectrometry was used, 
Function Average KIE 
Standard 
Deviation 
Percent Error 
Integrate 32.1 1.7 5.3 
Center 34.4 3.1 8.9 
Automatic Peak Detection 32.3 1.8 5.5 
 
Table 2. Average kH/kD, standard deviation, and percent error for the three integration functions. 
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oxidation products were collected using HPLC-UV (same conditions as above) into vials 
contianing BHT.  Collected products were introduced to the ion source (- APCI) by direct liquid 
introduction (DLI) using the same solvent conditions listed above. 
 Oxidation products of PUFA methyl esters were separated by HPLC-UV (250 x 4.6 mm 
silica column; 5 µm; elution solvent, 0.5 % isopropanol in hexanes; 1.0 ml/min; monitoring 
wavelength, 234 nm). 
Synthesis of 11-D1-linolenic acid 
 
 
1-Deutero-1-bromo-octa-2,5-diyne (2) 2-Iodoxybenzoic acid (IBX, 35.0 g) was added in one 
portion to a solution of 1,1-dideuteroocta-2,5-diyn-1-ol (1) [1] (5.50 g) in ethyl acetate (400 ml) 
(1,2-dichloroethane can be applied alternatively). The reaction mixture was stirred with 
simultaneous heating under reflux for 15 h until disappearance of (1) (TLC control). The reaction 
mixture was diluted with pentane (300 ml) and kept at 0oC for 3 h. The reaction mixture was 
filtered, and precipitate additionally washed with pentane. Methanol (20 ml) was added to the 
filtrate followed by NaBH4 (0.60 g). After stirring for 15 min (TLC control) the reaction mixture 
was washed with brine (50 ml). The organic layer was dried over Na2SO4 and solvent was gently 
removed under reduced pressure. The residue was purified by flash column (n-pentane/diethyl 
 
Figure 20. Synthetic route to 11-D1-linolenic acid (11-D1-Lnn). 
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ether 10:1) to yield 1-deuteroocta-2,5-diyn-1-ol (3.02 g, 55 %). IR (CCl4): ν̃ = 3622 cm-1. 1H NMR 
(CDCl3, δ): 4.25 (m, 1H, CHD), 3.19 (m, 2H, CH2), 2.16 (m, 2H, CH2), 1.63 (br. s., 1H, OH), 1.09 
(t, J = 7.5 Hz, 3H, CH3). 
13C NMR (CDCl3, δ): 82.3, 80.6, 78.2, 72.7, 51.0 (t, J = 23 Hz), 13.7, 
12.2, 9.7. 
To a solution of 1-deuteroocta-2,5-diyn-1-ol (3.00 g, 24.2 mmol) and pyridine (0.15 ml) in 
dry diethyl ether (15 ml), a solution of PBr3 (0.8 ml, 8.5 mmol) in diethyl ether (3 ml) was added 
dropwise with stirring over 10 min at -15°C under argon. The reaction mixture was allowed to 
gradually warm up to r.t. and then refluxed for 3.5 h with stirring. The reaction mixture was then 
cooled down to -10°C and 10 ml of cold water was added. When the residue dissolved, saturated 
NaCl (10 ml) and pentane (25 ml) were added, and the organic layer was separated. The aqueous 
fraction was washed with pentane (2 x 10 ml), and the combined organic fractions were washed 
with saturated NaHCO3 (5 ml), saturated NaCl (5 ml) and dried over Na2SO4 in the presence of 
traces of hydroquinone. The solvent was removed under reduced pressure. The residue was 
dissolved in pentane and filtered through silica gel (10 ml). Removal of the solvent gave the 
product (3.21 g, 71 %, 39 % starting from 1,1-dideuteroocta-2,5-diyn-1-ol (1)). IR (CCl4): ν̃ = 
2255 cm-1. 1H NMR (CDCl3, δ): 3.90 (m, 1H, CHD), 3.21 (q, J = 2.3 Hz, 2H, CH2), 2.16 (m, 2H, 
CH2), 1.12 (t, J = 7.5 Hz, 3H, CH3). 
13C NMR (CDCl3, δ): 82.6, 81.9, 75.2, 72.0, 14.8 (t, J = 24 
Hz), 13.7, 12.3, 9.8. 
11-Deuterooctadeca-9,12,15-triynoic acid ethyl ester (3) was synthesized as described for the 
synthesis of 11,11-dideuterooctadeca-8,12,15-triynoic acid methyl ester [1, 2]. CuI (6.40 g) was 
quickly added to 15 ml of stirred DMF (freshly distilled over CaH2), followed by dry NaI (5.10 g) 
and K2CO3 (7.20 g). Dec-9-ynoic acid ethyl ester (3.10 g) was then added in one portion, followed 
by bromide (2) (3.20 g). Additional 10 ml of DMF was used to rinse the reagents off the flask 
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walls into the bulk of reaction mixture, which was then stirred for 16 h at r.t. Saturated aqueous 
NH4Cl (25 ml) was then added with stirring, followed in a few minutes by saturated aqueous NaCl 
(15 ml) and then by a 5:1 mixture of hexane : ethyl acetate (30 ml). The mixture was further stirred 
for 15 min and then filtered through a fine mesh Schott glass filter. The residue was washed with 
hexane : ethyl acetate mixture several times. The organic fraction was separated, and the aqueous 
phase was additionally extracted with hexane (3 x 20 ml). The combined organic fractions were 
dried (Na2SO4), traces of hydroquinone were added, and the solvent was evaporated under reduced 
pressure. The residue was purified by flash column (hexane/ethyl acetate 25:1) to give compound 
3 (4.53 g, 95 %) of the title compound. 1H NMR (CDCl3, δ): 4.11 (q, J = 7.2 Hz, 2H, OCH2), 3.12 
(m, 3H, CH2 and CHD), 2.28 (t, J = 7.5 Hz, 2H, CH2CO), 2.15 (m, 4H, CH2), 1.61 (m, 2H, CH2), 
1.48 (m, 2H, CH2), 1.31 (m, 6H, CH2), 1.24 (t, J = 7.2 Hz, 3H, CH3), 1.11 (t, J = 7.4 Hz, 3H, CH3).  
11-Deutero-cis,cis,cis-octadeca-9,12,15-trienoic acid ethyl ester (4) was synthesized as described 
for the synthesis of 11,11-dideutero-cis,cis,cis-octadeca-9,12,15-trienoic acid methyl ester [1, 2]. 
A suspension of nickel acetate tetrahydrate (1.87 g) in 96 % EtOH (25 ml) was heated with stirring 
to approx. 60 - 70°C until the salt dissolved. The flask was flushed with hydrogen, and then 7.7 ml 
of NaBH4 solution (prepared by a 15 min stirring of NaBH4 suspension (0.43 g) in EtOH (10 ml) 
followed by filtering) was added dropwise over 5-10 min with stirring. In 5 min ethylenediamine 
(2.3 ml) was added in one portion, followed in 5 min by an addition of (3) (4.50 g) in EtOH (15 
ml). The reaction mixture was vigorously stirred under hydrogen (1 atm). The absorption of 
hydrogen stopped in about 2 h. To the reaction mixture, 70 ml of hexane and 3.3 ml of acetic acid 
were added, followed by water (6 ml) and the mixture was allowed to separate. Aqueous fractions 
were extracted by 5:1 mixture of hexane : ethyl acetate. The completion of extraction was 
monitored by TLC. The combined organic fractions were washed with diluted solution of HCl, 
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followed by saturated NaCl and saturated NaHCO3, and then dried over Na2SO4. The solvent was 
removed at reduced pressure. Silica gel (Silica gel 60, Merck; 162 g) was added to a solution of 
silver nitrate (43 g) in anhydrous MeCN (360 ml), and the solvent removed on a rotavap. The 
obtained impregnated silica gel was dried for 3 h at 50°C (aspiration pump) and then 8 h on an oil 
pump. 30 g of this silica was used per gram of product. The reaction mixture was dissolved in a 
small volume of hexane and applied to the silver-modified silica gel, eluted with gradient of 
hexane: ether (from 50:1 to 20:1). When the non-polar contaminants were washed off (control by 
AgNO3-impregnated TLC), the product was eluted with ether and the solvent evaporated under 
reduced pressure to give ester 4 (1.91 g, 42 %). IR (CCl4): ν̃ = 1740 cm-1. 1H NMR (CDCl3, δ): 
5.36 (m, 6H, CH-double bonds), 4.12 (q, 2H, J = 7.2 Hz, OCH2), 2.81 (m, 3H, CH2 and CHD), 
2.28 (t, J = 7.5 Hz, 2H, CH2CO), 2.06 (m 4H, CH2), 1.59 (m, 2H, CH2), 1.30 (m, 8H, CH2), 1.25 
(t, J = 7.2 Hz, 3H, CH3), 0.97 (t, J = 7.5 Hz, 3H, CH3). 
13C NMR (CDCl3, δ): 173.9, 131.9, 130.3, 
128.3, 128.2, 127.6, 127.1, 60.1, 34.4, 29.5, 29.1, 29.08, 29.06, 27.2, 25.5, 25.3 (t, J = 19.5 Hz), 
24.9, 20.5, 14.25, 14.23. 
11-Deutero-cis,cis,cis-octadeca-9,12,15-trienoic acid (5) To a solution of (4) (1.20 g, 3.9 mmol) 
in ethanol (8 ml), a solution of KOH (1.10 g, 19.6 mmol) in water (2.5 ml) was added in one 
portion. The reaction mixture was stirred at 40-50 °C for 15 min (control by TLC) and then diluted 
with water (20 ml). Diluted sulfuric acid was added to pH 2, followed by diethyl ether (15 ml) and 
hexane (15 ml). The organic layer was separated and the aqueous layer washed with diethyl 
ether/hexane mixture (3 x 10 ml). The combined organic fractions were washed with saturated 
aqueous NaCl and then dried over Na2SO4. The solvent was removed under reduced pressure and 
the residue was filtered through silica gel (2 ml, eluent: ethyl acetate/hexane 1:1). Evaporation of 
the solvent gave compound 5 (1.08 g, 98 %). HRMS (ESI-QTOF) m/z: [M-H]- Calcd for 
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C18H29DO2 278.2230; Found 278.2227. IR (CCl4): ν̃ = 1741, 1711 cm-1. 1H NMR (CDCl3, δ): 11.4 
(br. s., 1 H, COOH), 5.36 (m, 6H, CH-double bonds), 2.81 (m, 3H, CH2 and CHD), 2.35 (t, 
J = 7.5 Hz, 2H, CH2), 2.06 (m, 4H, CH2), 1.63 (m, 2H, CH2), 1.31 (m, 8H, CH2), 0.97 (t, J = 7.5 Hz, 
3H, CH3). 
13C NMR (CDCl3, δ): 180.3, 131.9, 130.2, 128.3, 128.1, 127.7, 127.1, 34.0, 29.5, 29.1, 
29.04, 28.99, 27.2, 25.5, 25.3 (t, J = 19.5 Hz), 24.6, 20.5, 14.2. 
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Chapter IV 
 
IN-VIVO EFFECTS OF D-PUFAS ON OXIDATIVE STRESS 
 
4.1. Introduction 
4.1.1. Lipid Peroxidation, Oxidative Stress, and D-PUFAs 
 Polyunsaturated fatty acids (PUFAs) are essential nutrients avidly taken up by cells, 
incorporated into phospholipid pools and used as one of the primary building blocks of membrane 
bilayers with more than 30 phospholipid molecules per every protein anchored in the bilayer being 
typical.1 Beyond their importance in imparting membrane structural integrity, PUFAs are also 
metabolized into several signaling compounds or hormones via enzymes such as the 
cyclooxygenases2 and lipoxygenases.3,4 Despite their importance in function, PUFAs are also 
extremely susceptible to attack by peroxyl and hydroxyl radical species.5,6 These oxygen centered 
radicals readily attack the bis-allylic hydrogen atoms, initiating a free radical chain reaction which 
can result in damage to lipid bilayers and related structures through the buildup of peroxides and 
via cis- to trans-isomerization of PUFA double bonds.7,8 This process, known as lipid 
peroxidation, has been implicated in a number of diseases including atherosclerosis,9,10 cancer,11 
acute lung injury,12,13 and neurodegenerative disorders such as Parkinson’s14,15 and Alzheimer’s 
disease.16 
 A common link between these diseases is oxidative stress arising from inflammation. 
Inflammation is generally described by heat, redness, swelling, and pain.17 It can be viewed as a 
classic biological stimulation-response system, or as an organisms’ response to invading 
microorganisms or other environmental exposures.17 Inflammation can also be triggered by 
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physical trauma. Regardless of the initiating event, the processes driving inflammation are 
complex and diverse with a number of proteins and small molecules playing specific roles in the 
inflammatory process.18 Lipid peroxidation has also been directly associated with the 
inflammatory process and can lead to significant cellular damage if left unchecked.18 
 A recent strategy has emerged to diminish lipid peroxidation in vivo based on isotopic 
reinforcement of the bis-allylic methylene, replacing hydrogen atoms with deuterium atoms at 
vulnerable sites.19 These deuterated PUFAs (D-PUFAs) have been shown to increase resistance of 
yeast to oxidative stress,20 to diminish neurodegeneration in a mouse model of Parkinson’s 
disease,21 and to rescue a mammalian cell model for Friedreich ataxia from succumbing to 
oxidative stress.22 Recent work has shown that in the absence of antioxidants, the free radical 
oxidation of 11,11-D2-linoleic acid (11,11-D2-LA) proceeds with a propagation rate constant some 
10-fold less than the propagation rate constant of the natural fatty acid, linoleic acid (LA).23 When 
oxidized in the presence of alpha-tocopherol (TocH) under conditions in which tocopherol-
mediated oxidation predominates,24 D-PUFAs underwent autoxidation at rates of up to 36-fold 
lower than the natural compounds.25 The high kinetic isotope effects (KIEs) measured in these 
experiments coupled with the demonstrated protective effects seen in various disease models 
suggest that D-PUFAs are much more resistant to autoxidation than natural PUFAs. Therefore 
these compounds may be well suited to protect against excessive lipid peroxidation during 
inflammatory processes. 
4.1.2. Inflammation 
 As discussed above, inflammation is a biological process marked by five distinct physical 
features: heat, redness, swelling, pain, and loss of function.17 Inflammation accompanies or causes 
numerous human diseases including atherosclerosis,26 cancer,27 lung,28,29 kidney,30,31 and fatty 
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liver diseases,32 as well as general bacterial infections. It is also a common driving feature of 
neurodegenerative disorders such as Parkinson’s and Alzheimer’s disease and amyotrophic lateral 
sclerosis.33 Macrophages play a prominent and complex role in inflammation since they are part 
of an organism’s innate immune system. 
 The innate immune response relies on the identification of conserved features of pathogens, 
otherwise known as pathogen-associated molecular patterns (PAMPs).34 A prime example is  
lipopolysaccharide (LPS), a common structural feature of Gram-negative bacteria. Macrophages 
are able to detect LPS and initiate inflammatory signaling through toll-like receptor 4 (TLR4), 
releasing a cascade of downstream responses to the pathogen.35,36 The response can manifest itself 
in a number of different ways including engulfment of the pathogen or the production of reactive 
oxygen species (ROS) and reactive nitrogen species (RNS) to kill the pathogen.37,38 Signaling 
molecules such as prostaglandins (PGs),39 leukotrienes,40 and interleukins41 are also released to 
recruit leukocytes in an effort to intensify the inflammatory response to the pathogen.42 Although 
macrophages are commonly associated with an invading pathogen, other environmental factors 
can induce an inflammatory response. Some of these factors include cigarette smoke43,44 and 
exposure to other air pollutants.45 
4.1.3. Lipid Peroxidation, Lipid Electrophiles, and Enzymatic Oxidation 
Oxidized PUFAs are generated during the inflammatory response through a number of 
different pathways. The PUFAs associated with lipid bilayers and other structural components of 
cells are susceptible to free radical oxidation, and the generation of ROS and RNS exacerbates the 
formation of lipid hydroperoxides and other oxidized species. Linoleic (LA) and arachidonic (AA) 
acids are primary targets of peroxidation. The free radical oxidation of these lipids proceeds 
through an identical first step in which a hydrogen atom is abstracted at a bis-allylic methylene 
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group. A delocalized pentadienyl radical is formed in this step and oxygen will rapidly add to this 
radical to give a lipid hydroperoxyl radical. The mechanism of free radical oxidation of LA has 
been discussed at length in previous chapters – typical products formed include HpODEs in either 
trans,cis- or trans,trans-configurations. The corresponding HODEs are formed after reduction of 
these hydroperoxides, and keto-octadecadienoic acids (KODEs) are formed through termination 
reactions. 
The free radical oxidation of AA is much more complex than LA. AA is more susceptible 
to free radical oxidation than linoleate due to the presence of three bis-allylic sites as compared to 
one on LA. As a consequence, the propagation rate constant for AA (201 ± 12 M-1 s-1)46 is roughly 
three times greater than that of LA (62 M-1 s-1).47,48 The two additional bis-allylic centers offer 
extra options for initial hydrogen atom abstraction and open up a much more diverse chemistry 
leading to oxidized products. 
In the presence of good hydrogen atom donors such as TocH, autoxidation of AA results 
in the formation of six major hydroperoxide products known as hydroperoxyeicosatetraenoates 
(HpETEs, Figure 1).49  
 
 
 
 
 
 
 
 Figure 1. Autoxidation of AA in the presence of a TocH gives 6 HpETE 
products, all with trans,cis-conjugated diene configuration. 
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When TocH is not present, autoxidation still produces the six trans,cis-HpETEs shown in 
Figure 1, yet little or none of the trans,trans-HpETEs are observed. This is in stark contrast to the 
major products from linoleate autoxidation in which the trans,trans-HpODEs are formed after β-
fragmentation of the trans,cis-peroxyl radical. This fragmentation proceeds at a rate of roughly 
700 s-1. However, PUFAs containing three or more double bonds are capable of undergoing 
peroxyl radical cyclization, which directly competes with β-fragmentation that occurs at a rate 
from 500 to 1000 s-1. This process, shown in Figure 2, accounts for the fact that little or no 
trans,trans-HpETEs are observed during autoxidation of AA.49 
 
 
 
 
 
 
 
The ability of AA to undergo the cyclization reaction discussed above results in a much 
more complex mixture of products during autoxidation. As cyclization of the initial peroxyl radical 
proceeds, four different regioisomers of isoprostanes are formed. Isoprostanes were first reported 
in 1990,16 and these compounds have since been used as biomarkers of endogenous lipid 
peroxidation50 as evidenced by a number of animal and clinical studies.51,52 The major 
regioisomers of isoprostanes are shown in Figure 3. 
  
 
Figure 2: When a PUFA has three or more double bonds, cyclization of the 
peroxyl radical is able to out-compete β-fragmentation. Little to none of the 
trans,trans-conjugated diene HpETEs are seen for this reason. 
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The inflammatory process generates oxygen radical species that not only attack PUFAs, 
but also target lipids that have already been oxidized. This secondary oxidation can lead to the 
formation of α,β-unsaturated aldehydes of differing electrophilicity, three of which have been 
extensively studied (4-hydroxy-2-nonenal (HNE), 4-oxo-2-nonenal (ONE), and malondialdehyde 
(MDA)).53 
 
 
  
 
 
 
HNE is capable of mediating a wide variety of biological processes through protein 
modification. This modification is thought to occur primarily through Michael addition to 
Figure 3. During autoxidation of arachidonic acid, peroxyl radicals at every position except for C5 
and C15 are able to cyclize and form four sets of regioisomers of isoprostanes. These isoprostanes 
are often used as biomarkers of oxidative stress in biological systems. 
Figure 4. Lipid electrophiles HNE, ONE, and MDA. Such electrophiles are 
formed during secondary oxidation of LA and AA. 
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nucleophilic amino acids such as histidine (His), cysteine (Cys), and lysine (Lys) residues.54 Once 
this adduction occurs, the function of the protein may be altered or lost all together. For instance, 
studies have shown that electrophilic modification of IκB kinase (IKK) results in altered function 
of the NF-κB (Figure 5) signaling pathway which plays an important role in the regulation of 
immune response to infection.55 Keap1, important for protection from oxidative injury through 
regulation of the transcription of antioxidant response element (ARE) genes, also shows altered 
function in the presence of lipid electrophiles.56,57 
 
 
 
 
 
 
 
 
 
 
 
  
While LA and AA are both subject to free radical oxidation reactions during inflammation, 
enzymatic oxidation also occurs when the inflammatory response is activated. Cyclooxygenase-2 
(COX-2), discussed in depth in Chapter 1, is expressed after activation of the TLR-4 signaling 
pathway.58 COX-2 acts on AA that has been released from the lipid bilayer by cytosolic 
Figure 5. HNE inhibition of IκB Kinase (IKK). NF-κB is retained in the 
cytoplasm by the inhibitory protein Iκβα, released only when Iκβα is 
phosphorylated, ubiquinated, or degraded. IKK phosphorylates Iκβα which 
leads to its degradation (1), after which NF-κB is released and translocates 
to the nucleus to modulate gene expression. HNE adducts IKK (2), 
inhibiting the degradation of Iκβα and in turn the translocation of NF-κB to 
the nucleus. 
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phospholipase A2 (cPLA2), generating prostaglandin H2 (PGH2) via bis-oxygenation and 
cyclization. Other eicosanoid signaling molecules such as PGE2 and PGD2 are then formed from 
PGH2 by various synthases.
2,59,60 COX-2 also generates monooxygenated species of AA such as 
11-(R)-HpETE and 15-(S)-HpETE, analogous to the HpETEs that are formed by peroxidation.61 
In circumstances where these HpETEs are of interest, chiral chromatography is essential in 
determining whether the HpETEs were generated by a free radical (racemic) or enzymatic process 
(optically enriched). Figure 6 shows the complexity of products derived from COX-2 activity. 
 
Figure 6. After expression, COX-2 acts on AA released from the lipid bilayer by cPLA2. The 
major product is PGH2, which is used by other synthases to produce a more diverse array of 
signaling eicosanoids. COX-2 is also able to synthesize monooxygenated AA products 11-(R)-
HpETE and 15-(S)-HpETE. 
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4.1.4. “Click Chemistry” 
 Due to the extent of damage cause from protein adduction by lipid electrophiles, there has 
been interest in identifying the proteins that are adducted and the  responsible electrophilic species. 
Early studies identified HNE adducts using Anti-HNE antibodies55,57,62,63,64 but in spite of the 
utility of those antibodies, cross reactivity with other lipid electrophiles has also been an issue.65,66 
Other methods have also been used in an attempt to identify lipids, electrophiles, and 
protein adducts in cellular systems. Stable isotope derivatives of lipids have seen use in tracking 
distribution of lipid classes in organelles,67 and powerful mass spectrometry techniques have been 
leveraged towards the identification of specific lipid electrophile adducts.68 Attempting to track 
specific lipids, metabolites, and decomposition products has proven to be difficult despite all of 
these efforts. Recently, new developments have emerged and shaped the way in which lipids and 
their metabolites are tracked throughout cellular systems. Affinity tags consisting of terminal 
alkynyl functionality on lipids have been successfully used to monitor the distribution of lipids 
throughout cellular membranes.69 Stable but reversible alkyne-cobalt complexes on phosphine-
modified silica were used to isolate lipid species containing the alkynyl tag, followed by mass 
spectrometry.70,69 
This terminal alkynyl tag can also be used to visualize and identify lipid electrophile-
protein adducts using “click chemistry”.71 “Click chemistry” refers to the copper-catalyzed 
Huisgen 1,3-dipolar cycloaddition reaction in which an azide is coupled to a terminal alkyne 
(Figure 7A).72 In initial studies, human colorectal cancer (RKO) cells were enriched with either 
terminally tagged azido-HNE (Az-HNE) or alkynyl-HNE (Al-HNE) in order to label proteins in 
intact cells. This was followed by conjugation to the appropriate biotin conjugated alkynyl 
(aBiotin) or azido (N3-Biotin) compounds, respectively (Figure 7B). Streptavidin beads were used 
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to pull down proteins, which had been adducted by aHNE or N3-HNE and conjugated to biotin 
following the click reaction. The beads were subsequently washed to release the proteins that were 
pulled down. Western blotting was used to verify that adducted proteins had indeed been captured 
by the streptavidin beads. Finally, proteomic analysis of the captured proteins revealed that a 
number of interesting proteins were adducted by the tagged lipid electrophiles and successfully 
captured by streptavidin bead purification.71 Basic workflow for these experiments, along with 
streptavidin Western blots for aHNE are shown in Figure 7C. 
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Figure 7. Click chemistry. A. Copper(I) catalyzed Huisgen 1,3-dipolar 
cycloaddition reaction between an azide and terminal alkyne; B. Variations of 
terminally-tagged alkynyl- or azido- HNE and biotin; C. General workflow of 
experiments using aHNE as the lipid electrophile. The Western blot shows 
protein pull-downs of vehicle (untreated) versus 5 μM treatment of aHNE. 
Cellular lysates (lane 1), breakthrough after washing streptavidin beads (lane 
2), and successive washes (lanes 3,4,5), with final wash eluting the adducted 
proteins (lane 6).71 
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4.2. Experimental Design 
 Inflammation accompanies a number of human diseases and disorders and is a significant 
source of oxidative stress in biological systems. The continual production of ROS and RNS results 
in an oxidative assault on lipids. As discussed in the introduction, D-PUFAs have been shown to 
provide protection from oxidative stress in a number of disease models. They have also been shown 
in solution to be less prone to free radical chain oxidation than their corresponding natural 
substrates. These findings stimulated the exploration of D-PUFAs in biological models of 
inflammation. 
 In the experiments described here, macrophages were used as a model for inflammation. 
As discussed above, macrophages play an important role in innate immune response to the invasion 
of pathogens. Macrophages are found in nearly every body system including the liver, lungs, 
blood, and lymph nodes.  The specific cell line used herein is RAW 264.7 macrophage-like cells. 
This line was derived from BALB/c mice transfected with the Abelson leukemia virus. This 
particular cell type is arguably one of the most studied cell lines in terms of lipidomics. It is the 
official cell of the Lipid Metabolites and Pathways Strategy (LIPID MAPS) project. A large 
compilation of data has been gathered in this cell line including lipid content, mechanisms of lipid 
metabolism, lipid metabolite profiles, and extensive signaling pathway data. 
 The RAW 264.7 macrophages were enriched with a number of different PUFAs, D-
PUFAs, and alkynyl PUFAs, all shown in Figure 8. The macrophages were activated using Kdo2-
Lipid A (KLA), which is a chemically defined analog of lipopolysaccharide (LPS) that also 
activates the TLR-4 signaling pathway. 
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Experiments were designed to address specific questions. The first question was how levels 
of protein adduction (from lipid electrophile formation) were affected by the presence of D-
PUFAs. Click chemistry and streptavidin Western blotting was used extensively to address this 
question. In a typical experiment RAW 264.7 macrophages were plated, enriched with a mixture 
of PUFAs (see Figure 8), allowed to grow, and activated using KLA, with 24 h between each step. 
Cells were collected, lysed, and treated with streptavidin beads to remove any biotinylated 
proteins. Click chemistry was then carried out using Az-Biotin, and proteins were separated by 
tris-glycine polyacrylamide gels (SDS-PAGE) and visualized by streptavidin Western blotting. 
The second question addressed was how levels of lipid metabolites – both from 
peroxidation reactions and enzymatic reactions – were affected by the presence of D-PUFAs. In 
these experiments, macrophages were plated and enriched with either PUFA or D-PUFA, allowed 
to grow, and activated with KLA (again with 24 h between each step). Cells were subsequently 
collected and lipids were extracted by Folch extraction. The lipid extracts were then hydrolyzed 
and analyzed by LCMS using both normal-phase and chiral columns. Reverse-phase methods were 
also utilized to monitor the extent of enrichment for the D-PUFAs and alkynyl analogs as needed. 
Figure 8. PUFAs used throughout RAW 264.7 macrophage experiments. 
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4.3. Results 
Griess Assay 
 Nitric oxide (NO), produced by nitric oxide synthase (iNOS), is a prevalent physiological 
messenger and effector molecule that is associated with oxidative stress.73 Nitrite (NO2
-), a stable 
decomposition product of NO, is commonly measured using the Griess assay. The assay relies on 
a diazotization reaction (Figure 9) that was originally discovered by Peter Griess in 1879.74  
 
 
Macrophages were plated and enriched with 15 μM LA, 8-D2-LA, or D4-LA. Unenriched 
controls were also plated. After +/- KLA treatment, 1 mL of media was removed from each plate. 
100 μL of each media sample was dispensed in a 96-well plate. 50 μL of sulfanilamide solution 
(10 mg/mL in aqueous 5% phosphoric acid) was added to each well. The plate was allowed to 
develop for 10 minutes in the dark at room temperature. 50 μL of NED solution (N-1-
napthylethylenediamine dihydrochloride in water, 1 mg/mL) was then added to each well. The 
plate was again developed at room temperature in the dark for 20 minutes. After incubation, 
absorbance of each well was measured using a plate reader at 550 nm. Absorbance values were 
plotted against a nitrite standard reference curve that was plated and exposed to Griess reagents at 
the same time. Data from this experiment (Figure 10) shows that enrichment with LA or D-PUFA 
does not affect the activity iNOS since NO2
- levels are relatively stable across all enrichment 
Figure 9. The diazotization reaction used in the Griess assay to measure nitrite concentrations in 
cellular media. 
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conditions. This suggests that the presence of D-PUFA does not negatively affect the TLR-4 
signaling pathway. 
 
 
 
 
 
Cyclooxygenase-2 Expression Levels 
 Similar to iNOS, cyclooxygenase-2 (COX-2) expression is induced when the TLR-4 
signaling pathway is activated. In order to determine if D-PUFAs had an effect on COX-2 
expression, macrophages were plated and enriched with 15 μM LA, 8-D2-LA, or D4-LA. 
Unenriched controls were also plated. After +/- KLA treatment the macrophages were pelleted, 
lysed, and proteins were separated using SDS-PAGE. Gels were transferred to 0.45 μm 
nitrocellulose, probed with a COX-2 antibody, and visualized using an Odyssey scanner. Bands 
corresponding to COX-2 were digitized using UN-SCAN-IT gel 6.1 in order to quantify any 
changes in expression level. Results from this experiment (Figure 11) indicate again that the TLR-
Figure 10. Griess assay results, comparing untreated and treated RAW 264.7 macrophages with 
and without KLA activation after no treatment or enrichment with LA, 8-D2-LA, or D4-LA. 
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4 signaling pathway is not affected by the presence of D-PUFAs as expression levels of COX-2 
are relatively stable across all enrichment conditions. 
 
 
 
 
 
 
 
 
 
Figure 11. COX-2 expression levels after various PUFA enrichments. Proteins were separated 
by SDS-PAGE, transferred to 0.45 μM nitrocellulose, and probed with a COX-2 antibody. 
Experimental conditions are found below the blot on the left. Band intensity for COX-2 for each 
enrichment conditions after KLA activation is shown on the right. 
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Protein Adduction Assays 
 In order to gauge the effects of D-PUFAs on protein adduction in activated macrophages, 
a number of experiments were conducted using click methods to detect adducted proteins. In the 
first experiment, macrophages were enriched with 15 μM alkynyl linoleic acid (aLA), 15 μM 
11,11-D2-alkynyl linoleic acid (D2-aLA), or a 15 μM mixture of aLA and D2-aLA (7.5 μM each). 
Macrophages were treated with +/- KLA and pelleted, lysed, then ligated to N3-Biotin. Proteins 
were separated using SDS-PAGE and the gels were transferred to 0.45 μm nitrocellulose. The blots 
were probed with the appropriate antibodies and visualized using an Odyssey scanner. The results 
are shown below in Figure 12.  
 
 
 
Figure 12. Western blot for aLA vs D2-aLA comparison. Macrophages were plated and enriched 
with 15 μM aLA, 15 μM mixture of aLA and D2-aLA (7.5 μM each), or 15 μM D2-aLA. 
Macrophages were treated with +/- KLA. Lysates were ligated to N3-Biotin and visualized using 
streptavidin Western blotting. The histogram (right) shows a comparison of band intensity for 
the three alkynyl PUFA treatments. 
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 Decreases in protein adduction were observed in macrophages enriched with the mixture 
of aLA and D2-aLA as well as D2-aLA enrichment alone. A different approach was attempted in 
which macrophages were enriched with 15 μM aLA, a 15 μM mixture of aLA and D4-LA (7.5 μM 
aLA, 7.5 μM D4-LA), a 30 μM mixture of aLA and D4-LA (15 μM aLA, 15 μM D4-LA), or 15 μM 
D4-LA. Under these conditions, streptavidin Western blotting would only identify protein adducts 
arising from aLA peroxidation as deuterium reinforcement had been moved to D4-LA (which bears 
no alkynyl functionality). Clear decreases in protein adduction were observed in cells that had been 
enriched with the mixtures of aLA and D4-LA. A Western blot from this experiment that shows 
decreased protein adduction in the presence of D4-LA is presented in Figure 13. 
 
 
 
 
Figure 13. Click blots for aLA and D2-aLA enriched macrophages. Macrophages 
were enriched with 15 μM aLA, a 15 μM mixture of aLA and D4-LA (7.5 μM of 
each), a 30 μM mixture of aLA and D4-LA (15 μM of each), or 15 μM D4-LA and 
treated with +/- KLA. The histogram (right) compares band intensity after 
enrichment with aLA or either concentration of aLA and D4-LA 
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Prostaglandin Formation 
 Activation of RAW 264.7 macrophages by KLA induces the expression of COX-2, an 
enzyme that catalyzes the formation of prostaglandins. In order to assess the activity level of COX-
2, levels of PGE2 and PGD2 in the media were determined. Cells were plated and enriched with 15 
μM LA or 15 μM D4-LA. After the activation step (+/- KLA), 4 mL of media was collected from 
each plate. Media was delivered directly into a falcon tube holding 4 mL of ethyl acetate containing 
the internal standard D4-prostaglandin E2. The media was extracted, and the organic layer blown 
dry. Residue was resuspended in methanol and analyzed by LC-MS. The levels these 
prostaglandins, displayed in Figure 14, decreased significantly in macrophages treated with D4-
LA. 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Prostaglandin formation in macrophages enriched with either LA or 
D4-LA. After activation, prostaglandin levels were significantly lower in 
macrophages, which had been enriched with D4-LA. 
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Incorporation and Metabolism of D4-LA 
Evidence has been presented that RAW 264.7 macrophages enriched with D4-LA reduced 
levels of protein adduction as well as prostaglandin (PGE2) formation. The presence of D-PUFA 
appeared, however, to have no negative effect on expression of various elements of the TLR-4 
pathway (iNOS and COX-2). In order to better understand these observations, an understanding 
of the ultimate fate and the level of incorporation of D4-LA was sought. To carry out these 
experiments, macrophages were plated and enriched with 15 μM LA or 15 μM D4-LA and 
comparisons of the activated and unactivated macrophages were made. Macrophages were pelleted 
and lipids were extracted using Folch extraction. The lipid fraction was subjected to hydrolysis, 
and free fatty acids were analyzed by LC-MS using reverse-phase chromatography. 
LC-MS analysis was carried out in negative mode using an atmospheric-pressure chemical 
ionization (APCI) source. RAW 264.7 macrophages are able to synthesize longer chained PUFAs 
from LA and linolenic acid. Therefore, the molecular ions for LA and D4-LA were monitored, as 
were arachidonic acid (AA) and 13,13,17,17-D4-arachidonic acid (D4-AA). Selective reaction 
monitoring was used with a low voltage in the collision cell, monitoring the parent molecular ion 
in both Q1 and Q3 (279.2 -> 279.2 for LA, etc.). Heptadecanoic acid (C17:0) was used as an 
internal standard. A typical chromatagram is shown in Figure 15. 
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Figure 15. Typical HPLC-MS chromatogram for the analysis of D4-LA and D4-AA in 
unactivated RAW 264.7 macrophages. Aside from the four main fatty acids and internal 
standard, stearic acid (C18:0) is also observed in the 283 -> 283 panel.  
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Levels of LA, D4-LA, AA, and D4-AA were analyzed for both unactivated and activated 
macrophages. The histogram in Figure 16 shows the total PUFA profile ([LA + AA] for untreated 
macrophages, [LA + AA + D4-LA + D4-AA] for treated macrophages) divided into fractions of 
the four major species of interest for all four treatment conditions listed above. 
 
 
 
 
 
 
Analysis of HODEs and HETEs 
RAW 264.7 macrophages were enriched with 15 μM LA or 15 μM D4-LA and activated 
with KLA. After 24 h, the macrophages were pelleted, 13(S)-D4-HODE was added as an internal 
standard, and lipids were extracted using the Folch method. The lipid fraction was hydrolyzed and 
analyzed by LCMS using negative mode APCI and normal-phase chromatography. The products 
monitored included hydroxyoctadecadienoic acids (HODEs), and hydroxyeicosatetraenoic acids 
(HETEs), products which arise after PPh3 reduction of their hydroperoxide parents HpODEs and 
HpETEs, respectively. 
Figure 16. Total PUFA profiles for macrophages enriched with 15 μM LA or 15 μM 
D4-LA, both unactivated and activated. The table on the right presents the legend for 
the histogram as well as the observed levels of each PUFA monitored (in ng/mg 
protein). 
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The 13- and 9-HODEs were monitored using an established SRM technique that had been 
previously reported.75,46 Typical chromatograms are shown in Figure 17A (15 μM LA enrichment) 
and 17B (15 μM D4-LA enrichment).  
 
 
 Experiments were run in triplicate, and both D0-HODE and D3-HODE levels were 
monitored. As can be seen in the bottom two panels of Figure 16B, D3-HODEs are difficult to 
analyze. These products arise from oxidation of D4-LA, and previous work suggests that linoleic 
acid containing deuterium at the bis-allylic center undergoes autoxidation with a propagation rate 
constant roughly 10-fold slower compared to the natural compound.23 Thus, these D-HODE 
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Figure 17. Typical normal-phase HPLC-MS chromatograms monitoring HODE formation in 
RAW 264.7 macrophages after KLA activation. Enrichments were either A. 15 μM LA; or B. 15 
μM D4-LA.  
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products are formed in low yields. Data from all of the analyses is included throughout this chapter, 
but the amounts recorded for the D3-HODEs should be considered as the upper limit for these 
compounds that constitute only a minor fraction of products formed. Comparisons of the HODE 
distribution (both D0- and D3-HODEs) from LA and D4-LA enriched macrophages were obtained, 
and total HODEs were compared for each enrichment condition. Macrophages enriched with D4-
LA showed a significant decrease in HODE levels compared to LA enriched macrophages. Data 
from these analyses is shown in Figure 18. 
 
 
Figure 18. Analysis of HODEs from macrophages enriched with 15 μM LA or 15 μM D4-LA.      
A. Histograms show the distribution of D0-HODE regioisomers after LA enrichment (+ KLA), and 
D0-/D3-HODE regioisomers after D4-LA enrichment (+ KLA); B. Comparison of D0-HODE levels 
(left) and D0- + D3-HODE levels (right) after LA or D4-LA treatment and KLA activation. 
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HETEs were also analyzed at the same time. Specifically, the 5-, 11-, and 15-HETEs were 
monitored. Both 5-HETE and 15-HETE are considered to be good markers for peroxidation of 
arachidonic acid since peroxyl radicals formed at those centers (5-OO· and 15-OO·) are not able 
to undergo direct cyclization to give isoprostane-like products.76 The presence of 5-HETE and 15-
HETE were too low for consistent analysis, a result that is likely due to β-fragmentation of the 
peroxyl radical and readdition of oxygen to give the 9-peroxyl radical (9-OO·) or 11-peroxyl 
radical (11-OO·), leading ultimately to the formation of isoprostanes (IsoP’s).76 The 11-peroxyl 
radical (11-OO·) is able to form IsoP’s, but can also form 11-HETE after hydrogen atom donation 
if good donors are present. 11-HETE may also be formed through COX-2 activity (i.e. inefficient 
conversion of AA to PGE2).
2,61 A typical chromatogram for the analysis of 11-HETE and its D3-
11-HETE compounds is shown in Figure 19. 
  
Figure 19. Analysis of 11-HETE and D3-11-HETE after activation of macrophages enriched with 
15 μM D4-LA by normal-phase HPLC-MS. The peak in the panel analyzing D3-11-HETE is 
possibly an epoxide product. Its identity is speculative at this time as authentic standards are 
needed for confirmation. 15(S)-D8-HETE was used as the internal standard (bottom panel). 
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Analysis of HODEs and HETEs by Chiral Chromatography 
 Chiral analysis was carried out on HODE and HETE products to determine whether 
products observed were from free radical or enzymatic oxidation. Due to low levels of oxidation 
in D4-LA enriched macrophages, multiple plates of cells were combined  to gain an acceptable 
signal. The HODEs from LA and D4-LA oxidation were monitored, as well as the 15-, 11-, and 5-
HETEs. Determination of the enantiomers present in macrophage samples was completed by 
comparison to enantiopure standards for each compound. A more in depth discussion is presented 
in the following Discussion section. 
4.4. Discussion 
 Inflammation is a complex process that results in a wide array of physiological responses. 
Macrophages are often seen as the first line of defense against invading pathogens, recognizing 
lipopolysaccharide (LPS) or other pathogen-associated molecular patterns (PAMPs)  and initiating 
a coordinated oxidative response and the recruitment of other immune cells. One consequence of 
inflammation is lipid peroxidation in proximate areas to the assault, a process that can result in 
significant oxidative damage. Isotopically reinforced PUFAs have recently been shown to be 
resistant towards free radical autoxidation with propagation rate constants some 10-fold less than 
that of the natural PUFAs.23 The observed kinetic isotope effect arises due to the replacement of 
the reactive H-atoms located at bis-allyic methylene groups by deuterium. This demonstrated 
isotopic resistance to free radical oxidation stimulated the exploration of how D-PUFAs would 
affect inflammatory processes in vivo. Thus, RAW 264.7 macrophages enriched with D-PUFAs 
were studied to enquire how the inflammatory process was affected by their presence in these cells. 
 Our first experiments focused on the effect of D-PUFAs on protein adduction. Since D-
PUFAs are resistant to autoxidation, we hypothesized that lipid electrophile formation would be 
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reduced. The first experiments were carried out comparing protein adduction in macrophages 
which had been enriched with aLA, D2-aLA, or a mixture of both. The blots from this experiment, 
presented previously in Figure 12, show reduced protein adduction in macrophages treated with 
D2-aLA compared to aLA treated controls. A decrease in protein adduction was seen for the mixed 
treatment of aLA and D2-aLA as well. This experiment demonstrated that isotopic reinforcement 
of PUFAs does indeed lower protein adduction.  
 In followup experiments, mixtures of aLA and D4-LA were used for these studies. 
Macrophages were enriched with aLA at 15 μM or the mixture of aLA and D4-LA at total 
concentrations of either 15 μM (7.5 μM of each) or 30 μM (15 μM of each). Western blots from 
these experiments showed decreases in protein adduction for macrophages enriched with both 15 
μM and 30 μM of the aLA/D4-LA mixture (Figure 20). This suggests that the presence of D-
PUFAs lowers levels of lipid peroxidation within the macrophage during activation and results in 
decreased protein adduction. Furthermore, reduction in protein adduction for both concentrations 
of the aLA/D4-LA mixture shows that this decrease is not simply due to the effects of dilution of 
the aLA in the original treatment conditions. In other words, a decrease in protein adduction is 
seen regardless of the concentration of aLA present during enrichment. 
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Other experiments were carried out to investigate if expression levels and/or activity of 
proteins that are activated by the TLR-4 pathway were altered. The first set of experiments looked 
specifically at iNOS activity. iNOS is responsible for the production of nitric oxide, an important 
physiological messenger during immune response. Nitric oxide decomposes to nitrite (NO2
-), and 
the Griess assay is used to measure its levels in media. Sampling of media from macrophages 
subjected to different enrichment conditions showed that levels of nitrite, and thus the activity of 
iNOS, were not affected by the presence of D-PUFAs (presented previously in Figure 10). 
Similarly, COX-2 expression was found to decrease slightly after enrichment with LA as well as 
Figure 20. Comparison of protein adduction after KLA activation of RAW 264.7 
macrophages treated with aLA or mixtures of aLA and D2-aLA. The histogram 
(right) shows a comparison of band intensity from each enrichment condition. 
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D-PUFAs (Figure 21). However, expression levels between macrophages which had been enriched 
with any of the lipids showed no statistical difference. These data suggest that major signaling and 
response pathways associated with the TLR-4 cascade suffered no significant changes after 
macrophages were enriched with D-PUFAs. 
 
  
 
 
 
 
 
 
 
 
 
 
In order to better understand the metabolic fate of D-PUFAs, analysis of the PUFA profile 
of macrophages after enrichment with LA or D4-LA was carried out by LCMS. The results show 
that macrophages biosynthesize D4-AA from D4-LA, with deuterium atoms presumably at carbons 
C13 and C17. D-PUFAs as a whole were found to comprise 50-60% of the total PUFA content of 
the macrophage after enrichment with 15 μM D4-LA. Furthermore, D4-AA was the major D-PUFA 
present in both unactivated and activated macrophages comprising roughly 86% and 72% of the 
total D-PUFA present, respectively (see Results, Figure 16). 
Figure 21. COX-2 expression levels as determined by Western blotting. Blots were 
digitized using UN-SCAN-IT gel 6.1, and bands corresponding to COX-2 were 
quantified and normalized to the actin band. 
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By monitoring PGE2 levels in media, COX-2 activity was found to decrease 40-50% in 
macrophages that had been treated with D4-LA (see Results, Figure 14) even though COX-2 
expression levels were relatively unaffected by the presence of D-PUFAS (Figure 21). This 
suggests that the decrease in PGE2 formation must be the result of deuterium substitution in D4-
AA at C13. The first step in prostaglandin biosynthesis involves hydrogen atom abstraction at C13 
by the tyrosyl radical in the COX-2 active site,2 and isotopic substitution at that center is consistent 
with decreased PGE2 formation. Abstraction of deuterium at C13 apparently involves a significant 
isotope effect. 
Analysis of Linoleic Acid Oxidation Products (HODEs) 
 Analysis of LA and AA oxidation products derived from free radical oxidation (HODEs 
and HETEs) was also carried out to provide mechanistic insight. Oxidation products from activated 
macrophages were analyzed by LCMS using previously described methods.75,46 Analysis showed 
that the total level of D0-HODEs from LA oxidation were reduced by over 70% in D4-LA enriched 
macrophages, dropping to 70 ± 3 ng/mg protein compared to 247 ± 67 ng/mg protein in LA 
enriched macrophages. When including the D3-HODEs from D4-LA oxidation, total HODE levels 
still saw a significant drop to 94 ± 6 ng/mg protein (a roughly 60% reduction). This data is shown 
in Figure 22. 
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One possible explanation for the reduction in total D0-HODE levels in this study could be 
due to the fact that incorporation of D4-LA results in an overall reduction of LA levels in the 
macrophages. Indeed, LA levels after KLA activation in D4-LA enriched macrophages do decrease 
from roughly 23% to about 6% of the LA in the total PUFA pool (see Figure 16). To address this 
explanation, analysis of the data to determine the fraction of oxidation of the total LA can be done 
using Equation 1: 
 
[𝐷0−𝐻𝑂𝐷𝐸]
[𝐿𝐴]
= 𝑂𝑥𝑖𝑑𝑖𝑧𝑒𝑑 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑜𝑓 𝐿𝐴   ( 1 ) 
 
Figure 22. Comparison of D0-HODEs (left) and D0- + D3-HODEs (right) from 
LA and D4-LA treated macrophages. 
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Using Equation 1, the fraction of oxidized LA was calculated to be unchanged when 
macrophages were treated with D4-LA. This data, along with the concentration of LA for each 
enrichment condition are shown below in Figure 23. 
 
 According to these data, D0-HODE formation was unchanged after enrichment with D4-
LA. However, D4-LA treatment results in a roughly 69% decrease in the total endogenous LA in 
the macrophages.  The drop in LA is accounted for by the incorporation of D4-LA. Our 
observations suggest that ‘total LA’ levels, or [LA] + [D4-LA], in macrophages enriched with 15 
μM D4-LA are similar to LA levels in macrophages after enrichment with 15 μM LA (Figure 24). 
  
 
Figure 23. Data showing the concentration of LA (ng/mg protein) (left) and the oxidized fraction 
of LA (right), calculated using Equation 1, for KLA activated RAW 264.7 macrophages enriched 
with 15 μM LA or 15 μM D4-LA. The table gives absolute values for these data points. 
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The oxidized fraction of total LA was calculated using Equation 2: 
 
[𝐷0−𝐻𝑂𝐷𝐸+𝐷3−𝐻𝑂𝐷𝐸]
[𝐿𝐴+𝐷4−𝐿𝐴]
= 𝑂𝑥𝑖𝑑𝑖𝑧𝑒𝑑 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑜𝑓 𝑇𝑜𝑡𝑎𝑙 𝐿𝐴 ( 2 ) 
 
Taking into account the total LA present, including the natural and deuterated forms, the oxidized 
fraction (D0-HODEs + D3-HODEs) of the total LA measured in the macrophages enriched with 
15 μM D4-LA is significantly decreased in comparison to LA enriched macrophages.  
The distribution of HODEs between the four isomers also provides valuable insight into 
how peroxidation is affected after D4-LA enrichment (Table 1). In macrophages enriched with LA 
the trans,cis-HODEs are formed preferrentially over the trans,trans-HODEs. The 9-trans,cis-
HODE dominates the mixture. The same trend in HODE distribution is seen in macrophages 
Figure 24. Data showing the concentration of total LA ([LA] + [D4-LA], ng/mg protein) (left) and 
the oxidized fraction of total LA (right), calculated using Equation 2, for KLA activated RAW 
264.7 macrophages enriched with 15 μM LA or 15 μM D4-LA. The table gives absolute values for 
these data points. 
178 
 
treated with D4-LA. Solution oxidations of LA at high concentrations give the 9- and 13-HODE 
regioisomers in more comparable amounts. A similar distortion in the HODE distribution has been 
noted previously during the autoxidation of 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine 
(PLPC) in liposomes. At high concentrations of PLPC (0.5 M) the trans,cis- to trans,trans-HODE 
ratio (0.70) was found to favor the trans,cis-HODE products. In this instance, the asymmetrical 
product distribution was attributed to different local environments for the 9- and 13-peroxyl 
radicals.46  
 
 
An additional complication to the interpretation of the macrophage HODE data is the fact 
that COX-2 can convert LA into 9-trans,cis-HODE, providing another explanation for the 
asymmetrical product distribution. When LA is the substrate taken into the COX-2 active site, the 
expected product resulting from enzymatic activity is the 9-(R)-HODE based on the enzyme 
mechanism for hydrogen atom abstraction at the bis-allylic carbon (C11).77,78,79 In order to 
understand whether or not COX-2 was a contributing factor in the preference for 9-trans,cis-
HODE formation, the enantiomeric purity of the HODE products was analyzed using chiral 
chromatography mass spectrometry. The 9-trans,cis-HODE was of particular interest due to its 
prevalence HODE mixtures from both LA and D4-LA enriched macrophages. In macrophages 
enriched with D4-LA, the 9-(R)-HODE was found to be preferred by 4 to 1 over the 9-(S)-HODE 
Table 1. Distribution of HODEs after free radical oxidation of linoleic acid in solution, and in 
activated RAW 264.7 macrophages following enrichment with LA or D4-LA. 
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(Figure 25).  This observation is consistent with the notion that roughly two-thirds of the 9-HODE 
product is formed enzymatically via the COX pathway, with the remainder of this product being 
formed by a non-enzymatic free radical mechanism. 
  
  
Chromatograms of lipid metabolite extracts from LA enriched macrophages were more 
complex than those from D4-LA enriched macrophages and this complexity makes analysis of the 
optical purity of lipid metabolites formed in these incubations difficult. LA supplemented 
macrophages are subjected to a much more oxidative environment than D4-LA enriched cells. The 
presence of D-PUFA lowers levels of peroxidation significantly, gives a clean chromatogram of 
LA oxidation products and allows for the enzymatic oxidation profile of LA to be observed. 
Figure 25. Analysis of D0-9-trans,cis-HODE to determine enantiomeric distribution (R vs. S) in 
activated macrophages after enrichment with 15 μM D4-LA. The HPLC-MS chromatograms on 
the left show enantiopure standards for 9-(R)-trans,cis-HODE, 9-(S)-trans,cis-HODE, and D0-9-
trans,cis-HODE extracted from the macrophages.  
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Analysis of Arachidonic Acid Oxidation Products (HETEs) 
 11-HETE was found to be the major hydroxyeicosatetraenoic acid product formed and 
efforts were focused on the analysis and quantitation of D0- and D3-11-HETEs. The levels of 11-
HETE were reduced significantly after enrichment with D4-LA, and calculation of the percentage 
of oxidation of the entire AA pool ([AA + D4-AA]) showed once again that this decrease in HETE 
formation was not purely due to dilution of AA by the presence of D4-AA (Figure 26). 
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Analysis of HETEs on a chiral column was carried out to determine the optical purity of 
the products formed during macrophage activation. RAW 264.7 macrophages were enriched with 
LA or D4-AA and the 5-, 11-, and 15-D0-HETEs were analyzed. Chromatograms from the LCMS 
analysis of metabolites from D4-LA enriched macrophages are presented below in Figure 27.  
 
 
Again the chromatograms of lipid metabolite extracts from LA enriched macrophages were 
of lower quality than macrophages enriched with D4-LA, likely due to the reasons mentioned 
previously. In macrophages enriched with D4-LA the 15-D0-HETE is found largely in the S-
configuration, with small amounts of R-enantiomer falling in the shoulder of the peak. The 11-D0-
HETE is found in primarily the R-configuration as expected from COX-2 activity. The 5-D0-HETE 
shows a modest preference for the S-enantiomer over the R-enantiomer. The formation of 15(S)-
Figure 27. Analysis of 5-, 11-, and 15-D0-HETEs to determine enantiomeric distribution (R vs S) 
in activated macrophages after enrichment with 15 μM D4-LA. Analysis was carried out using 
chiral chromatography and HPLC-MS. 
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D0-HETE and 11(R)-D0-HETE suggests that enrichment of macrophages with D4-LA (and 
subsequent metabolism to D4-AA) has no negative effect on COX-2 activity with respect to the 
formation of the expected HETE enantiomers. It does however lower total levels of HETEs (Figure 
26) and PGE2 (Figure 14 in Results). 
4.5. Conclusions 
 Incorporation of D-PUFAs into several cellular systems and animal disease models has 
shown that these compounds have the ability to alleviate oxidative stress. Physical data on the fate 
of these D-PUFAs, including oxidation products, has not previously been reported in biological 
systems. The studies herein offer an in depth look at D-PUFA interactions in macrophages where 
an inflammatory response is easily induced by KLA. 
 The D4-LA is rapidly taken up by the macrophages and metabolized to D4-AA, both of 
which comprise 50-60% of the total LA and AA pools depending on activation state of the 
macrophage. The presence of these D-PUFAs significantly reduces lipid peroxidation as evidenced 
by the reduction in HODE levels. Furthermore, the percent oxidation of the total LA pool is 
significantly reduced which suggests that D-PUFAs are responsible for the reduction in lipid 
peroxidation as opposed to merely diluting the oxidizable substrates to give the appearance of 
reduced lipid peroxidation. Enrichment with D4-LA also resulted in significant reductions in  
protein adduction by lipid electrophiles as seen in Western blots. Finally, significant cellular 
functions associated with the TLR-4 pathway are not negatively affected. Nitric oxide formation 
was unaffected by the presence of D-PUFAs, meaning that its expression was not negatively 
affected. In the same way, COX-2 expression was unaffected by D-PUFA supplementation. 
Despite normal expression levels, the production of PGs was significantly reduced, as were levels 
of 11-HETE. 
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 The data presented in this chapter suggests that D4-LA and other D-PUFAs may be 
excellent candidates as small molecules that can reduce oxidative stress in systems where chronic 
inflammation exists while allowing normal cellular processes to operate as usual. This suggests 
that levels of systematic inflammation may be reduced by the presence of these D-PUFAs, 
reducing the need for treatments using selective COX-2 inhibitors which are commonly associated 
with a number of undesirable side effects,80,81 and by providing protection from free radical 
oxidation in diseases where free radical damage is heavily associated with progression such as 
Friedreich’s ataxia and Parkinson’s disease. 
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4.7. Experimental 
Materials 
 All reagents were obtained from Sigma-Aldrich, St. Louis, MO, unless otherwise noted. 
Natural fatty acids and internal standards were purchased from Cayman Chemical, Ann Arbor, MI. 
Alkynyl linoleic acid (aLA) was synthesized as previously described.82 Deuterated fatty acids were 
provided by Retrotope, Inc., Los Altos, CA. 100 mM stock solutions of PUFAs (natural, alkynyl, 
and deuterated) in ethanol were made prior to experiments and stored at -80 ˚C.  RAW 264.7 
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macrophages were obtained from American Type Culture Collection (ATCC), Manassas, VA. 
Invitrogen Dulbecco’s Modified Eagle Media - GlutaMAX (DMEM+GlutaMAX) was purchased 
from ThermoFiscer Scientific, Waltham, MA. Fetal bovine serum (FBS) was purchased from Atlas 
Biologicals, Fort Collins, CO. 
Mass Spectrometry 
PGE2 was analyzed according to a previously published method.
83 HODE and HETE 
analysis was also carried out according to the literature.46, 75 Analysis of R and S distribution for 
HODEs and HETEs was carried out using the same mass spectrometry settings identical to that of 
HODE and HETE analysis. Chromatography was carried out on a Chiracel AD-H column (250 x 
4.6 mm, 5 μm, 1.0 mL/min, elution solvent: 3% ethanol, 0.1% acetic acid in hexanes). Free fatty 
acids were separated on a Discovery C18 column (150 x 2.1 mm, 5 μm, 0.2 mL/min, elution 
solvent: 0.1% acetic acid in methanol). 
RAW 264.7 Culture 
 RAW 264.7 macrophages were plated at 1 x 106 cells in 8 mL of DMEM+GlutaMAX and 
10% FBS in 100 mm plates or 3.5 x 106 cells in 20 mL of DMEM+GlutaMAX and 10% FBS in 
150 mm plates. Macrophages were incubated for 24 h at 37 ˚C. The old media was removed. 
DMEM+GlutaMAX and 10% FBS containing desired concentration of alkynyl, deuterated, or 
natural PUFA was added to each plate. After incubation for 24 h, the old media was removed and 
DMEM+GlutaMAX +/- Kdo2-Lipid A (100 ng/mL) was added. After a final incubation for 24 h, 
cells were scraped into fresh media and pelleted at 1000 rpm for 5 min. 100 μL of a BHT and PPh3 
solution (10 mg BHT and 25 mg PPh3 in 10 mL ethanol) was immediately added to the cell pellet. 
Pellets were stored at -80 ˚C until further analysis. 
Biotin Conjugation and Western Blotting 
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 Cells were lysed in 1 mL lysis buffer (1% IGEPAL + 50 mM HEPEs + 100 mM NaCl + 
0.5% PIC). Debris were pelleted at 16000g at 4 ˚C for 10 min. The supernatant was transferred to 
a new microcentrifuge tube and NaBH4 (5 mM in H2O) was added. Samples were turned end over 
end for 1 h at room temperature. Reduction was quenched by the addition of 10 μL of acetone. 50 
μL of streptavidin beads were added to each sample, again turning end over end for 2 hr at room 
temperature. Beads were pelleted at 100g for 1 min. Supernatant was transferred to a new 
microcentrifuge tube. A bicinchoninic acid assay (BCA assay) was performed to determine total 
protein concentration of each sample. Samples were diluted accordingly to 240 μL total volume 
with water togive a final protein concentration of 0.5 μg/μL. 
 Stock solutions of 100 mM TCEP, 100 mM CuSO4, 10 mM TBTA, and 20 mM N3-Biotin 
were made, and 2.5 μL of each was added to each sample, resulting in a final sample volume of 
250 μL and 1 mM TCEP, 1 mM CuSO4, 0.1 mM TBTA and 0.2 mM N3-Biotin. Samples were 
turned end over at room temperature overnight. Samples were then diluted 1:1 with 95:5 
Laemli:BME loading buffer and boiled for 10 min.  
 Samples were then loaded on 4-20% Biorad gel with 4 μL (4 μg protein) loaded to each 
lane. Gels were run at 140V until completion. The gel was transferred to a 0.45 μM nitrocellulose 
membrane at 100V for 1 hr. The membrane was then rocked in Odyssey blocking buffer for 30 
min at room temperature. The membrane was then rocked in 5 mL enhancced Odyssey blocking 
buffer (10 μL Tween 20, 10 μL SDS) with Actin (goat, 1:500) and SAIRDye 800 CW (streptavidin, 
1:5000) at 4 ˚C overnight. Blots were washed with TBST (3 x 5 min.) at room temperature. 
Membrane was then rocked in 5 mL enhanced Odyssey blocking buffer containing 2˚ antibody 
(donkey anti-goat IRDie 680LT, 1:5000) for 45 min. at room temperature. Blot was again washed 
with TBST (3 x 5 min.) and scanned on Odyssey scanner. 
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Analysis of Free Fatty Acids and Lipid Metabolites 
 After treatment and activation, cells were scraped and pelleted according to the procedure 
outlined above. Excess media was removed. 100 μL of a solution containing BHT and PPh3 (10 
mg and 25 mg, respectively, in 10 mL EtOH) was added immediately. 100 μL of 17:0 standard 
(10 μg/mL) and 40 μL D8-15(S)-HETE (10 μg/mL) were added. Cells were taken up in 2 mL 5% 
HCl (aq.) and extracted with 3 mL Folch solvent (2:1 CHCl3/MeOH with 50 mg/L BHT). The 
organic layer was collected, blown dry, and resuspended in methanol (1 mL). 3M LiOH (1 mL) 
was added, after which samples were incubated at 37 ˚C for 1 hr. Samples were acidified with con 
HCl and extracted with 1 mL of 4:1 ethyl acetate:CHCl3. The organic layer was blown dry. 
Samples were stored at -80 ˚C until analysis. 
Griess Assay 
 In order to assess iNOS activity, nitrite (NO2
-) present in the media after activation was 
quantified using the Griess assay. Macrophages were plated according to the ‘RAW 264.7 
Macrophage Culture’ section above and enriched with 15 μM LA, 8-D2-LA, or D4-LA. Unenriched 
controls were also plated. After +/- KLA treatment, 1 mL of media was removed from each plate. 
100 μL of each media sample was dispensed in a 96-well plate. 50 μL of sulfanilamide solution 
(10 mg/mL in aqueous 5% phosphoric acid) was added to each well. The plate was allowed to 
develop for 10 minutes in the dark at room temperature. 50 μL of NED solution (N-1-
napthylethylenediamine dihydrocholride in water, 1 mg/mL) was then added to each well. The 
plate was again developed at room temperature in the dark for 20 minutes. After incubation, 
absorbance of each well was measured using a plate reader at 550 nm. Absorbance values were 
plotted against a nitrite standard reference curve which was plated and exposed to Griess reagents 
at the same time. 
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Cyclooxygenase-2 Expression 
 Macrophages from the Griess Assay were collected and lysed according to the ‘RAW 264.7 
Macrophage Culture’ section. A BCA assay was run to determine protein concentration, and 
samples were diluted to 4 mg protein/mL in water (100 μL total volume). Samples were diluted 
1:1 in Laemli:BME (95:5) loading buffer and boiled for 10 min. Samples were then loaded onto a 
4-20% precast gel, with 15 μL (7.5 mg total protein) into each well. Gels were run at 150V until 
completion, followed by transfer to 0.45 μM nitrocellulose membrane at 100V for 1 hr. Blots were 
rocked in Odyssey blocking buffer for 1.5 hr at room temperature, followed by rocking in 5 mL of 
1:1 TBST:Odyssey blocking buffer with 10 μL SDS, COX-2 antibody (1:1000) and actin (goat, 
1:2500) overnight at 4 ˚C. 
 Blots were washed with TBST (2 x 15 min) at room temperature, then rocked in 5 mL of 
1:1 TBST:Odyssey blocking buffer with 10 μL SDS and donkey anti-rabbit IR Dye 680LT 
(1:5000) and donkey anti-goat 800CW (1:5000) for 1 hr at room temperature. Blots were once 
again washed in TBST (2 x 15 min) and scanned using the Odyssey scanner. 
Prostaglandin Formation 
 In order to assess the activity level of COX-2, levels of PGE2 in the media were determined. 
Macrophages were plated according to the ‘RAW 264.7 Macrophage Culture’ section and enriched 
with 15 μM LA or 15 μM D4-LA. After the activation step (+/- KLA), 4 mL of media was collected 
from each plate. Media was delivered directly into a falcon tube holding 4 mL of ethyl acetate 
containing the internal standard D4-prostaglandin E2. The media was extracted, and the organic 
layer blown dry. Residue was resuspended in methanol and analyzed by LC-MS. 
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